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ABSTRACT OF THE DISSERTATION 
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by 
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Professor Nasim Annabi, Chair 
 
Bioadhesives, such as tissue sealants, hemostatic agents, and tissue sealants have gained increasing 
popularity for addressing wound management for traumatic and surgical injuries. This new 
generation of adhesive demonstrates significant advantages over traditional suturing and stapling 
techniques that can lead to infection, leakage of bodily fluid and gas, as well as secondary damage 
to tissues. Bioadhesives can be most broadly classified based on internal or external administration. 
While bioadhesives designed for external use are most widely used for topical application, such as 
wound closure, internal bioadhesives are surgically implanted and, therefore, require 
biocompatibility and strong adhesive ability to wet tissues. Further, hydrogel-based bioadhesives 
may be designed with nanoparticles or biopolymers that impart specific functionality, such as 
conductive or hemostatic properties. Scaffolds designed with conductive biomaterials have been 
extensively investigated in the field of tissue engineering based on their ability to support the 
function of excitable cell types, such as cardiomyocytes and neurons. Bioadhesives have also been 
designed to promote hemostasis for applications such as surgical sealants. In first two sections of 
this project, we aimed to develop conductive bioadhesives for cardiac tissue repair by combining 
highly biocompatible gelatin methacryloyl (GelMA), with an electrically conductive choline-
 iii 
based bio ionic liquid (Bio-IL). Here, we chemically modified gelatin to form photocrosslinkable 
hydrogels in the presence of visible or UV light, depending on the photoinitiator used. Conductive 
hydrogels were fabricated with varying concentrations of GelMA and Bio-IL, which resulted in 
scaffolds with high biocompatibility, as well as tunable electrical conductivity, and mechanical 
strength. We then demonstrated the ability of Bio-IL conjugated hydrogels to transduce 
physicochemical stimuli and modulate the growth of primary CMs in both 2D and 3D cultures in 
vitro. In addition, we demonstrated that the engineered hydrogels were highly biodegradable and 
biocompatible in vitro, and that they did not elicit inflammatory responses when implanted in vivo. 
Our following project investigated the development of cardiopatches using electrospun GelMA 
conjugated with Bio-IL. The resulting cardiopatches demonstrated tunable conductive and 
mechanical properties by optimizing the concentration of GelMA and Bio-IL used during 
synthesis. GelMA/Bio-IL cardiopatches exhibited excellent adhesiveness to cardiac tissues, and 
biocompatibility both in vitro and in vivo. CMs and CFs seeded on the surface of cardiopatches 
demonstrated excellent cell attachment and proliferation, and the scaffold supported the expression 
of gap junction proteins indicating the cells ability to function synchronously. Taken together, 
these conductive bioadhesives demonstrated excellent potential to be readily tailored to cardiac 
tissue regenerative therapies. Lastly, our group developed a hemostatic surgical sealant with robust 
mechanical properties based on the biopolymers GelMA and elastin-like polypeptide (ELP). These 
adhesive hydrogels were rendered hemostatic by the incorporation of the synthetic clay Laponite 
(LA) and were rapidly photocrosslinked in the presence of UV radiation using the photoinitiator 
Irgacure 2959. We demonstrated the highly tunable mechanical and adhesive properties of these 
nanocomposite hydrogels by varying the concentrations of GelMA and ELP. Likewise, we 
demonstrated the excellent hemostatic performance of these scaffolds both in vitro and in vivo by 
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varying the concentration of LA. Our nanocomposite GelMA/ELP/LA hydrogels also showed 
remarkable biocompatibility both in vitro and in vivo and did not elicit an inflammatory response 
when implanted subcutaneously. 
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List of Figures 
Figure 1: Synthesis and applications of ECHs. Conductive materials including conductive nanoparticles 
(a), conductive polymers (b), or ionic liquids (c) are incorporated into hydrogel precursors to form ECHs 
with high electrical conductivity. ECHs are becoming increasingly useful for many biomedical applications, 
including biosensors (d), drug delivery systems (e), and tissue engineering (f) 
 
Figure 2. Synthesis and applications of ECHs formed by using conductive NPs. Schematic for the 
formation of alginate hydrogels and gold nanowires (NW)-alginate ECHs. Cardiomyocytes are cultured in 
alginate hydrogels formed small clusters and beated asynchronously. However, cardiomyocytes cultured in 
alginate-NW ECHs formed organized cardiac-like tissue and beat synchronously. Components of 
engineered cardiac tissue are shown: cardiac cells (red), alginate pore walls (blue), NW (yellow) (a). 
Current/Potential graph of alginate hydrogels and alginate-NW ECHs showing higher electrical 
conductivity exhibited by the ECHs (b). Hematoxylin and eosin (H&E) staining images based on in vitro 
studies showed thick tissue in the NW-alginate ECHs (ci, cii), whereas the samples containing pure alginate 
showed non-continuous tissue separated by pore walls (di, dii). [1], Copyright 2011. Synthesis of ECHs by 
coating graphene oxide (GO) with methacryloyl-substituted tropoelastin (MeTro) (e). Elastic modulus of 
MeTro hydrogels and MeTro/GO ECHs demonstrating that the addition of GO significantly increases the 
elastic modulus (f). Torsion test on MeTro hydrogel and MeTro/GO ECH was conducted by twisting 
scaffolds for multiple rounds. Significant deformation was observed in MeTro hydrogel, however, 
MeTro/GO ECHs did not display any deformation (g). The overall impedance of MeTro hydrogels, 
MeTro/GO ECHs, and MeTro/reduced GO (rGO) ECHs shows that electrical resistance was the lowest for 
ECHs fabricated with rGO (h). [2], Copyright 2016. Schematic for the fabrication of CNT-embedded 
GelMA ECHs using dielectrophoresis force to align CNTs in GelMA. Highly aligned CNTs were observed 
in under 1 min, and the GelMA prepolymer was photocrosslinked using UV light (i). Young’s modulus of 
GelMA hydrogels, and ECHs containing GelMA and both randomly arranged and aligned CNTs. Results 
showed that the alignment of CNTs in GelMA-based ECHs resulted in a stiffer material as compared to 
ECHs fabricated with randomly dispersed CNTs (j). Electrical evaluation of these ECHs demonstrated that 
the incorporation of CNTs into hydrogels resulted in lower impedance compared to pristine GelMA 
hydrogels. Further the conductivity of these ECHs could be finely tuned by adjusting the concentration of 
CNTs in the system (k). [3], Copyright 2016. Scale bar= 200 µm (ci, di), 20 µm (cii, dii). 
 
Figure 3. Structure and physical properties of ECHs formed by using conductive polymers. In vivo 
antibacterial activity test using hydrogels formed with carboxymethyl chitosan (CMCS-Odex), quaternized 
chitosan (QCS40-Odex), and quaternized chitosan with 3% (w/v) polyaniline (PANi). Oxidized dextran 
(Odex) was used as a crosslinker to form these ECHs. Results showed that engineered PANi-incorporated 
ECHs exhibited high antimicrobial properties (a). PANi-incorporated ECHs also exhibited high electrical 
conductivity (b). These ECHs demonstrated increased C2C12 cell proliferation with an increasing 
concentration of PANi, after 3 days of culture (c). [4], Copyright 2015. ECH developed by crosslinking 
polypyrrole (PPy) with hyaluronic acid (HA). Mechanical testing of HA-based ECHs with varying 
concentrations of PPy demonstrated that higher concentrations of PPy results in higher elastic modulus (d). 
In addition, higher concentrations of PPy increased electrical conductivity up to samples containing 50 mM 
(e). Plot of the number of attached 3T3 cells seeded on the surface of HA-based ECHs containing 50 mM 
PPy. These results showed that HA/PPy ECHs supported cell adhesion and the proliferation of 3T3 cells 
 x 
up to 5 days (f). [5], Copyright 2016. Schematic for the synthesis of ECHs by adding PEDOT (red) and 
PEG (blue) to the surface of an electrode. Biorecognition molecules (purple) are added into the gel by 
attaching to -COOH groups of PEDOT. Capture of B-IFN-g molecules (red dot) resulted in a change in the 
electrical signal of the ECH (g). Assessment of the mechanical properties of PEG hydrogels, as well as 
PEDOT and PEDOT/PEG ECHs. Here the results showed that by adding PEDOT to PEG did not 
significantly change the elastic modulus compared to pure PEG hydrogels (h). However, the addition of 
PEDOT resulted in a significant increase in electrical conductivity (i), which is necessary for application in 
the field of biosensors. [6], Copyright 2016.  
 
Figure 4. Electrospinning microfabrication technique is a simple method for generating fibrous 
scaffolds that are suitable for many applications including tissue engineering, biosensors, and drug 
delivery systems. Schematic for an electrospinning set up consists of a polymer dissolved in solvent being 
injected out of a metal nozzle (a). A high voltage power supply is connected to a metal nozzle and a metal 
collector creating an electrical field. A polymeric solution is then slowly pumped out of the syringe and 
spun onto the metal collector. Representative SEM image of a blend electrospun PELA/CNT fibrous 
scaffold with a 5% CNT concentration showing high alignment of fibers and 2 µm fiber diameter (b). 
Mechanical study of electrospun PELA/CNTs demonstrated that ECHs fabricated with higher 
concentrations of CNTs resulted in a higher Young’s modulus (c). Electrical evaluation of electrospun 
ECHs showed that these fibrous scaffolds exhibited higher conductivity when fabricated with a higher 
concentration of CNTs in both blended and coaxial electrospun PELA/CNT scaffolds (d). Beating rate of 
CMs when seeded on PELA/CNT fibrous scaffolds and cultured for 10 days. The beating rate for ECHs 
coaxially electrospun with a 5% CNT concentration (C5) achieved an average beating rate of 70-80 
times/min, which is similar to that rate of CMs seeded on other non-conductive hydrogels (e). [7], Copyright 
2016. 
 
Figure 5. 3D printing of conductive hydrogels for different biomedical applications. Pressure sensors 
were fabricated by 3D printing a conductive self-healing (CSH) hydrogel composed of PPy-grafted chitosan 
and poly(acrylic acid), and coating them with a thin layer of PDMS (a). When applied to the wrist, the 
sensor could detect blood flow pulses in the veins below the skin in real-time (b) (Adapted from [8]). 
Hydrogel prepolymer solution containing sodium alginate, gold nanorods, and GelMA was bioprinted via 
a co-axial nozzle, in which the alginate prepolymer solution in the core was crosslinked by calcium ions 
flown in the sheath (c). Lattice-like structures could be printed, and hydration was maintained by the 
continuous flow of the aqueous sheath solution. Cardiomyocytes printed in these structures expressed 
higher levels of Cxn43 cardiac junction protein and exhibited higher contraction rates compared to controls 
(d) (Adapted from [9]). 
 
Figure 6. Micropatterning and self-assembling of ECHs for different biomedical applications. 
Schematic of GelMA-GNR ECHs that were photocrosslinked in the presence of UV light in a microgrooved 
PDMS mold. The resulting ECH was seeded with CMs, which aligned within the microgrooves (a). 
Live/dead assay performed using CMs seeded on pure GelMA hydrogels (b) and GelMA-GNR ECHs (c). 
Live cells were stained in green, while dead CMs were stained in red, confirming high cell viability after 7 
days of cell culture (adapted from [10]). Schematic of supramolecular organic-inorganic composite capable 
of self-healing via interactions between oligomer chains (pink lines) with micro nickel and urea groups 
(blue and purple shapes) (d). Representative stress-strain curves for ECHs containing 31% micro nickel 
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volume ratio under different healing conditions showing that healing efficiency was found to be a function 
of time (e) (adapted from [11]). Schematic of composite ECHs constructed with partially reduced GO using 
polydopamine, crosslinked with polyacrylamide (f) (adapted from [12]). Scale bars= 100 µm (b, c). 
 
Figure 7. ECHs for tissue engineering applications. The addition of electrically conductive materials 
(red circles) can be used to provide conductive properties to intrinsically insulating hydrogels (a). These 
ECHs could be used to deliver relevant biophysical stimuli to cardiomyocytes in vitro, such as mechanical 
and biological cues, or electrical stimulation/pacing. These maturation cues have been shown to trigger 
phenotypical changes that ultimately lead to fully mature and functional cardiomyocytes. ECHs have been 
used to develop conductive nerve conduits as an alternative to nerve autografts for nerve regeneration and 
repair (adapted from [13]) (b). ECHs could provide physiological stimuli that mimic native nerve tissues 
and induce the differentiation of progenitor cell types to neural lineages (adapted from [14]) (c). ECHs 
deliver biomimetic topographical and electrical cues in vitro to form highly oriented cellular constructs 
with tissue-level functionality (adapted from [10]) (d). Scale bars= 100 µm (d upper image), 20 µm (d 
lower image). 
 
Figure 8. Synthesis and characterization of Bio-IL functionalized GelMA hydrogels. The panels show 
schematics of the proposed reactions for (a) the acrylation of choline bicarbonate to form Bio-IL, and (b) 
the reaction between GelMA and Bio-IL in the presence of Eosin Y and visible light to form GelMA/Bio-
IL hydrogel. 1H-NMR analysis of (c) Bio-IL prepolymer, (d) GelMA prepolymer, and (e) GelMA/Bio-IL 
composite hydrogel. GelMA/Bio-IL hydrogels were formed by using 1% VC, 1.5% TEOA, and 0.1 mM 
Eosin Y at 120 s light exposure. 
 
Figure 9. Electrical conductivity of the engineered polymer/Bio-IL hydrogels crosslinked by visible 
light. (a) Experimental set-up of the two-probe electrical station used to measure the electrical conductivity 
of the engineered hydrogels. Conductivity measurements of Bio-IL conjugated (b) GelMA and (c) PEGDA 
hydrogels at different polymer concentrations and polymer/Bio-IL ratios (1% VC, 1.5% TEOA, 0.1 mM 
Eosin Y, and 120 s exposure to visible light were used to form GelMA and PEGDA hydrogels). (d) 
Electrical conductivity of 15% GelMA/Bio-IL composite hydrogels at 50/50 ratio, which was stretched up 
to 0%, 20%, 30%, and 40% strain level demonstrating no significant changes in conductivity after 
stretching. (e) Schematic of ex vivo experiments performed using rat abdominal muscle tissues, connected 
using 15% final polymer concentration and 50/50 GelMA/Bio-IL ratio, and pure GelMA hydrogels (f) 
Threshold voltages at which contraction was achieved using 15% final polymer concentration GelMA/Bio-
IL at 50/50 and 20/80 ratios, as well as pure 15% GelMA hydrogels. Error bars indicate standard error of 
the means, asterisks mark significance levels of p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***). 
 
Figure 10. Mechanical properties of Bio-IL conjugated GelMA and PEGDA hydrogels crosslinked 
with visible light. Compressive moduli for (a) GelMA/Bio-IL and (b) PEGDA/Bio-IL hydrogels 
engineered by varying polymer concentration and polymer/Bio-IL ratios. Elastic moduli for (c) 
GelMA/Bio-IL and (d) PEGDA/Bio-IL hydrogels with varying polymer concentration and polymer/Bio-
IL ratios (1% VC, 1.5% TEOA, 0.1 mM Eosin Y, and 120 s light exposure were used to form GelMA and 
PEGDA hydrogels). Error bars indicate standard error of the means, asterisks mark significance levels of p 
< 0.05 (*), p < 0.01 (**), and p < 0.001 (***). 
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Figure 11. Ultimate stress and ultimate strain of Bio-IL functionalized GelMA and PEGDA hydrogel 
crosslinked with visible light. Ultimate strain values for (a) GelMA/Bio-IL and (b) PEGDA/Bio-IL 
hydrogels engineered by varying polymer concentration and polymer/Bio-IL ratios. Ultimate stress for (c) 
GelMA/Bio-IL and (d) PEGDA/Bio-IL hydrogels with varying polymer concentration and polymer/Bio-
IL ratios (1% VC, 1.5% TEOA, 0.1 mM Eosin Y, and 120 s light exposure were used to form GelMA and 
PEGDA hydrogels). Error bars indicate standard error of the means, asterisks mark significance levels of p 
< 0.05 (*), p < 0.01 (**), and p < 0.001 (***). 
 
Figure 12. Pore characteristics, in vitro swelling, and degradation of polymer/Bio-IL hydrogels 
Representative SEM images of (a) GelMA/Bio-IL and (b) PEGDA/Bio-IL hydrogels formed by using 
100/0 and 50/50 polymer/Bio-IL ratio at 15% (w/v) polymer concentration (1% VC, 1.5% TEOA, and 0.1 
mM Eosin Y at 120 s light exposure were used to form the hydrogels).  Average pore sizes of (c) 
GelMA/Bio-IL and (d) PEGDA/Bio-IL hydrogels at varying polymer concentrations and polymer/Bio-IL 
ratios. Swelling ratios of (e) GelMA/Bio-IL and (f) PEGDA/Bio-IL hydrogels at 15% final polymer 
concentration and 50/50 polymer/Bio-IL ratio in DPBS after 4, 8 and 24 h. Degradation of (g) GelMA/Bio-
IL and (h) PEGDA/Bio-IL hydrogels at 15% final polymer concentration and 50/50 polymer/Bio-IL ratio 
in DPBS supplemented with 10% FBS over a two-week period. Error bars indicate standard error of the 
means, asterisks mark significance levels of p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***). 
 
Figure 13. 2D in vitro studies using GelMA/Bio-IL hydrogels seeded with CMs. Representative 
live/dead images from CMs cultured on (a) GelMA (control) and (b) GelMA/Bio-IL hydrogels on days 1 
and 5 (scale bar = 200 μm). Representative F-Actin/DAPI stained images from CMs seeded on (c) GelMA 
and (d) GelMA/Bio-IL on days 1 and 5. (e) Cell viability quantification of CMs cultured on the hydrogels 
after 1, 3, and 5 days of culture. (f) Quantification of metabolic activity, RFU (relative fluorescence 
intensity) using PrestoBlue assay, 1, 3, and 5 days after seeding with CMs. Immunofluorescent staining of 
sarcomeric α-actinin in CMs seeded on GelMA (g) and GelMA/Bio-IL (h) hydrogels on day 7 (scale bar = 
25 μm). (i) Characterization of synchronous contraction in CMs seeded on GelMA and GelMA/Bio-IL 
hydrogels over 7 days of culture. (*p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001). 
 
Figure 14. In vitro 3D cell encapsulation of cardiomyocytes (CMs) and cardiac fibroblasts (CFs) in 
GelMA/Bio-IL hydrogels. CMs and CFs (2:1 ratio) were 3D encapsulated inside visible light-crosslinked 
GelMA (control) and GelMA/Bio-IL hydrogels. Representative live/dead images from CMs/CFs 
encapsulated in GelMA hydrogels (a, b) and GelMA/Bio-IL (c, d) at days 1 and 7 post-encapsulation. 
Representative F-Actin/DAPI fluorescent images of CMs/CFs encapsulated in GelMA (e, f) and 
GelMA/Bio-IL (g, h) hydrogels, at days 1 and 7 post-encapsulation (scale bar = 200 μm). (i) Quantification 
of cell viability for 3D-encapsulated CMs/CFs at days 1, 4, and 7 post-encapsulation. (j) Quantification of 
metabolic activity, RFU (relative fluorescence intensity) using PrestoBlue assay, at days 1, 3, and 5 post-
encapsulation. (k) Quantification of cell proliferation based on DAPI-stained cell nuclei, at days 1, 4, and 
7 post-encapsulation. (l) Characterization of synchronous contraction in co-cultures of CMs/CFs 3D-
encapsulated in GelMA (control) and GelMA/Bio-IL hydrogels over 7 days of culture. (*p < 0.05, **p < 
0.01, ***p < 0.001 and ****p < 0.0001). All hydrogels were synthesized using 15% (w/v) final polymer 
concentration and 50/50 polymer/Bio-IL ratio. Error bars indicate standard error of the means, asterisks 
mark significance levels of p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***). 
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Figure 15. In vivo biodegradation and biocompatibility of GelMA/Bio-IL composite hydrogel using a 
rat subcutaneous model. (a, b) Evaluation of the in vivo degradation of GelMA/Bio-IL on days 0, 4, 14 
and 28 post implantation (n = 4). (a) In vivo degradation of GelMA/Bio-IL hydrogels based on weight loss 
of the implants. The in vivo degradation profile of GelMA/Bio-IL hydrogels exhibits an approximately 
linear behavior during 28 days after implantation. (b) Images of the GelMA/Bio-IL composite hydrogels at 
0, 4, 14, and 28 days after implantation. (c-e) Hematoxylin and eosin (H&E) staining of GelMA/Bio-IL 
sections after (c) 4 days, (d) 14 days, and (e) 28 days of implantation (scale bars = 500 µm). The H&E 
shows a negligible amount of inflammatory cells. (f-h) Fluorescent immunohistochemical analysis of 
subcutaneously implanted GelMA/Bio-IL hydrogels showing no significant local lymphocyte infiltration 
(CD3) at days (f) 4, (g) 14 and (h) 28 (scale bars = 200 µm), are exhibiting remarkable macrophages (CD68) 
only at day (i) 4 but significantly disappeared at days (j) 14 and (k) 28 (scale bars = 200 µm). Green, red 
and blue colors in (f-k) represent the GelMA/Bio-IL hydrogels, the immune cells, and the cell nuclei 
(DAPI). 1% VC, 1.5% TEOA, and 0.1 mM Eosin Y at 120 s light exposure were used to form the hydrogels. 
All hydrogels were synthesized using 15% final polymer concentration and 50/50 polymer/Bio-IL ratio. 
 
Figure 16. Synthesis and physical properties of engineered cardiac patches. a) Schematic of the 
fabrication of GelMA/Bio-IL cardiopatches using HFIP to prepare a prepolymer solution with GelMA. 
Representative SEM images of GelMA/Bio-IL cardiopatches fabricated with a b) 0, and c) 33 %(v/v) 
concentration of Bio-IL. d) The electrical conductivity of cardiac patches fabricated with varying 
concentrations Bio-IL. e) The electroconductive properties of cardiopatches after incubation in DPBS at 37 
°C for 2 and 4 d show no significant change in conductivity during biodegradation. The f) swelling ratio 
and g) degradation rate of cardiopatches following incubation in DPBS at 37 °C. h) The elastic modulus of 
cardiopatches increased when fabricated with higher concentrations of GelMA, and with higher 
concentrations of Bio-IL. Error bars indicate standard error of the means, asterisks mark significance levels 
of p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***). 
 
Figure 17. Mechanical properties of cardiac patches. a) The ultimate strain and b) ultimate stress 
exhibited by GelMA/Bio-IL cardiopatches. Error bars indicate standard error of the means, asterisks mark 
significance levels of p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***). 
 
Figure 18. Strong adhesion of cardiac patches to heart tissue, and propagation of electrical signals 
through patches to stimulate excitable cell types. a) Representative image demonstrating the high 
adhesion of cardiac patches to cardiac tissues. b) H&E staining of cardiac patch on rat cardiac tissue. c) 
Experimental setup of wound closure adhesion test using Instron 5944 mechanical tester conducted with 
excised rat cardiac tissue. d) Results showed that the adhesion to cardiac tissue significantly increased when 
cardiac patches were fabricated with a higher concentration of Bio-IL. e) Experimental setup of the burst 
pressure analysis conducted on the explanted heart of Wistar rats. f) There was no significant difference 
between the burst pressures of a healthy heart, and the heart containing a physical defect supported with 
GelMA/Bio-IL cardiac patches. g) Schematic of experimental designed used to investigate the propagation 
of electrical impulses across cardiac patches to stimulate explanted muscle tissue. h) Conductive patches 
fabricated with a 100% (v/v) Bio-IL concentration exhibited a lower threshold voltage to excite muscle 
tissue when compared with patches fabricated with 33% (v/v) Bio-IL concentration. Error bars indicate 
standard error of the means, asterisks mark significance levels of p < 0.05 (*), p < 0.01 (**), and p < 0.001 
(***). 
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Figure 19. Characterization of the adhesion to wet tissues of cardiac patches. a) Schematic of wound 
closure test on cardiac patches using porcine skin. b) Patches displayed an increasing adhesion strength to 
porcine skin when fabricated with increasing concentration of Bio-IL. Additionally, these GelMA/Bio-IL 
cardiac patches showed a significantly higher adhesion strength when compared with commercially 
available tissue sealants, such as CoSEAL, and Evicel. c) Schematic of burst pressure set up to evaluate 
adhesion properties of cardiac patches on porcine intestinal tissues. d) Similarly, these patches exhibited an 
increasing burst pressure strength when fabricated with an increasing concentration of Bio-IL. The burst 
pressure strength of GelMA/Bio-IL cardiac patches was also greater than CoSEAL, and Evicel. Error bars 
indicate standard error of the means, asterisks mark significance levels of p < 0.05 (*), p < 0.01 (**), and p 
< 0.001 (***). 
 
Figure 20. 2D co-culture of cardiomyocytes (CMs) and cardiac fibroblasts (CFs) on electrospun 
GelMA/Bio-IL patches. The in vitro cytocompatibility of the engineered patches was evaluated using 2D 
co-cultures of freshly isolated CMs and CFs (ratio 2:1) growing at different concentrations of Bio-IL (i.e., 
0%, 33%, 66%, and 100% (v/v)). a) Representative Live/Dead images of CMs/CFs growing on 0% and 
66% Bio-IL (v/v) at day 7 post-seeding. b) Representative actin/DAPI images of CMs/CFs growing on 0% 
and 66% Bio-IL (v/v) at day 7 post-seeding. Bar graphs showing the quantification of c) cell viability, d) 
cell density, and e) metabolic activity of 2D co-cultures of CMs/CFs at days 1, 4, and 7 post-seeding, 
growing at different concentrations of Bio-IL (i.e., 0%, 33%, 66%, and 100% (v/v)). Representative 
immunofluorescent images of CMs/CFs at day 7 post-seeding growing on the surface of f) 0%, and g) 66% 
Bio-IL (v/v) patches (green: sarcomeric α-actinin, red: connexin 43, blue: DAPI). h) Characterization of 
the beating frequency (beats/min) of CMs/CFs throughout 7 days of culture growing at different 
concentrations of Bio-IL (i.e., 0%, 33%, 66%, and 100% (v/v)). Quantification of the relative levels of 
expression (i.e., intensity of fluorescence) of i) connexin 43, and j) sarcomeric α-actinin in co-cultures of 
CMs/CFs at day 7 post-seeding. 
 
Figure 21. In vivo investigation of GelMA/Bio-IL cardiac patches using a murine model of MI via 
permanent ligation of LAD coronary artery. a) Murine in vivo surgical procedure required cutting the 
skin on the left side of the chest exposing the left ventricle of the heart. Permanent ligation of the LAD 
coronary artery was performed. Three groups including a control (no treatment), GelMA patch, and b) 
GelMA/Bio-IL patch was used to treat infarction directly below the site of ligation. c) UV-irradiation was 
used for 300 s to crosslink cardiac patch and provide adhesion to wet tissue. d,e) Following 21 days post 
implantation, rats were sacrificed and their hearts were removed for histological evaluation. Representative 
images of Masson’s trichrome, sarcomeric-a actinin, and connexin 43 histological analysis for f) control, 
g) GelMA patch, and h) GelMA/Bio-IL patch groups. 
 
Figure 22. Synthesis and characterization of nanocomposite hydrogels. Gelatin methacryloyl (GelMA) 
(a), elastin-like polypeptide (ELP) (b), and Laponite (LA) (c) were utilized to engineer hemostatic 
hydrogels with high elasticity for application as a surgical sealant for lung tissue. (d) Schematic for the 
fabrication of these nanocomposite hydrogels by photocrosslinking prepolymer solutions in the presence 
of Irgacure 2959 and UV irradiation for 180 s. (e) The engineered hemostatic surgical sealants may be used 
to properly seal lung tissue following the removal of a section of tissue. 
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Figure 23. Mechanical characterization of hemostatic and highly elastic hydrogels for applications as 
surgical sealants for soft tissues. Elastic moduli for hydrogels containing (a) varying concentrations of 
GelMA and ELP, as well as for (b) hemostatic hydrogels containing 10% GelMA, 10% ELP, and varying 
concentrations of LA. Ultimate strain for hydrogels containing (c) varying concentrations of GelMA and 
ELP, as well as for (d) hemostatic hydrogels containing 10% GelMA, 10% ELP, and varying concentrations 
of LA. Compressive moduli for hydrogels containing (e) varying concentrations of GelMA and ELP, as 
well as for (f) hemostatic hydrogels containing varying concentrations of LA. Error bars indicate standard 
error of the means, asterisks mark significance levels of p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), and p 
< 0.0001 (****). 
 
Figure 24. In vitro swelling behavior and degradation rates of hemostatic and highly elastic hydrogels 
for applications as lung tissue sealants. Swelling ratios of highly elastic hydrogels containing (a) 10% 
GelMA and varying concentrations of ELP, as well as (b) 10% GelMA/10% ELP and varying 
concentrations of LA. Results showed that the addition of ELP into the hydrogels led to less water uptake 
due to the presence of hydrophobic elastin motifs. Degradation rates of elastic hydrogels containing (c) 
10% GelMA and varying concentrations of ELP, as well as (d) nanocomposite hydrogels containing 10% 
GelMA/10% ELP and varying concentrations of LA. Our results show that the addition of ELP significantly 
slowed down the degradation of the engineered hydrogels after 28 d. 
 
Figure 25. In vitro sealing properties of hemostatic hydrogel for application as a lung tissue sealant. 
(a) Schematic for the modified standard test method to determine adhesion strength (ASTM F2458-05) of 
GelMA/ELP/LA nanocomposite hydrogels. Adhesion strength for (b) elastic hydrogels containing varying 
concentrations of both GelMA and ELP, as well as for (c) nanocomposite hydrogels containing 10% 
GelMA/10% ELP and varying concentrations of LA. (d) Schematic of a standard lap shear test (ASTM 
F2255-05) to determine the shear strength of GelMA/ELP/LA nanocomposite hydrogels. Shear stress of 
(e) elastic hydrogels containing varying concentrations of GelMA and ELP, as well as (f) nanocomposite 
hydrogels containing 10% GelMA/10% ELP and varying concentrations of LA. (g) Schematic for the 
standard burst pressure test (ASTM F2392-04) to determine the burst pressure for GelMA/ELP/LA 
hydrogels. (h) Burst pressure for elastic hydrogels containing varying concentrations of both GelMA and 
ELP using collagen sheets as a substrate. (i) Burst pressure for nanocomposite hydrogels fabricated with 
10% GelMA/10% ELP and varying concentrations of LA. Error bars indicate standard error of the means, 
asterisks mark significance levels of p < 0.05 (*), and p < 0.01 (**). 
 
Figure 26. In vitro evaluation of LA on the clotting of whole blood. (a) Clot formation as a function of 
time and composition of hemostatic lung tissue sealants. (b) Quantitative clot time for whole blood added 
to nanocomposite hydrogels. (c) Quantitative clot mass measured at 14 mins following the addition of 
whole blood to hydrogels fabricated with 10% GelMA/10% ELP and varying concentrations of LA. Error 
bars indicate standard error of the means, asterisks mark significance levels of p < 0.01 (**), p < 0.001 
(***), and p < 0.0001 (****).  
 
Figure 27. In vitro cytocompatibility evaluation of GelMA/ELP/LA hydrogels. Representative 
live/dead images of human lung fibroblast cells (hLFCs) seeded on the surface of (a) GelMA, (b) 
GelMA/ELP, and (c) GelMA/ELP/LA hydrogels after 1 day post-seeding. Representative live/dead images 
of hLFCs seeded on the surface of (d) GelMA, (e) GelMA/ELP, and (f) GelMA/ELP/LA after 5 days post-
seeding. Representative phalloidin (green)/DAPI (blue) stained images from hLFCs seeded on (g) GelMA, 
(h) GelMA/ELP, and (i) GelMA/ELP/LA after 1 day post-seeding. Representative phalloidin/DAPI images 
of hLFCs seeded on (j) GelMA, (k) GelMA/ELP, and (l) GelMA/ELP/LA after 5 days post seeding. (m) 
Quantification of cell viability for hLFCs seeded on the surface of engineered hydrogels at days 1, 4, and 7 
post-seeding. (n) Quantification of cell proliferation based on DAPI-stained cell nuclei at days 1, 4, and 7 
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post-seeding. (o) Quantification of metabolic activity, relative fluorescence units (RFU), using a PrestoBlue 
assay at days 1, 4, and 7 post seeding. 
 
Figure 28. In vivo biodegradation and biocompatibility of nanocomposite GelMA/ELP/LA hydrogels 
using a rat subcutaneous implantation model. (a) Representative images of GelMA, GelMA/ELP, and 
GelMA/ELP/LA hydrogels before implantation (day 0), and on days 7, 28, and 56 post-implantation. (b) 
In vivo biodegradation of the engineered hydrogels on days 0, 7, 28, and 56 post-implantation, based on 
weight loss of the implant (n=4). Hematoxylin and eosin (H&E) staining of 20 %(w/v) GelMA hydrogel 
sections (hydrogels with the surrounding tissue) after (c) 7, (d) 28, and (e) 56 days of implantation (scale 
bar = 200 µm). H&E staining of GelMA/ELP 10/10 %(w/v) hydrogel sections after (f) 7, (g), 28 and (h) 56 
days implantation. H&E staining of GelMA/ELP/LA 10/10/2 %(w/v) hydrogel sections after (i) 7, (j), 28, 
and (k) 56 days post implantation. Hydrogels were formed using 0.5% Irgacure 2959 and 180 s UV 
exposure time. 
 
Figure 29. In vivo evaluation of nanocomposite hydrogels as hemostats using a rat liver bleeding 
model. (a) Schematic of engineered hydrogel placement onto a lethal liver wound. Representative images 
of (b) Surgicel hemostatic patch and (c) GelMA/ELP/LA nanocomposite hydrogels being used to accelerate 
blood clotting in a rat in vivo liver bleeding model. (d) Quantification of in vivo blood loss after application 
of GelMA/ELP/LA nanocomposite hydrogels shows significant improvement compared to treatment with 
GelMA hydrogels or Surgicel hemostatic patch. Error bars indicate standard error of the means, asterisks 
mark significance levels of p < 0.0001 (****). 
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Introduction 
Hydrogels are three dimensional (3D) networks of hydrophilic polymeric networks that 
can be formed through different mechanisms such as physical entanglement, electrostatic 
interactions, or covalent chemical crosslinking[15]. Hydrogels are remarkably suitable for a wide 
range of applications such as drug delivery, tissue engineering, and soft electronics for biomedical 
devices, due to their high hydration, tunable physical properties, and porous architecture[16, 17]. 
These characteristics also enable the diffusion of biomolecules, oxygen, and metabolic waste 
across the 3D structure of hydrogels, which is an important trait for substrates used in the 
physiological context[18, 19]. Hydrogels can also be tuned to mimic biochemical, mechanical, and 
topographical cues from the native extracellular matrix (ECM), in order to modulate physiological 
responses in cells and tissues[20]. Therefore, several naturally-derived and synthetic-based 
polymers, as well as various fabrication methods have been reported for the design and 
manufacture of hydrogels with different physicochemical properties[21, 22]. These polymers may 
be used individually or in combination with other polymers to yield composite hydrogels with 
increased functionality. Moreover, hydrogels may be further modified through the incorporation 
of chemical or biological active moieties such as growth factors, cell binding and protease-
sensitive sites, or other stimuli-responsive molecules to promote their functions[23]. Although 
hydrogels have been demonstrated to be highly versatile platforms for different biomedical 
applications, their insulating nature often limits their potential for the modulation of electrically-
sensitive cells and tissues such as cardiac and neural tissues[24]. 
In recent years, the development of advanced biomaterials and chemistries combined with 
micro- and nanotechnologies have improved the ability to control the properties and functionality 
of hydrogels for a wide range of applications (Figure 1)[20]. For instance, the incorporation of 
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inherently conductive materials to hydrogels via blending, doping or chemical modification have 
led to the development of new class of electroconductive hydrogels (ECHs)[25]. ECHs are 
composite biomaterials that combine the electroconductive capabilities of different materials with 
the intrinsic properties of crosslinked hydrogel networks[26]. Several strategies for the synthesis 
of ECHs have been reported such as the incorporation of conductive polymers (CPs) (e.g. 
polyaniline (PANi), polypyrrole (PPy), polythiophene (PTh), and poly(3,4-
ethylenedioxythiophene) (PEDOT)) within a hydrogel network[26-30]. The organic nature of CPs 
greatly facilitates their chemical modification to incorporate different bioactive functional motifs 
into ECHs and provide them with high conductivity and processability[25]. ECHs can also be 
engineered by the in situ reduction of metal ions within the polymer network to form metallic 
nanoparticles (NPs)[31]. In this regard, different types of NPs have been used for the engineering 
of nanocomposite ECHs with tunable electrical, mechanical and optical properties[32]. For 
example, the incorporation of one dimensional carbon nanotubes (CNTs) and two dimensional 
(2D) graphene has been shown to impart high electrical conductivity and increased mechanical 
strength to hydrogels[33]. In addition, our group has recently demonstrated the engineering of 
ECHs with intrinsic electrical conductivity through the functionalization of different hydrogels 
with a choline-based bio-ionic liquid (Bio-IL)[34]. This diverse range of synthesis methodologies 
has led to the development of ECHs with distinct physical and biochemical properties, which offer 
unique advantages for different biomedical applications, such as tissue engineering, drug delivery, 
and engineering biosensors and medical devices[27]. Strategies for designing these therapeutic and 
diagnostic ECH-based technologies often includes electrical characteristics biomimetic to that of 
the native tissue (Table 1).  
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Figure 1: Synthesis and applications of ECHs. Conductive materials including conductive 
nanoparticles (a), conductive polymers (b), or ionic liquids (c) are incorporated into hydrogel 
precursors to form ECHs with high electrical conductivity. ECHs are becoming increasingly useful 
for many biomedical applications, including biosensors (d), drug delivery systems (e), and tissue 
engineering (f). 
 
Previous studies have demonstrated the ability of ECHs to mediate the adhesion, proliferation, 
migration, and differentiation of different cell types including cardiomyocytes (CMs), neurons, 
fibroblasts, endothelial cells, human mesenchymal stem cells (hMSCs), and preosteoblasts[35]. In 
addition, recent advances in hydrogel synthesis and fabrication techniques have led to the 
engineering of multifunctional ECHs that are able to sense and respond to different 
physicochemical stimuli[25]. This new class of smart ECHs have been increasingly used for a 
variety of applications, ranging from stimulating and recording electrodes, tissue engineered 
constructs, and electrically controlled drug release devices and biosensors[27]. Furthermore, the 
development of advanced microengineering techniques have allowed the accurate recapitulation 
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of the complex microarchitectural features of physiological tissues[36]. In this regard, different 
patterning and templating approaches have been used to fabricate micro-scale structures of ECHs 
using a broad range of biocompatible and biodegradable materials[37]. With the advent of 
microengineering techniques such as 3D printing, electrospinning, and other lithography-based 
approaches, it is possible to exert precise control over the composition, geometry, and spatial 
arrangement of cells and biomolecules within ECHs. This unprecedented degree of customization 
holds remarkable potential for the engineering of smart interfaces and biomimetic scaffolds for 
fundamental research and clinical applications. 
 
Table 1. ECHs can be tailored to mimic the electrical properties of native tissues when used for 
cardiac and neural tissue engineering. 
Native Tissue Conductivity (S/cm) Reference 
Myocardium (transversely) 0.0016 [38, 39] 
Myocardium (longitudinally) 5 ´ 10-5 [38, 39] 
Brain 0.0015 – 0.0030 [40] 
 
Here, we review all major biomaterials used for the synthesis of ECHs. We describe the 
most significant conductive materials incorporated into hydrogels to impart electroconductivity. 
Furthermore, while recent review articles have detailed different fabrication strategies to form 
hydrogels with specific architectures[41-43], here we review the the advanced microfabrication 
technique of electrospinning, which is utilized in the fabrication of ECHs for biomedical 
applications. 
1.   CRITICAL LITERATURE REVIEW 
In this section, we first review the different conductive biomaterials that have been used to 
develop ECHs. These conductive biomaterials have unique advantages and disadvantages to their 
application, as well as expected conductivity ranges for these systems (Table 2). We then review 
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the process of electrospinning and what the advantages and limitations are for implementing this 
technique to form cardiac patches.      
1.1. Biomaterials used to impart electroconductivity to hydrogels 
1.1.1. Gold nanoparticles 
Metallic NPs are colloids ranging from 1 to 100 nanometers in size featuring a high surface 
area-to-volume ratio[44], which exhibit chemical and physical properties much different from that 
of bulk metals[45]. Gold NPs (AuNPs) and silver NPs (AgNPs) are of particular interest to 
engineer ECHs for applications requiring electroactive properties. In recent years, AuNPs have 
gained significant interest due to their unique conductive[46], optical[47-49], and magnetic 
properties[50, 51]. These characteristics have been shown to be particularly advantageous for the 
development of biosensors[52], and drug delivery systems[53], as well as various tissue 
engineering applications[54]. Apart from their ease of synthesis, their  high stability[55] and 
biocompatibility[48-50], and tunable properties of AuNPs by varying their structural size and 
shape make them attractive candidates for the  synthesis of ECHs for biomedical applications. 
Some of the drawbacks of incorporating AuNPs into ECHs is their tendency to generate reactive 
oxygen species (ROS). ROS are oxygen-derived small molecules that are naturally produced 
endogenously from several sources including through cellular respiration in the mitochondria and 
from an incomplete reduction of oxygen and NADPH in the plasma membrane[56]. At moderate 
concentrations, ROS play critical roles in the regulation of cell function, such as cell growth, 
migration, or apoptosis, however, high concentrations of these molecules can result in damage of 
proteins, lipids, and DNA potentially leading to diseases and necrosis[57, 58]. Recently, ECHs 
have been designed that incorporate AuNPs for the purpose of generating high concentrations of 
ROS in order to eradicate diseased cells[59, 60]. However, when developing ECHs for 
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regeneration of damaged tissues, it is important to note that due to their small size, AuNPs are 
capable of penetrating cell membranes and cause cellular dysfunction. Therefore, significant 
efforts have been conducted to determine the ideal size and shape of AuNPs, and to optimize their 
in vivo pharmacokinetics for therapeutic and clinical applications[61]. 
Investigations involving tissue regenerative strategies have utilized AuNPs owing to their 
enhanced electrical properties, which may be imparted to scaffolds and provide adequate coupling 
between adjacent cells[62]. ECHs formed based on AuNPs have been used for cardiac, bone, and 
nerve tissue engineering, due to their biocompatibility, high mechanical strength, and 
conductivity[63, 64]. GelMA is a photocrosslinkable biopolymer that has been widely used for 
tissue engineering applications as it is capable of supporting cell adhesion due to the presence of 
Arg-Gly-Asp (RGD) motifs[65]. A recent study conducted by Navaei et al. demonstrated the 
effectiveness of gold nanorods (GNRs) embedded in GelMA hydrogels to develop cardiac tissue 
constructs[50]. Hydrogels containing a larger concentration of GNRs showed lower electrical 
impedance, compared with control samples containing GelMA only. This lower impedance 
reflected the high electrical conductivity of hybrid hydrogels embedded with GNR, which in turn 
facilitated electrical propagation and promotes CM coupling[50]. The incorporation of GNRs also 
had a significant effect on the swelling ratio and the porosity of the hydrogels, which are key in 
the ability of a hydrogel to mediate nutrient and gas exchange[50, 66]. Furthermore, in vitro studies 
demonstrated that CMs seeded on the surface of GNR-embedded ECHs exhibited homogeneous 
distributions, as compared to control hydrogels without GNRs. Gold nanowires (GNWs) have also 
been incorporated into polymeric scaffolds for the synthesis of ECHs for tissue engineering 
applications. For instance, Dvir et al. reported the addition of GNWs to alginate scaffolds, to 
improve electrical communication between cells for engineering functional cardiac patches 
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(Figure 2a)[67]. By incorporating GNWs, these conductive scaffolds demonstrated increased 
electrical conductivity, enhancing the function of cardiac tissue constructs (Figure 2b). CMs and 
fibroblasts were also seeded onto scaffolds under static and electrically stimulated conditions 
before implantation. Hematoxylin and eosin staining revealed better-aligned CMs within GNW 
embedded scaffolds after 8 days of culture (Figure 2c), compared to a pure alginate matrix (Figure 
2d)[67]. These results demonstrated the potential of GNW-loaded hydrogels in tissue engineering, 
for the development of materials that modulate excitable cells. 
AuNPs have been used to engineer ECHs for a wide range of biomedical applications 
including biosensing, bioimaging, and tissue engineering owing to their high electrical 
conductivity, unique optical properties, low inherent toxicity, and large surface area. These 
properties make AuNPs a useful tool as recognition elements for detection of specific biological 
analytes. AuNP-incorporated ECHs have also been used to develop drug delivery systems with the 
capability to trigger the release of loaded molecules. Further, these versatile biomaterials have 
demonstrated the ability to improve cell-cell coupling in ECHs developed for cardiac and neural 
tissue engineering. However, challenges still exist in the fabrication of AuNP-incorporated ECHs 
for biomedical applications. For instance, while widely considered to be noncytotoxic, their slow 
rate of clearance from the physiological environment needs to be considered when designing 
implantable ECHs containing AuNPs. In addition, the preparation of AuNPs is time consuming 
and costly, and multistep reactions may result in cytotoxicity. Another consideration is that AuNPs 
tend to aggregate together during synthesis of ECHs due to their large surface area. Nevertheless, 
AuNP-incorporated ECHs have shown promise to be successfully developed into tomorrow’s 
therapeutic and diagnostic innovations. 
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Figure 2. Synthesis and applications of ECHs formed by using conductive NPs. Schematic for 
the formation of alginate hydrogels and gold nanowires (NW)-alginate ECHs. Cardiomyocytes are 
cultured in alginate hydrogels formed small clusters and beated asynchronously. However, 
cardiomyocytes cultured in alginate-NW ECHs formed organized cardiac-like tissue and beat 
synchronously. Components of engineered cardiac tissue are shown: cardiac cells (red), alginate 
pore walls (blue), NW (yellow) (a). Current/Potential graph of alginate hydrogels and alginate-
NW ECHs showing higher electrical conductivity exhibited by the ECHs (b). Hematoxylin and 
eosin (H&E) staining images based on in vitro studies showed thick tissue in the NW-alginate 
ECHs (ci, cii), whereas the samples containing pure alginate showed non-continuous tissue 
separated by pore walls (di, dii). [1], Copyright 2011. Synthesis of ECHs by coating graphene 
oxide (GO) with methacryloyl-substituted tropoelastin (MeTro) (e). Elastic modulus of MeTro 
hydrogels and MeTro/GO ECHs demonstrating that the addition of GO significantly increases the 
elastic modulus (f). Torsion test on MeTro hydrogel and MeTro/GO ECH was conducted by 
twisting scaffolds for multiple rounds. Significant deformation was observed in MeTro hydrogel, 
however, MeTro/GO ECHs did not display any deformation (g). Overall impedance of MeTro 
hydrogels, MeTro/GO ECHs, and MeTro/reduced GO (rGO) ECHs shows that electrical resistance 
was the lowest for ECHs fabricated with rGO (h). [2], Copyright 2016. Schematic for the 
fabrication of CNT-embedded GelMA ECHs using dielectrophoresis force to align CNTs in 
GelMA. Highly aligned CNTs were observed in under 1 min, and the GelMA prepolymer was 
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photocrosslinked using UV light (i). Young’s modulus of GelMA hydrogels, and ECHs containing 
GelMA and both randomly arranged and aligned CNTs. Results showed that the alignment of 
CNTs in GelMA-based ECHs resulted in a stiffer material as compared to ECHs fabricated with 
randomly dispersed CNTs (j). Electrical evaluation of these ECHs demonstrated that the 
incorporation of CNTs into hydrogels resulted in lower impedance compared to pristine GelMA 
hydrogels. Further the conductivity of these ECHs could be finely tuned by adjusting the 
concentration of CNTs in the system (k). [3], Copyright 2016. Scale bar= 200 µm (ci, di), 20 µm 
(cii, dii). 
 
Table 2. Advantages and disadvantages of the incorporation of common conductive biomaterials to 
form ECHs and the conductivity of these systems.  
 
Conductive 
materials 
Advantages Disadvantages Conductivity 
(S/cm) 
Refs 
AuNPs/ 
polymer 
• Tunable conductivity 
• Generally biocompatible 
• AuNP cytotoxicity is not fully 
understood 
• Synthesis of AuNPs may be 
difficult depending on target 
particle size 
• Possible generation of ROS 
8.0 ´ 10-4 – 
1.0 ´ 10-2 
[46-
49, 68, 
69] 
AgNPs/ 
polymer 
• High conductivity 
• Highly antibacterial 
• AgNPs increase brittleness of ECH  
• Possible generation of ROS 
1.0 ´ 10-4 – 
5.8 ´ 10-1 
[70-
76] 
Graphene/ 
polymer 
• High conductivity 
• Robust mechanical 
strength 
• Generally biocompatible 
• Complicated fabrication method for 
GO 
• rGO frequently aggregates during 
ECH synthesis 
• Cytotoxicity of GO, rGO is not 
fully understood 
4.0 ´ 10-5 – 
5.8 ´ 10-1 
[2, 77-
80] 
CNTs/ 
polymer 
• High conductivity 
• Robust mechanical 
strength 
• CNTs frequently show aggregation 
during ECH synthesis 
• CNTs increase brittleness of ECHs 
• Cytotoxicity not fully understood 
5.0 ´ 10-5 – 
9.0 
[3, 79, 
81, 
82] 
PANi/ 
polymer 
• Facile synthesis 
• Antimicrobial 
• Highly conductive 
• Facilitates cell 
proliferation 
• Fabrication requires harsh chemical 
environment 
5.0 ´ 10-4 – 
1.2 ´ 10-2 
[27, 
83, 
84] 
PPy/ 
polymer 
• Facile synthesis 
• Biocompatible 
• Environmentally Stable 
• Poor solubility in polar solvents 
• Poor mechanical strength, brittle 
1.2 ´ 10-3 – 
1.2 ´ 102 
[4, 85-
87] 
PEDOT/ 
polymer 
• High conductivity • Poor mechanical strength, brittle 
• Cytotoxicity not fully understood 
6.7 ´ 10-4 – 
1.0 ´ 10-1 
[88-
92] 
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• Facilitates cell 
proliferation 
• Biocompatible 
• High stability 
Bio-IL/ 
polymer 
• High conductivity 
• Biocompatible 
• Variable cytotoxicity 1.4 ´ 10-4 – 
1.0 ´ 10-2 
[34, 
93-96] 
 
1.1.2. Silver nanoparticles 
AgNPs have also been used in combination with several types of polymers and biomaterials 
to engineer ECHs with enhanced electrical conductivity, as well as antimicrobial properties. The 
ability to eliminate bacteria in the clinical setting is the main driving force behind the success of 
AgNPs in the biomedical field. The antimicrobial properties of AgNPs are mainly due to the 
oligodynamic effect, a biocidal effect characterized by the binding of small metal ions to reactive 
groups, which results in the denaturing of cellular proteins in bacteria[97]. AgNPs are highly active 
against many types of gram-positive and gram-negative bacteria, including antibiotic-resistant 
bacterial strains[72, 73, 97-99]. However, similar to AuNPs, AgNPs have the potential to generate 
ROS that are capable of damaging protein, lipids, and DNA [100]. Therefore, it is necessary to 
determine cytotoxic effects of ECHs fabricated with AgNPs. 
Recently, AgNPs have also been incorporated into ECHs to impart electrical conductivity 
into these systems. The combination of antimicrobial and conductive properties makes AgNPs an 
attractive material for use in biomedical applications such as wound and burn dressings[101], 
coatings for surgical instruments[102], and biosensors[103]. In addition, AgNPs have also been 
used in a wide variety of industrial applications related to commercial sanitization, including areas 
of food packaging, textiles, plastics, soaps, and water treatment[104].  
The incorporation of AgNPs into polymeric networks can influence the mechanical and swelling 
properties of ECHs. Previous studies have reported that the addition of AgNPs to 
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polyvinylpyrrolidone (PVP) and polyvinylalcohol (PVA) hydrogels led to increased mechanical 
stiffness[74].  
Like AgNPs, silver nanowires (AgNWs) are another type of biocompatible material that 
have been used to develop ECHs for flexible bioelectronics. Recently, Ahn et al. developed an 
ECH by incorporating AgNW-based microelectrodes into a PAM-based hydrogel using a 
photolithographic process[105]. These materials displayed excellent electrical properties, where 
the conductivity could be accurately tuned by controlling the AgNW width, and spin coating 
speed[105]. Further, they possessed robust mechanical properties and excellent flexibility 
necessary for use with biological tissues. This study described a process to develop AgNW-based 
ECHs that are promising materials for use as flexible bioelectronic devices. 
While incorporation of AgNPs and AgNWs into hydrogels is a noteworthy strategy to 
engineer ECHs, progress of these systems tailored for biomedical applications has been slow 
compared that of AuNPs. Most of the research involving AgNPs is greatly interested with their 
antimicrobial properties. None the less, AgNPs have been found to possess excellent conductive 
and optical properties, and incorporation of AgNPs into polymer-based hydrogels has little effect 
on their mechanical properties. Taken together, the properties of AgNP-ECHs make them suitable 
materials for a wide range of biomedical applications, including drug delivery systems, biosensors, 
and flexible electronics.  
1.1.3. Graphene 
Graphene is a 2D hexagonal lattice of carbon that possesses unique mechanical and 
conductive properties. Although pure graphene is extremely difficult to produce due to its atomic 
thickness, several methods have been reported for the synthesis of graphene derivatives[77-79]. 
One common derivative is graphene oxide (GO), where oxygen atoms form bonds with the carbon 
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lattice and create small imperfections in the lattice structure[77-79]. However, oxidized graphene 
exhibits poor electrical conductivity, and must be deoxidized to be used in the synthesis of ECHs. 
Oxidized graphene can be deoxidized through the repair of the sp2 carbon bonds, which yields a 
conductive reduced graphene oxide (rGO)[77]. In addition, hydrothermal reduction of high 
concentration graphene oxide solutions can also be used to produce chemically converted 
graphene[78]. While graphene has been incorporated into many synthesis strategies to develop 
ECHs with robust electrical and mechanical properties, cytotoxicity remains to be a concern when 
these nanoparticles used for biomedical applications. The toxic effects demonstrated by graphene 
can be influenced by their size, shape, surface charge, surface area, and functional groups[106]. 
Future studies involving graphene nanoparticles must investigate the in vitro and in vivo 
biocompatibility as well as the mechanisms of cytotoxicity before seeking approval from the Food 
and Drug Administration (FDA).   
In a recent study, GO NPs were incorporated inside a highly elastic methacryloyl-
substituted tropoelastin (MeTro) hydrogel to form ECHs for cardiac tissue engineering 
applications[107]. The covalent bonds between polymeric chains, along with hydrophobic and 
electrostatic interactions between MeTro and GO yielded ECHs with excellent mechanics, 
electrical conductivity, and biocompatibility (Figure 2e)[107]. ECHs containing GO nanoparticles 
were similar in mechanically stiffness to control MeTro hydrogels, however these ECHs a longer 
elongation at their breaking point (Figure 2f). As a MeTro-based ECH, this material possessed 
robust mechanical flexibility making them ideal for various tissue engineering applications where 
dynamic movement is required (Figure g). In addition, MeTro/GO ECHs displayed excellent 
electrical properties with significantly lower electrical resistance compared with non-GO 
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hydrogels (Figure 2h). Furthermore, these scaffolds supported the growth and function of CMs in 
2D cultures and elicited no inflammatory response when implanted in a rat model[107].  
There has also been an increase in the attention GO-loaded ECHs has received for use in 
drug delivery systems owing primarily to their remarkable conductive[108] and magnetic[109] 
properties of GO. In one recent study, Servant et al. took advantage of these conductive properties 
when synthesizing stimuli-responsive hydrogels composed of poly(methacrylic acid) (PMMA) 
and ball-milled graphene (GBM) to control the release of small molecules in vivo. PMMA/GO 
ECHs exhibited remarkable electrical properties with bulk resistance of these materials decreasing 
with an increasing concentration of GBM. These smart ECHs were evaluated for their ability to 
control the release a small molecule drug in vivo, using 14C-sucrose as a model drug, and 
subcutaneous implantation into CD-1 mice as a model. Mice were electrically stimulated using 
10V for 1 min periods at 2 h intervals, a relatively low voltage and short time period. The release 
profile of 14C-sucrose showed that PMMA/GO ECHs greatly outperformed control PMMA 
hydrogels with 5.5% 14C-sucrose released in the blood 8 min following electrical stimulation[108]. 
The development of advanced drug delivery systems that are able to control the release of 
molecules is a vastly important biomedical field. This work demonstrates that GO can be used to 
develop smart ECHs which do just that. 
GO-incorporated ECHs have demonstrated their potential to be developed for different 
tissue engineering application such as cardiac and neural tissue engineering, owing to their 
excellent mechanical, and conductive properties. The amphiphilic nature of GO provides it with a 
structure that is deemed as biocompatible, however, more in vitro and in vivo investigations are 
required to evaluate the reaction these materials elicit to living tissues. In addition, the superior 
fluorescence quenching, and surface functionalization observed by GO make them excellent 
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materials for use in biosensors and drug delivery systems. The unique chemical and physical 
properties of GO make it and excellent candidate for development into future biotechnological and 
biomedical applications. 
1.1.4. Carbon nanotubes 
CNTs are nanostructures comprised of a cylindrical lattice of carbon atoms and are 
characterized either as single-walled or multi-walled nanotubes. CNTs have gained significant 
interest due to their unique properties, including high compressive and tensile strength, as well as 
high electrical conductivity[79, 81, 82, 110-112]. CNTs have been shown to be useful for 
engineering ECHs due to their ability to reduce brittleness and significantly increase electrical 
conductivity. However, they can also be difficult to incorporate into ECHs due to their unique 
chemical structure, which is characterized by strong Van der Waals forces, high hydrophobicity, 
and low entropy[81]. The combination of these factors often leads to the aggregation of CNTs in 
solution, making homogenous mixtures difficult to produce[81]. 
The field of cardiac tissue engineering has also greatly benefited from the synthesis of 
CNT-embedded ECHs. A recent study conducted by Ahadian et al. used dielectrophoresis to align 
CNTs in a GelMA-based hydrogel (Figure 2i), which enhanced the cardiac differentiation of 
embryoid bodies cultured in the microwells of patterned ECHs[113]. CNT-loaded ECHs exhibited 
higher elastic moduli (Figure 2j), lower electrical resistance, and supported increased beating of 
the cells as compared to pure GelMA hydrogels (Figure 2k). These results demonstrated that the 
engineered materials could be suitable for broad applications within regenerative medicine and 
cell therapy where conductivity of the matrix plays an important role[113]. 
Incorporation of CNTs into polymeric networks to develop ECHs has become a reliable 
strategy to produce scaffolds with excellent conductivity and mechanical strength. These traits 
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make them suitable biomaterials for use in tissue engineering applications. In addition, CNTs 
possess excellent stability, and magnetic properties making them excellent candidates for a wide 
range of other biomedical applications, such as biosensors or drug delivery systems. However, the 
future direction of CNTs in ECHs should focus on in vivo models that address biocompatibility 
concerns, especially those that arise from health effects with the respiratory system. If CNTs can 
be incorporated into biocompatible ECHs without toxicological or inflammatory issues, these 
nanoparticles will be excellent candidates for modern biomedical applications in the future.  
1.1.5. Polyaniline 
PANi is an electrically conductive polymer with a conjugated backbone that has been 
widely used for the synthesis of ECHs due its mechanical stability, ease of fabrication, and low 
manufacturing costs[114-118]. Previous studies have reported the use of several derivatives of 
PANi, including its most reduced form (leucoemeraldine), its fully oxidized form 
(pernigranalline), and a partially oxidized form (emeraldine)[119, 120] for the formation of ECHs. 
Many natural and synthetic polymers have been used in conjunction with PANi to engineer ECHs. 
For instance, Xia et al. described the development of ECHs using PANi and polyacrylic acid 
(PAA), by reacting positively charged aniline monomers with the negatively charged COO– 
functional groups in PAA[84]. Their results showed that the addition of PANi increased the 
electrical conductivity, as well as compressive and elastic moduli of the resulting ECHs. In 
particular, this improved electrical conductivity was likely due to PANi fibers filling in small pores 
of the PAA hydrogel[84]. A similar study conducted by Zhao et al. described the engineering of 
an injectable ECH using quaternized chitosan and PANi for regenerative tissue engineering 
applications[121]. The engineered ECH was shown to possess high antibacterial activity against 
Gram-negative and Gram-positive bacteria (Figure 3a), as well as increased electrical 
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conductivity (Figure 3b) and swellability. In addition, in vitro studies using C2C12 myoblasts 
demonstrated that ECHs containing higher concentrations of PANi showed significantly increased 
cell proliferation as compared to pure chitosan hydrogels grafted with oxidized dextran as a control 
group (Figure 3c). This study introduced a new class of bioactive scaffolds that may be tailored 
for a variety of tissue engineering applications, such as scaffolds for cardiac and nerve tissue 
regeneration[121].  
As a conductive polymer, PANi has gained the most attention for the development of ECHs 
designed for biomedical related applications. This is due to the high electrical conductivity, 
stability, and unique redox properties found in PANi, as well as ease of synthesis and low cost[122, 
123]. However, some limitations have slowed the development of PANi-incorporated ECHs for 
biomedical applications, such as harsh processing conditions, toxicity, and nonbiodegradability. 
Future investigations should evaluate PANi combined with other monomers to develop ECHs that 
possess high conductivity, as well as biodegradability, and biocompatibility. 
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Figure 3. Structure and properties of ECHs formed by using conductive polymers. In vivo 
antibacterial activity test using hydrogels formed with carboxymethyl chitosan (CMCS-Odex), 
quaternized chitosan (QCS40-Odex), and quaternized chitosan with 3% (w/v) polyaniline (PANi). 
Oxidized dextran (Odex) was used as a crosslinker to form these ECHs. Results showed that 
engineered PANi-incorporated ECHs exhibited high antimicrobial properties (a). PANi-
incorporated ECHs also exhibited high electrical conductivity (b). These ECHs demonstrated 
increased C2C12 cell proliferation with an increasing concentration of PANi, after 3 days of 
culture (c). [4], Copyright 2015. ECH developed by crosslinking polypyrrole (PPy) with 
hyaluronic acid (HA). Mechanical testing of HA-based ECHs with varying concentrations of PPy 
demonstrated that higher concentrations of PPy results in higher elastic modulus (d). In addition, 
higher concentrations of PPy increased electrical conductivity up to samples containing 50 mM 
(e). Plot of the number of attached 3T3 cells seeded on the surface of HA-based ECHs containing 
50 mM PPy. These results showed that HA/PPy ECHs supported cell adhesion and the 
proliferation of 3T3 cells up to 5 days (f). [5], Copyright 2016. Schematic for the synthesis of 
ECHs by adding PEDOT (red) and PEG (blue) to the surface of an electrode. Biorecognition 
molecules (purple) are added into the gel by attaching to -COOH groups of PEDOT. Capture of 
B-IFN-g molecules (red dot) resulted in a change in the electrical signal of the ECH (g). 
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Assessment of the mechanical properties of PEG hydrogels, as well as PEDOT and PEDOT/PEG 
ECHs. Here the results showed that by adding PEDOT to PEG did not significantly change the 
elastic modulus compared to pure PEG hydrogels (h). However, the addition of PEDOT resulted 
in a significant increase in electrical conductivity (i), which is necessary for application in the field 
of biosensors. [6], Copyright 2016.  
 
1.1.6. Polypyrrole 
PPy is an electroconductive polymer that has been used for the synthesis of ECHs due to 
its facile synthesis, environmental stability, tunable mechanical properties, and 
biocompatibility[124-127]. PPy has also been used for other purposes, including drug delivery 
systems[128-130] and bio-electrodes[131, 132], as well as the engineering of cardiac tissue 
constructs[133, 134] and artificial muscles[135]. A recent study conducted by Yang et al., reported 
the combination of PPy with hyaluronic acid (HA) by conjugating N-(3-aminopropyl) pyrrole onto 
HA polymer chains yielding ECHs with enhanced electrical conductivity (Figure 3d)[136]. Their 
results showed that the elastic modulus and electrical conductivity of the engineered ECHs 
increased concomitantly with increasing concentrations of PPy up to 50mM (Figure 3e). The 
highest electrical conductivity obtained by these PPy-incorporated ECHs was approximately 7.3 
mS cm-1, when fabricated with a 0.5 mM PPy concentration (Figure 3f)[136]. In vitro cell studies 
conducted by seeding 3T3 cells on PPy-ECHs showed increased cell adhesion and proliferation, 
as compared to pure HA hydrogels. Taken together, these results demonstrated that PPy-
incorpotated ECHs could be used to develop tissue engineering scaffolds in conjunction with 
excitable cell types, as well as for future prosthetic devices. 
The excellent redox properties of PPy have also made them attractive materials for use in 
the development of patterned electrodes for the skin. In a recent study, Hur et al. developed a PPy-
incorporated smart ECH using agarose as the polymeric network[85]. This strategy yielded 
remarkable ECHs that were not only highly conductive, but also contained thermoplastic 
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properties, which enabled thermal or light-assisted healing of the network. These ECHs exhibited 
mechanical properties that were similar to that of human skin, with a Young’s modulus of 27-46 
kPa, while also possessing an electrical conductivity in the same range as other ECHs fabricated 
using CPs (0.35 S cm-1)[85]. By developing ECHs with similar mechanical flexibility and self-
healing properties, as well as high electrical conductivity, these materials have demonstrated ideal 
physical and chemical properties for applications involving flexible electronics and biosensors.  
PPy has become a very popular CP for the fabrication of ECHs suitable for biomedical 
applications. Importantly, these CPs exhibit good in vitro and in vivo biocompatibility and 
excellent stimulus-responsive properties, as well as high thermal stability[123]. These traits make 
them excellent biomaterials for use in biomedical related applications, such as biosensors, drug 
delivery, and flexible electronics. PPy may also be used for tissue engineering applications where 
excitable cell types are found, such as neural[137] and cardiac tissue[138]. Some challenges in 
fabrication of good quality PPy-incorporated ECHs is overcoming their poor solubility in polar 
solvents and mechanical stiffness, which can often become brittle. Future research into PPy-
incorporated ECHs may focus on incorporation with natural polymers with good biodegradation 
profiles and cell adhesion to be used for biomedical applications. 
1.1.7. Polythiophenes / PEDOT 
Polythiophenes (PThs) are another innately electroconductive polymer that has been used 
to impart electrical conductivity to ECHs due to their solubility, high thermal stability, and 
excellent electrical conductivity when in a doped state[88, 139]. However, the use of PThs for 
biomedical applications is often limited due to the increased weight and rigidity of PThs, which 
can potentially decrease the mechanical and electroactive performance of resulting ECHs[88]. 
Unlike PThs, its derivative poly(3,4-ethylenedioxythiophene) (PEDOT) is commonly used in the 
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synthesis of ECHs due to its biocompatibility, cost-effectiveness[140], and electrochemical 
stability in aqueous solutions[141-146]. While PEDOT itself is conductive, increased electrical 
conductivity, as well as cationic conductivity is rendered when PEDOT is combined with 
poly(styrene sulfonate) (PSS)[147]. PEDOT:PSS also maintains suitable conductivity in the 
physiological environment, and may be cleared by the renal system, which has resulted in 
significant attention in a variety of biomedical-related fields, such as tissue engineering[90, 91].  
Recent studies have shown that PEDOT-incorporated ECHs can be used to closely mimic 
the conductive and mechanical properties of certain tissues, making them suitable to use as 
scaffolds for tissue engineering. A study by Kim et al. reported that native cardiac tissue has an 
elastic modulus within the range of 10-100 kPa, and has a conductivity ranging from 10-3 S/cm to 
10-2 S cm-1. In one study, Kim et al. reported the formation of an ECH based on a RDG modified 
polyethylene glycol (PEG) containing PEDOT with an elastic modulus of 21 ± 4 kPa and a 
conductivity of 1.69 × 10-2 S cm-1[90]. In vitro cell studies using electro-responsive H9C2 cells 
were conducted to determine the effect of PEDOT on cell attachment and proliferation. Their 
results showed that PEDOT-containing ECHs supported cell adhesion and proliferation without 
compromising the electrical and physiochemical properties of the hydrogel, and thus was found to 
be a promising candidate for applications such as tissue engineering of muscle and nerve 
tissue[148].  
PEDOT has also investigated for use to develop ECHs for biosensors. Recently, Shin et al. 
developed a PEDOT/PEG-based ECH to detect specific antigen molecules in the physiological 
context. The outer layers of these sensors were coated in the ECH loaded with a cytokine-specific 
antibody, which is attached to a PEDOT-COOH group. Once these biosensors come in contact 
with the IFN-gin analyte, the ECHs undergo a quantifiable decrease in electrical conductivity that 
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would serve at the detection mechanism (Figure 3g). Despite the high mechanical strength of 
PEDOT, PEDOT/PEG ECHs exhibited an elastic modulus of 7.58 ± 0.84 kPa, which was similar 
to that of pure PEG hydrogels and within the range for use in many biological systems (Figure 
3h). In contrast with non-conductive PEG hydrogels, PEDOT/PEG ECHs exhibited remarkable 
electrical conductivity that was highly distinguishable from control samples (Figure 3i). These 
ECHs demonstrated a system that was successfully able to transfer the detection of an analyte into 
an electrochemical signal. These results suggest that PEDOT is an effective material to impart 
electrical conductivity for future biosensor applications. 
Advancements in the development of PEDOT-incorporated ECHs have led to promising 
innovations in areas including biosensors, implantable electrodes, and drug delivery systems. 
Investigators are able to take advantage of the high electrical conductivity, as well as chemical and 
environmental stability exhibited by PEDOT. Further, PEDOT has been widely reported as a 
biocompatible material with many in vitro investigations displaying no cytotoxicity. However, due 
to high mechanical stiffness of this material, the foreign body response may disrupt performance 
when PEDOT-incorporated ECHs are implanted in soft tissues, such as in the brain. While these 
ECHs have displayed excellent properties for biomedical applications, long term in vitro and in 
vivo investigations are required to determine effects of surrounding tissues before they may be 
transition into the clinical setting. Taken together, PEDOT-incorporated ECHs are a promising 
biomaterial for future biomedical related therapeutic and diagnostic strategies.  
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1.1.8. Ionic liquid 
Ionic liquids (ILs) have been implemented in a wide range of industrial applications, 
including fuel cells[93], solar cells[94], batteries[95], and sensors[149] due to their many unique 
properties such as low volatility, non-flammability, high thermal stability, and high ionic 
conductivity[150-154]. ILs are liquids comprised completely of ions from salts, which have a 
melting point below 100°C. There are many sub-categories of ILs, including room temperature 
ILs, task-specific ILs, polyionic liquids, and supported IL membranes[153]. Previous studies have 
focused on the characterization of the physical structure and properties, nano-organization and 
self-assembly, and advanced chemical transformations of ILs[155]. Recently, it has been 
demonstrated that ECHs may be engineered by combining ILs with polymers for applications in 
tissue engineering, electrochemical biosensors, electro-stimulated controlled drug release systems, 
and neural prosthetics[156, 157].  
For example, ECHs can be formed by polymerizing monomers in ILs to increase the 
electrical conductivity of these scaffolds. This approach was demonstrated by Liang et al., using 
microcrystalline cellulose and PPy as polymers, to form a network in 1-butyl-3-
methylimidazolium chloride (BMIMCl) IL[157]. BMIMCI was used in this study to provide a 
solvent that could dissolve cellulose while protecting its structure from degradation. The swelling 
of ECHs was found to be dependent on the microcrystalline cellulose concentration, with higher 
concentrations exhibiting lower swelling ratios. Furthermore, the mechanical properties were 
substantially improved with the incorporation of PPy, increasing from a maximum stress of 1.53 
MPa for control samples, to 26.25 MPa for PPy-containing ECHs[157]. Their results also 
demonstrated that the composite hydrogels synthesized using ILs were suitable for the 
development of biological and semiconducting materials, as well as drug delivery systems and 
neural prosthetics[157]. In another study, Robinson et al. develop a synthetic sensing skin by 3D 
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printing two inks; one that was ionically conductive, and one that was electrically insulating[156]. 
For this, they used the conductive 1-decyl-3-methylimidazolium chloride IL, while the insulating 
material was a silicone elastomer. This approach was used to print a micropatterned material that 
could act as stretchable capacitive sensors. Both inks were extruded and polymerized in situ to 
form a layer of ECHs, and a layer of insulating silicone. The resulting capacitive skin demonstrated 
excellent adhesion to actuation chambers, as well as the ability to detect a compressive force of 
approximately 2 N. The combination of an ECH with the insulating silicone led to the development 
of the first printable skin to demonstrate enabled tactile sensing and kinesthetic feedback[156].  
1.2. Microfabrication techniques used to develop ECHs 
1.2.1. Electrospun fibers 
The primary goal for the design of tissue engineered scaffolds is to develop materials that 
structurally and functionally mimic the native ECM. The ECM is a complex network of proteins, 
proteoglycans, and glycosaminoglycans that provides physical support for cells[158, 159]. 
Furthermore, the ECM is responsible for the promotion of cell adhesion and migration, as well as 
proliferation, and function[160]. This is achieved, in part, due to the complex nanostructure of 
protein fibers, such as collagen and elastin[160], and the presence of specific ligands and growth 
factors[161, 162]. Protein fibers may range in diameter from several tens to several hundred 
nanometers. In this regard, electrospinning has been increasingly used for the synthesis of polymer 
fibers that resemble the fibrous architecture of the ECM. Electrospinning systems are comprised 
of three main components; a high voltage supplier capable of generating 10-20 kV of potential, a 
a small diameter metal nozzle, and a metal collector (Figure 4a)[163-165]. The generated 
electrical field drives the polymer feed to the grounded metal collector in a process that is referred 
to as a whipping mode, which is characterized by increased acceleration and oscillation[163, 166, 
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167]. The solvent used in the polymer feed is mainly evaporated or solidified in the electrospinning 
process, and trace amounts of solvent in the fibers may be removed using vacuum after synthesis.  
Electrospun conductive fibrous scaffolds have been widely used in tissue engineering and 
biomedical applications due to the promotion of favorable cellular responses, such as increased 
adhesion and proliferation[168-170].  
Another recent study by Malki et al. investigated ECHs fabricated by electrospun albumin 
and then absorbing AuNRs into the fibers to engineer cardiac patches capable of cardiac tissue 
regeneration following myocardial infarction (MI)[171]. Through the electrospinning of albumin, 
a porous scaffold composed of ribbon-like fibers with a thickness of 0.5 µm, was developed that 
closely resembled the structure of cardiac tissue[171]. Further, the incorporation of AuNRs to these 
cardiac patches improved electrical conductivity that would assist in the cell-cell interactions that 
are responsible to synchronous heart beating. The AuNR-incorporated cardiac patches were 
evaluated in vitro through cardiomyocyte encapsulation within these hybrid scaffolds to analyze 
the expression of the gap junction protein connexin 43 (Cxn43), which is responsible for cell-cell 
signaling. Their results showed that after 7 days of cell culture there was a significant expression 
of Cxn43, as well as pronounced actinin striation, suggesting the cells ability to contract 
synchronously[171]. The electrical enhancement of these electrospun scaffolds yielded cardiac 
patches which were able to support cardiomyocyte contraction and may be used to improve the 
function of cardiac tissue following MI. 
In another study, Liu et al. developed ECHs with architecture that closely resembled the 
cardiac microenvironment through electrospinning poly(ethylene glycol)-poly(𝖣,𝖫-Lactide) 
(PELA) copolymers with CNTs onto a spinning mandrel[7]. Their approach investigated the 
efficacy of both blend electrospinning and coaxial electrospinning techniques. Blend 
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electrospinning involves mixing CNTs and PELA into a polymer solution. Coaxial electrospinning 
follows the same principles, however, two separate solutions, one containing PELA and the other 
CNTs, were coaxially and simultaneously electrospun through different capillary tubes into the 
same nozzle. Electrospinning PELA/CNT onto a rotating mandrel resulted in aligned fibers with 
diameters between 2-3 µm (Figure 4b). These blended and coaxial electrospun scaffolds 
demonstrated that higher CNT concentrations resulted in higher mechanical stiffness, 
concomitantly (Figure 4c). Further, scaffolds fabricated with higher concentrations of CNTs 
yielded higher electrical conductivity (Figure 4d). These electrospun scaffolds were also 
evaluated to determine beating strength of CMs when seeded on fibrous mats for up to 10 days. 
Results showed that CMs seeded on electrospun scaffolds fabricated with 5% CNTs had 
significantly higher average beating rates (70-80 beats/min) when compared to scaffolds fabricated 
with 3%, 4%, and 6% CNT concentrations (Figure 4e). All PELA/CNT electrospun scaffolds 
evaluated showed synchronous beating, except for those fabricated with 6% CNTs. The 
electrospinning microfabrication technique was used in this study to produce conductive patches 
for cardiac tissue engineering by creating fibrous scaffolds that mimic the organized cardiac 
muscle fibers of the heart.  
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Figure 4. Electrospinning microfabrication technique is a simple method for generating 
fibrous scaffolds that are suitable for many applications including tissue engineering, 
biosensors, and drug delivery systems. Schematic for an electrospinning set up consists of a 
polymer dissolved in solvent being injected out of a metal nozzle (a). A high voltage power supply 
is connected to a metal nozzle and a metal collector creating an electrical field. A polymeric 
solution is then slowly pumped out of the syringe and spun onto the metal collector. Representative 
SEM image of a blend electrospun PELA/CNT fibrous scaffold with a 5% CNT concentration 
showing high alignment of fibers and 2 µm fiber diameter (b). Mechanical study of electrospun 
PELA/CNTs demonstrated that ECHs fabricated with higher concentrations of CNTs resulted in a 
higher Young’s modulus (c). Electrical evaluation of electrospun ECHs showed that these fibrous 
scaffolds exhibited higher conductivity when fabricated with a higher concentration of CNTs in 
both blended and coaxial electrospun PELA/CNT scaffolds (d). Beating rate of CMs when seeded 
on PELA/CNT fibrous scaffolds and cultured for 10 days. The beating rate for ECHs coaxially 
electrospun with a 5% CNT concentration (C5) achieved an average beating rate of 70-80 
times/min, which is similar to that rate of CMs seeded on other non-conductive hydrogels (e). [7], 
Copyright 2016.  
  
Electrospinning is a facile method that allows precise control over many parameters of the 
synthesis process, such as voltage applied, distance from the nozzle to collector, and flow rate. In 
addition, metal collectors may be static, generating randomly arranged fibers, or rotating, which 
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results in highly aligned fibers. By adjusting these parameters, it is possible to engineer ECHs with 
finely tuned fiber morphology and geometry. Using advanced electrospinning set-ups, ECHs with 
enhanced microarchitecture, porosity, mechanical properties, and electrical conductivity have been 
fabricated with exceptional properties for biomedical applications. Further, electrospinning 
provides a method to optimize the patterning of cells or bioactive ligands in a way that is 
biomimetic to the structure and morphology of natural tissues. Further characterization including 
in vivo studies, however, will be required for electrospun ECHs before they may be used for such 
applications as treatment of medical diseases in the clinical setting. Future electrospinning 
considerations should also seek to improve cost-effectiveness and increase the yield of fibrous 
scaffolds. Nonetheless, modern electroactive scaffolds, with excellent scalability, reproducibility, 
and consistency show promise for use in future biomedical applications such as cardiac and neural 
tissue engineering.  
1.2.2. 3D printing 
3D printing technology has significantly improved over the past few decades, enabling the 
creation of complex 3D structures that might otherwise be impossible to fabricate with traditional 
molding techniques or top-down milling procedures [172]. Not surprisingly, this technology has 
made its way into the biomedical field to form complex structures which have great potential to 
contribute to our understanding of healthy and diseased tissue states [173], expand our treatment 
options for those diseases [174], or fabricate medical devices [175]. In addition, the turnover time 
for these structures or devices is appreciably less than many molding or fabrication processes, 
which can reduce lead time and accelerate products to patient timelines. 
For many biomedical applications, engineering biomaterials with biomimetic mechanical 
properties have been a challenge. This mechanical mismatch has inspired widespread interest in 
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the field of flexible electronics and electroactive tissue engineering [176]. To this end, the design 
of soft and conductive materials has been an emerging area of research in recent decades. Since 
the hydrostatic and mechanical properties of hydrogels are very similar to human tissues, they are 
an obvious choice as a material for fabricating complex 3D bioprinted structures for biomedical 
applications. In this section, we will review recent work in the field of 3D printing of ECHs and 
the applications targeted for the formulations and technology. 
One of the common applications of 3D printed ECHs is as pressure/motion sensors or as 
biosensors [177]. For these applications, tuning the geometrical or chemical structure of the ECHs 
can modulate its electrical properties and causes a proportional response, signaling the occurrence 
of an event. In the case of pressure or motion sensors, the compression or extension of the hydrogel 
causes a corresponding change in electrical resistance and thus the generation of an electrical signal 
[178]. For biosensors, an analyte of interest binds to the conductive material and induces a change 
in its electrical properties, causing the signal to be generated [6]. Normally these sensors require 
advanced fabrication techniques to achieve the complex landscape for the sensor design. 3D 
printing can eliminate the need for costly tooling and equipment that is typically required to form 
these patterns and enables rapid formation of multiple designs at minimal cost and significantly 
reduced lead time. In some cases, elastomeric polymers, such as polydimethylsiloxane (PDMS), 
are utilized as printing substrates onto which the conductive hydrogel can be patterned with the 
printing device [179]. The PDMS helps to maintain the overall stability of the printed structure 
and provides a template for the sensing function of the device. While non-hydrogel conductive 
elastomers can be used for pressure or motion sensors [180], detection of water-soluble analytes 
might not be as sensitive or accurate if non-porous hydrophobic materials, such as PDMS, are 
used. For example, inkjet printing was used to pattern a nanostructured PANi hydrogel for 
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multiplex detection of glucose, lactate, and triglycerides in real time selectively and with high 
sensitivity [181]. The use of printing for the devices enabled them to fabricate pages of sensor 
arrays with 96 electrodes in minutes. In comparison, traditional photolithography patterning 
methods would require pre-fabrication of photomasks and careful substrate preparation and 
washing and cleaning steps before the device could be realized. Pressure sensors were fabricated 
by printing a conductive self-healing hydrogel composed of polyacrylic acid and PPy (Figure 5a), 
wherein changes in pressure caused a corresponding change in electrical resistance [182]. The 
devices were coated with a thin layer of PDMS to contain the conductive gel and pressed onto the 
wrist for taking blood pulse readings. These printed devices could be used as wearable sensors that 
conformed to the shape of the arm, finger, or wrist (Figure 5b). One group designed a photocurable 
conductive and elastic hydrogel that could be printed using digital light processing (DLP) 
stereolithography (SLA) [183]. The printed constructs were not tested for specific applications, 
but the formulation and printing technology combined are promising for applications where a 
transparent, elastic, and conductive hydrogel is required, such as for optogenetics [184]. Careful 
deliberation of the materials and methods will undoubtedly improve the performance and 
capabilities of 3D printed conductive hydrogel-based devices in the near future. 
Recapitulation of complex tissues in vitro is becoming increasingly more possible as 
advanced microfabrication strategies evolve. 3D bioprinting has enabled the generation of features 
in an additional dimension compared to 2D patterning methods and has provided scientists with 
the capacity to form biomimetic tissue structures in vitro. Ultimately, the goal of this technology 
is to generate full-scale tissues or organs that can replace organ donation and transplants, thus 
reducing issues with donor availability and chronic organ rejection [185]. Bioprinted hydrogels 
with improved electrical conductivity have been shown to improve the function of electroactive 
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tissues, such as cardiac and neural tissue [67, 186]. For example, PEGDA hydrogels mixed with 
various concentrations of amine functionalized multi-walled carbon nanotubes (MWCNTs) was 
3D printed into grid-like structures for nerve regeneration [187]. Results showed that neural stem 
cells (NSCs) proliferated more and differentiated early on scaffolds containing MWCNTs 
compared to controls without conductive nanotubes. In addition, exogenous electrical stimulation 
in the form of biphasic pulses enhanced neuronal maturity for structures containing the MWCNTs 
as confirmed by quantitative polymerase chain reaction (qPCR). A similar study targeting cardiac 
tissue utilized a bioink containing GNRs, GelMA, and sodium alginate with a co-axial printing 
system, where sodium alginate was used as a structural material that was rapidly crosslinked as 
aqueous calcium chloride was extruded through the shell of the nozzle (Figure 5c) [9]. CMs 
encapsulated in the 3D printed GelMA/GNR hydrogel structure expressed higher levels of Cxn43 
cardiac junction protein and exhibited higher contraction rates than GelMA controls (Figure 5d). 
These results show promise as materials that can help us design cell-laden 3D printed structures 
with enhanced tissue function that may enable tissue replacement in the future.  
 31 
 
Figure 5. 3D printing of conductive hydrogels for different biomedical applications. Pressure 
sensors were fabricated by 3D printing a conductive self-healing (CSH) hydrogel composed of 
PPy-grafted chitosan and poly(acrylic acid), and coating them with a thin layer of PDMS (a). When 
applied to the wrist, the sensor could detect blood flow pulses in the veins below the skin in real-
time (b) (Adapted from [8]). Hydrogel prepolymer solution containing sodium alginate, gold 
nanorods, and GelMA was bioprinted via a co-axial nozzle, in which the alginate prepolymer 
solution in the core was crosslinked by calcium ions flown in the sheath (c). Lattice-like structures 
could be printed, and hydration was maintained by the continuous flow of the aqueous sheath 
solution. Cardiomyocytes printed in these structures expressed higher levels of Cxn43 cardiac 
junction protein and exhibited higher contraction rates compared to controls (d) (Adapted from 
[9]). 
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3D printing has been widely used in the biomedical field. Its simplicity, low cost, 
minimization of waste, and ever-advancing capability have made this technique an extremely 
powerful tool that will revolutionize our ability to iterate designs in ways previously not possible. 
ECHs have proven utility for applications where an electrically active, flexible, and hydrated 
material is required, such as in sensing devices and for tissue culture. The combination of these 
approaches has provided researchers with the means to create complex structures with 
unprecedented speed and precision. For 3D printed conductive hydrogel motion sensors, the 
capabilities tested thus far were limited to simple events, such as hand or arm movement [179]. 
More sophisticated devices capable of sensing motion and responding could be used as medical 
devices, such as a film that can sense heartbeat rhythms and provide an electrical stimulation 
impulse if arrhythmia is detected. An ongoing challenge in biosensors is improving selectivity 
[188]. Hydrogel compositions could be chemically modified to improve selectivity and prevent 
false positive or false negative responses. For 3D bioprinting, designing ECHs bioink with 
biocompatibility and printability is a major limitation, especially in the case of printing complex 
cell-laden 3D structures. In addition, the ability to directly print integrated electrochemical probes 
into 3D printed devices would enable interrogation and stimulation of electroactive cells 
encapsulated in the structure [189]. Finally, the resolution of 3D printing is rapidly improving, and 
decreased feature size can shrink the overall size of devices or sensors and increase the fidelity of 
bioprinted structures that mimic native tissues. These improvements will enable 3D printing 
combined with ECHs to contribute even further to multiple facets of the biomedical field. 
1.2.3. Micropatterning of ECHs 
 
Micropatterned hydrogels have been used in a wide range of biomedical applications, such 
as drug delivery [190, 191], and tissue engineering [192]. Some of the most commonly used 
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techniques for micropatterning of hydrogels include microfluidics [193], magnetic [194] and 
acoustics guided hydrogel assembly [195]. However, micropatterned non-conductive hydrogels 
could impede electrical cell-cell coupling and lead to signal deferment inside the scaffolds [67]. 
This in turn could potentially limit their application in the context of physiological environments 
where excitable cell types are present such as nerve and cardiac tissues. Therefore, micropatterning 
of ECHs has gained significant attention, and different techniques have been investigated to 
generate unique architectures of micropatterned ECHs for biomedical applications [196]. For 
example, in a study by Kim et al., conductive PEDOT-incorporated ECHs were patterned to 
develop flexible electrodes [197]. Briefly, a PEDOT film was prepared by reacting a liquid phase 
PEDOT monomer casting with the oxidant Fe(III) tosylate. A UV-induced photopolymerization 
of PEG was then performed using a photolithography technique at the PEG/PEDOT interface using 
a photomask. The PEG hydrogel was then peeled off removing the region of PEDOT film that was 
exposed to UV irradiation. Finally, a second PEG gelation step was performed on the remaining 
patterned PEDOT film, which left it embedded in the hydrogel. Micropatterned PEDOT-embedded 
ECHs exhibited high electrical conductivity coupled with flexible mechanical properties, which 
demonstrate their potential for  biomedical applications such stimuli-responsive drug delivery 
systems and growth factor delivery systems [197].  
In another study, Wu et al. reported the engineering of conductive GelMA-PANi ECHs in 
patterned hexagonal geometries, by utilizing digital projection stereolithography [198]. This was 
achieved by injecting GelMA-PANi precursor solution in a chamber and crosslinked in organized 
patterns using a computer-aided design-based digital mask. GelMA/PANi ECHs demonstrated 
remarkably lower impedance (2.9 ± 0.3 kW) compared to control GelMA hydrogels (6.9 ± 0.7 kW), 
at physiologically relevant frequencies. In addition, in vitro cell studies were used to investigate 
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the effect that these micropatterned ECHs on the morphology of adhered cells. This was done 
using C3H/10T1/2 murine mesenchymal progenitor cells (10T1/2s) cells seeded on the surface 
GelMA and GelMA/PANi samples and cultured for 5 days. Results showed that 10T1/2s cells 
seeded on GelMA/PANi ECHs demonstrated better adhesion and viability after 5 days compared 
to pristine GelMA [197]. Further, while 10T1/2s cells adhered exclusively to GelMA in control 
samples, migration between the hexagonal patterns was observed in GelMA/PANi ECHs.  
More recently, Navaei et al. described a technique for micropatterning CMs onto ECHs by 
incorporating conductive GNRs into GelMA hydrogels to create microgrooved architectures [10]. 
Their approach utilized a micro-mold composed of PDMS with a microgrooved topography. A 
prepolymer solution containing GelMA and GNRs was pipetted on a 3-(Trimethoxysilyl)propyl 
methacrylate (TMSPMA)-coated slide, and the PDMS micromold was placed on top.  (Figure 6a). 
The solution was then photopolymerized through exposure to UV irradiation. The resulting ECH 
constructs possessed microgrooves that were 50 µm in width. GelMA/GNR ECH constructs also 
exhibited significantly lower impedance (1.35 ± 0.36 kW) as compared with pristine GelMA (15.58 
± 9.18 kW) samples. In addition, cellular viability and morphology was investigated in vitro by 
seeding CMs between the microgrooves of GelMA-GNR and GelMA constructs. Their results 
showed there was an enhanced organization and spreading of CMs on GelMA/GNR ECHs (Figure 
6b), when compared to pure GelMA hydrogels (Figure 6c) after 7 days of culture. This study 
demonstrated the efficacy of micropatterning techniques to fabricate ECHs with and highly 
organized structures that could be used to develop native-like cardiac tissues.  
Micropatterning of ECHs has also been performed to enhance therapies designed to 
stimulate nerve tissue regeneration. In a recent study, Lee et al. developed an ECH composed of 
PED and AgNWs with parallel microridges using a standard soft lithography process [199]. 
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Briefly, a microgrooved PDMS stamp was fabricated and placed on a polyethylene terephthalate 
(PET) film. A prepolymer solution containing PEG and AgNWs was then injected between the 
grooves of the stamp and the PET film. The prepolymer solution was then photopolymerized using 
UV irradiation, and the PDMS stamp was peeled from the ECH. Electrical characterization of 
these ECHs was conducted using Comsol Multiphysics software to simulate the current at the wall 
of PEG/AgNW and PEG samples when a voltage of 10 V was applied. Results of this simulation 
showed that PEG/AgNW exhibited a significantly higher current as compared to pure PEG 
hydrogels due to the higher conductivity [199]. To determine if these materials could support the 
differentiation of NSCs into neurons, and guide neurite outgrowth, NSCs were incubated and 
grown into neurospheres, then seeded on PEG/AgNW and PEG samples. Following 1 day of 
culture, an intermediated electrical stimulus of 5, 10, and 20 V was applied. Results showed that 
neurite growth was much higher in the PEG/AgNW ECHs compared to PEG hydrogels [199]. 
Further, the neurite growth followed the microgrooves of the ECH, while neurite growth on PEG 
hydrogels appeared more randomly dispersed. The combination of high conductivity, robust 
mechanical properties, and micropatterns that support the differentiation of NSCs into neurons 
suggests that these ECHs are suitable for applications involving excitable cell types, such as 
neuronal and cardiac tissue engineering.  
Overall, micropatterning of ECHs is a facile and precise method to control the 2D 
arrangement in a way that mimics the ECM of natural tissues. Advanced micropatterning 
techniques can also be used to guide cellular interactions thus influencing the function of tissues. 
However, the use of micropatterning ECHs does have some limitations. For example, one 
challenge is determining an appropriate UV exposure time that would photocrosslink hydrogels, 
but not affect cellular viability. Another limitation is the inability to micropattern 3D constructs 
 36 
that closely represent the microenvironment in vivo. However, ECHs with micropatterned surfaces 
shows potential in developing future 2D modeling systems that emulate human physiological 
functions. Taken together, micropatterned ECHs holds great potential for the development of 
stimuli-responsive systems for biomedical innovations, and to facilitate the development of new 
therapeutics aimed towards cardiac and neural tissue regeneration, as well as biosensors and drug 
delivery systems.  
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Figure 6. Micropatterning and self-assembling of ECHs for different biomedical 
applications. Schematic of GelMA-GNR ECHs that were photocrosslinked in the presence of UV 
light in a microgrooved PDMS mold. The resulting ECH was seeded with CMs, which aligned 
within the microgrooves (a). Live/dead assay performed using CMs seeded on pure GelMA 
hydrogels (b) and GelMA-GNR ECHs (c). Live cells were stained in green, while dead CMs were 
stained in red, confirming high cell viability after 7 days of cell culture (adapted from [10]). 
Schematic of supramolecular organic-inorganic composite capable of self-healing via interactions 
between oligomer chains (pink lines) with micro nickel and urea groups (blue and purple shapes) 
(d). Representative stress-strain curves for ECHs containing 31% micro nickel volume ratio under 
different healing conditions showing that healing efficiency was found to be a function of time (e) 
(adapted from [11]). Schematic of composite ECHs constructed with partially reduced GO using 
polydopamine, crosslinked with polyacrylamide (f) (adapted from [12]). Scale bars= 100 µm (b, 
c). 
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1.2.4. Self-assembly / Self-healing of ECHs 
Directly combining conductive components such as CPs and NPs into polymeric networks 
has been regarded as the most straightforward approach to synthesize ECHs [200-202]. However, 
conventional approaches to fabricating ECHs yields matrices with randomly suspended 
conducting components, which limits the ability to impart morphologies that enhance cell-material 
interactions [203]. To address this issue, self-assembly approaches have been introduced as an 
efficient strategy to develop a new class of smart materials with the ability to spontaneously form 
complex structures without external participation [204, 205]. Self-assembled hydrogels are 
characterized by the interaction of weak noncovalent bonds to form networks, such as hydrogen 
bonds, ionic interactions, van der Waals forces, and p-p stacking [206]. However, the absence of 
covalent bonds in these networks may result in weak mechanical properties making them 
unsuitable for biomedical applications. Therefore, it is often necessary to engineer self-assembling 
ECHs with either strong noncovalent bonds (e.g. ionic interactions, metal-ligand coordination), or 
multiple weak interaction sites (e.g. hydrogen bonds, VDW forces) [207].  
Due to its unique structure, graphene has become a popular biomaterial capable of 
imparting self-assembling properties to ECHs. Self-assembled graphene hydrogels (SGH) have 
been increasingly used in multiple applications such as drug delivery systems [208], 
supercapacitors [209], and devices for human motion detection [210]. One study conducted by Xu 
et al., engineered SGHs with 3D networks that were fabricated using a single-step hydrothermal 
approach [204]. Briefly, this was achieved by heating 2 mg/mL of a homogenous GO solution to 
180 °C for 12 h using an autoclave. The effect of this treatment hydrothermally reduced GO 
creating graphene sheets, which self-assembled into ECHs via p-p stacking interactions. 
Characterization of these SGHs showed that these materials exhibited high electrical conductivity 
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(5 ´ 10-3 S cm-1), high storage modulus (450-490 kPa), and high thermal stability [204]. It was 
therefore proposed that these self-assembling ECHs were suitable for biomedical applications, 
such as drug delivery systems, and tissue engineering.  
ECHs with self-healing properties have also gained significant attention based on their 
ability to spontaneously restore the original functionality of ECHs after being damaged, which can 
prolong service life and avoid failure in therapeutic or diagnostic biomaterials [211]. This new 
class of smart material relies on dynamic and reversible noncovalent bonds, such as hydrophobic 
interactions, host-guest interactions, or hydrogen bonding to autonomous crosslink polymeric 
networks following physical, chemical, or mechanical damage to the ECHs [12]. Advanced self-
healing smart materials, used for biomedical applications such as wound healing, where cuts, 
scratches, and breaks are common, would improve performance and lower the overall cost of these 
systems [211].  
A study by Tee et al., described the development of biomimetic electronic skin sensors 
with enhanced mechanical sensing and self-healing properties [11]. This composite ECH was 
formed by using a supramolecular polymer capable of forming hydrogen bonds with itself, coupled 
with micro-nickel particles with nanoscale surface modifications (Figure 6d) [11]. The resulting 
ECH was able to self-heal by forming new hydrogen bonds in response to mechanical trauma, 
which in turn restores the structural integrity of the hydrogel. An important feature of 
supramolecular polymeric networks is their glass transition below room temperature, which allows 
for better movement of polymer chains after damage. These ECHs exhibited high electrical 
conductivity (40 S cm-1), and increasingly higher elastic moduli with increasing concentrations of 
micro nickel particles. In addition, the engineered ECHs were able to electrically heal within 15 
seconds after damage occurred (Figure 6e), which could enable the engineering of electric skin 
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sensors, as well as flexible biosensors.  
In another study, Han et al. developed a mussel-inspired self-adhesive, self-healing, 
stretchable ECH to be used as implantable and wearable bioelectronics [12]. These ECHs were 
fabricated in three steps. Briefly, dopamine was prepolymerized to form polydopamine (PDA). 
Next, partially reduced GO (pGO), where both GO and rGO were present, was achieved by 
exposure to PDA. Lastly, pGO and PDA were polymerized in the presence of acrylamide 
monomers, forming PDA/pGO/PAM composite ECHs (Figure 6f). The resulting pGO and PDA 
chains interacted with PAM forming hydrogen bonds and 𝜋-	𝜋 stacking between catechol groups 
[12]. This ECH exhibited high conductivity, the ability to electronically and mechanically heal 
after damage, as well as high stretchability and toughness. Furthermore, the ECH possessed 
excellent attachment to native skin without the use of additional adhesives. Both in vitro studies 
using bone marrow stem cells and in vivo studies in a rabbit model demonstrated the high 
biocompatibility of the engineered ECHs. These studies demonstrate that self-healing ECHs hold 
great potential for the development of implantable and flexible bioelectronics. 
Smart ECHs capable of self-assembling have been utilized as scaffolds for various 
biomedical applications. Further, self-healing ECHs have been engineered to autonomously adapt 
to dynamic environments and serve to lengthen the service life of these implantable gels. Both of 
these classes of materials rely on weak noncovalent bonds to assemble and repair polymeric 
networks. However, due to the absence of stronger covalent bonds, these self-assembling and self-
healing ECHs often lack the proper mechanical stiffness necessary for use as tissue regenerative 
therapies or drug delivery systems. In addition, the rational design of such complex structures is 
often a challenge and prediction of ECHs behaviors is often based on empirical observations. 
Regardless, the benefits of these smart ECHs make them attractive materials for many biomedical 
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related applications where self-regulation and durability are required.  
1.3. Biomedical applications of ECHs 
1.3.1. Tissue engineering 
Polymeric hydrogels have been extensively used as scaffolds to mimic biological 
functionality and induce the proliferation, differentiation, and migration of cells, both in vitro and 
in vivo (Figure 7a). Cells in physiological environments are exposed to various types of 
physicochemical cues that modulate the development and regeneration of tissues, including 
endogenous electric fields from excitable cell types. Therefore, ECHs have been increasingly 
explored for the engineering of functional tissue constructs, to control the behavior and promote 
the regeneration of excitable tissues [212]. To this end, the use of ECHs for the engineering of 
scaffolds for neural cell encapsulation, nerve conduits, and electrode coatings for neural tissue 
interfaces has been widely reported (Figure 7b). Previous studies have shown that neuroblastic 
PC-12 cells under electrical stimulation in vitro exhibit increased proliferation and differentiation 
[13, 213-215], as well as a higher number of neurites with a greater overall length [123]. This 
behavior has been mainly associated to enhanced fibronectin adsorption onto the ECHs, coupled 
with the direct effect of the electrical field on the integral membrane proteins of these cells [216, 
217]. In a different study by Yow et al., hMSCs growing on PPy-collagen hydrogels exhibited 
neuronal-like morphology and upregulation of noggin, MAP2, neurofilament, ß tubulin III, and 
nestin neural markers [218]. Using a similar approach, Yang et al. recently demonstrated that PPy-
alginate hydrogels promoted the adhesion and growth of hMSCs, as well as overexpression of Tuj1 
and MAP2 neural differentiation markers (Figure 7c) [14]. In addition, the engineered PPy-
alginate hydrogels were shown to possess high biocompatibility in vivo, as demonstrated by 
subcutaneous implantation experiments. These studies demonstrate that ECHs are remarkably 
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advantageous to study the effects of electrical fields on stem cells and/or neural cells in vitro, and 
to engineer heterocellular neural tissue constructs and interfaces for in vivo implantation. 
 
Figure 7. ECHs for tissue engineering applications. The addition of electrically conductive 
materials (red circles) can be used to provide conductive properties to intrinsically insulating 
hydrogels (a). These ECHs could be used to deliver relevant biophysical stimuli to cardiomyocytes 
in vitro, such as mechanical and biological cues, or electrical stimulation/pacing. These maturation 
cues have been shown to trigger phenotypical changes that ultimately lead to fully mature and 
functional cardiomyocytes. ECHs have been used to develop conductive nerve conduits as an 
alternative to nerve autografts for nerve regeneration and repair (adapted from [13]) (b). ECHs 
could provide physiological stimuli that mimic native nerve tissues and induce the differentiation 
of progenitor cell types to neural lineages (adapted from [14]) (c). ECHs deliver biomimetic 
topographical and electrical cues in vitro to form highly oriented cellular constructs with tissue-
level functionality (adapted from [10]) (d). Scale bars= 100 µm (d upper image), 20 µm (d lower 
image). 
 
The complex organization and microarchitecture of the myocardium, along with the 
electrical and mechanical coupling between CMs, are critical for the maintenance of the 
synchronous contractility of the heart [219, 220]. In recent years, the engineering of cardiac tissue 
 43 
constructs using hydrogel-based biomaterials with biomimetic physicochemical cues have 
demonstrated great promise for cardiac tissue regeneration and repair [20, 221]. For instance, Dong 
et al. recently described the engineering of an injectable, self-healing ECHs based on chitosan-
graft-aniline tetramer (CS-AT) and dibenzaldehyde-terminated poly(ethylene glycol) PEG-DA 
[222]. Their results demonstrated that the engineered ECH could be used to deliver C2C12 and 
H9c2 myoblasts in vivo, and that they possessed high biocompatibility and biodegradability. In 
another study by Baei et al., thermosensitive chitosan-AuNPs ECHs were shown to support the 
proliferation, migration, and differentiation of hMSCs, as shown by the expression of the α-myosin 
heavy chain (α-MHC) and Nkx-2.5 cardiac markers [46].  Furthermore, in addition to electrical 
stimulation, the delivery of mechanical and topographical cues could also be incorporated into 
multifunctional ECHs. In this regard, Gelmi et al. recently reported the use of a PLGA-PPy 
hydrogel as an electromechanically active scaffold to promote the engraftment, proliferation, and 
differentiation of induced pluripotent stem cells (iPSCs) into CMs [223]. The mechanical actuation 
of the scaffold enabled individual microfiber actuation to provide encompassing, coherent 
physiological strain to individual cells, which mimicked the native mechanical flow and force in 
the heart. In another study by Navaei et al., 50 µm microgrooves were incorporated into gelatin 
GelMA hydrogels with electrically conductive GNRs (Figure 7d) [10]. Fluorescent images 
revealed uniform, dense, and highly aligned cellular organization, as well as enhanced cytoskeletal 
alignment and cellular connectivity. 
 In addition to cardiac and neural cell types, ECHs have also been shown to modulate the 
proliferation and differentiation of preosteoblasts MC3T3-E1 for bone tissue engineering [224], as 
well as human primary skin fibroblasts for wound healing [225, 226]. However, conventional 
methods for engineering ECHs through the incorporation of conductive nanomaterials and 
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polymers are often associated with poor solubility, processability, biodegradability, and 
biocompatibility [227]. To address these limitations, our group recently reported a new method to 
engineer electroconductive materials from inherently non-conductive polymers, through the 
conjugation of a choline-based Bio-IL [34]. Our results demonstrated that GelMA/Bio-IL ECHs 
could be used to modulate the proliferation and contractile function of primary rat CMs in vitro. 
Furthermore, as current understanding of biological processes increases, and new multifunctional 
smart biomaterials are developed, novel applications of ECHs in tissue engineering will be 
explored. For instance, ECHs could be used to engineer bioactuators that transduce electrical 
stimuli into mechanical force, which in turn could be used as biomimetic muscle fibers [228]. 
ECHs could also be used to develop transparent and deformable touch sensors for emerging 
applications, such as bionic skin, as well as flexible/wearable biomedical devices [229]. 
 
2. EXPERIMENTAL 
2.1. Synthesis of biomaterials 
2.1.1. Synthesis of gelatin methacryloyl (GelMA): GelMA was synthesized as 
previously described[230]. Briefly, 10 g of gelatin (derived from fish or porcine sources) was 
dissolved in 100 mL phosphate buffered solution (DPBS) and heated to 50 °C. Then, 8 mL 
methacrylic anhydride (Sigma-Aldrich) was added dropwise to the gelatin solution under vigorous 
stirring at 50 °C to modify the lysine groups on the gelatin chains. The solution was then diluted 
with DPBS and dialyzed (Spectrum Laboratories, MWCO = 12-14 kDa) against deionized water 
at 50 °C for 5 d to remove any unreacted methacrylic anhydride. After sterile filtration using a 
vacuum filter (0.22 µm pore size), the solutions were subsequently lyophilized for 4 days, and the 
final GelMA product was stored at room temperature until experimental use. 
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2.1.2. Synthesis and expression of elastin-like polypeptide (ELP): The 
photocrosslinkable ELP sequence was expressed as previously described in our previous 
study[231]. This ELP sequence consists of 70 repeats of pentapeptide VPGVG, in which the first 
valine was replaced with an isoleucine every five pentapeptides (i.e., ([VPGVG]4[IPGVG])14). In 
addition, Lys-Cys-Thr-Ser (KCTS) residues were added to both sides of the ELP sequence to 
render it photocrosslinkable via the formation of S-S thiol bonds. This ELP was expressed using 
Escherichia coli (E. coli) as a host followed by the purification of the ELP via inverse transition 
cycling, as previously described[232]. Briefly, the ELP solutions were alternatively equilibrated 
and centrifuged above and below their thermal transition temperature (Tt = 29 °C in 1% (w/v) 
solution). Because the ELP protein precipitates at high temperatures and is soluble at low 
temperatures, these temperature changes provide a way to remove contaminates resulting in pure 
ELP. The purified ELP solution was then dialyzed in a water bath at 4 °C against DI water, and 
stored at room temperature after lyophilization.  
 
2.1.3. Synthesis of conductive hydrogels: ECHs were synthesized by mixing 
different ratios of methacrylated polymers and Choline acrylate (Bio-IL). Bio-IL was synthesized 
by mixing choline bicarbonate with acrylic acid at a 1:1 mole ratio. The mixture was reacted at 50 
°C for 5 h, then purified by evaporation overnight in a vacuum at room temperature. GelMA and 
PEGDA were two polymers used to form ECHs with Bio-IL. GelMA was synthesized using the 
method previously described in literature[233]. Briefly, 10% (w/v) gelatin solution was reacted 
with 8 mL of methacrylic anhydride for 3 h. The solution was then dialyzed for 5 days to remove 
any unreacted methacrylic anhydride, and then placed in a -80 °C freezer for 24 h. The frozen 
acrylated polymer was then freeze-dried for 7 days. The PEGDA used for this research was 
purchased from Sigma Aldrich (average Mn 700). To form polymer/Bio-IL hydrogels, the 
 46 
prepolymer and Bio-IL were added to distilled water at varying final polymer concentrations and 
polymer/Bio-IL ratios, then mixed with 1.5% TEOA, 1% VC, and 0.1 mM Eosin Y, which acted 
as the photoinitiator. Hydrogels were rapidly photocrosslinked in the presence of visible light at a 
wavelength of 475 nm for 120 s, using a LS1000 FocalSeal Xenon Light Source, manufactured by 
Genzyme.  
2.1.4. Cardiopatch fabrication: Porcine GelMA was synthesized using the 
previously described method[230]. A prepolymer solution was then prepared by mixing 10, 12.5, 
and 15 %(w/v) of GelMA in HFIP solvent (Sigma-Aldrich), and placed in a syringe with a 27G 
needle (Figure 8a). The prepolymer solution was then pumped out of the syringe at a rate of 1 
mL/h. A high voltage power source (Glassman High Voltage, Inc., Series EH) was attached to the 
needle of the syringe, and to a metal collector that the GelMA polymer was drawn to, creating a 
fibrous mat. Fibrous scaffolds were then removed from the collector plate and placed in a vacuum 
to remove any remaining solvent. Scaffolds were then placed in a solution bath containing 1.25 
%(w/v) photoinitiator Irgacure 2959 (Sigma-Aldrich) in ethanol. Bio-IL was also synthesized 
using the previously discussed methodology[234]. Four concentrations of Bio-IL in water were 
prepared including 0, 33, 66, and 100 %(v/v). Scaffolds were placed in a refrigerator to prevent 
the dissolving of GelMA fibers in Bio-IL/water solution. A volume of 1 mL Bio-IL was then 
placed on the surface of GelMA fibrous scaffolds and immediately crosslinked using UV 
irradiation for 300 s on each side of the scaffold.  
2.2. In vitro characterization of biomaterial properties 
2.2.1. 1H NMR characterization of GelMA/Bio-IL hydrogels: 1H NMR 
analyses were performed to characterize GelMA/Bio-IL composite hydrogels using a Varian 
Inova-500 NMR spectrometer. 1H-NMR spectra were obtained from choline bicarbonate, choline 
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acrylate (Bio-IL), GelMA prepolymer, and GelMA/Bio-IL hydrogels. Methacrylated groups were 
identified due to the presence of peak values at d=5.3 and 5.7 ppm. The decreasing rate for the 
C=C double bond signals %− !(#$#)!& ' in methacrylate group of GelMA was associated with the 
extent of crosslinking of composite hydrogel as well as conjugation of Bio-IL to GelMA. This area 
decrease was calculated using the following equation:  
 𝐃𝐞𝐜𝐚𝐲	𝐨𝐟	𝐦𝐞𝐭𝐡𝐚𝐜𝐫𝐲𝐥𝐚𝐭𝐞	𝐠𝐫𝐨𝐮𝐩	(%) = 	 ;𝐏𝐀𝐛 − 𝐏𝐀𝐚𝐏𝐀𝐛 > × 𝟏𝟎𝟎 (1) 
Where 𝑷𝑨𝒃 and 𝑷𝑨𝒂 represent the peak areas of methacrylated groups before and after 
photocrosslinking, respectively. Accordingly, 𝑷𝑨𝒃 − 𝑷𝑨𝒂 corresponds to the concentration of 
methacrylated groups consumed in the photocrosslinking process. ACD/Spectrus NMR analysis 
software were used to integrate the area under the peaks and all the data was analyzed with respect 
to phenyl group peaks at d=6.5-7.5 ppm. 
2.2.2. Mechanical testing: Mechanical testing on engineered ECHs were 
performed using an Instron 5542 mechanical tester. Both the elastic and compressive modulus 
were analyzed for each of hydrogels with varying final polymer concentration and polymer/Bio-
IL ratios. Composite hydrogels were created by using PDMS molds, which formed rectangular 
hydrogels (length: 12.00 mm, width: 5.00 mm, depth: 1.25 mm) for tensile test and cylindrical 
hydrogels (diameter: 5.5 mm, height: 4 mm) for compression test. A volume of 70 𝜇L of 
prepolymer solution was used to form photocrosslinked ECHs. ECHs were allowed to swell in 
DPBS for 4 h at 37 °C prior to mechanical testing. At least 5 samples were tested for each 
condition. 
For the compression test, hydrogels were placed between two compression plates, and 
compression was applied to each sample at a rate of 1 mm/min. Compression (mm) and load (N) 
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were recorded during each test using Bluehill software. Compression modulus was calculated as 
the tangent slope of the initial linear region of the stress-strain curve between 0 mm/mm and 0.1 
mm/mm compressive strain. For the tensile tests, hydrogels were held between two tensile grips 
and stretched at a rate of 1 mm/min until failure. The elastic modulus was calculated as the tangent 
slope of the stress-strain curve. At least 5 samples were tested per condition to obtain average and 
standard deviation. 
2.2.3. In vitro evaluation of electrical conductivity: ECHs with varying final 
polymer concentration and polymer/Bio-IL ratios were crosslinked in a rectangular PDMS mold 
and allowed to dry for 24 h. Once dried, conductivity analysis was performed using a two-probe 
electrical station connected to a Hewlett Packard 4155A Semiconductor Parameter analyzer. The 
dimensions of each hydrogel were measured and placed in a relaxed state where the two probes 
penetrated the hydrogels - one at each end (Figure 9a). The HP 4155A was set to measure current 
in the presence of an electrical stimulation ranging from -1 to 1 volt. The results were then analyzed 
to determine conductivity values. At least 5 samples were tested for each condition. 
2.2.4. Ex vivo evaluation of electrical conductivity: Adult female Wistar rats 
were provided by the Institutional Animal Care and Use Committee (ICAUC) at Northeastern 
University (Boston, MA, USA). All experiments were performed in accordance with relevant 
guidelines and regulations. Immediately after euthanasia, the rectus abdominis muscles were 
dissected and cut into 10 × 10 mm pieces. The tissue samples were then transferred to a glass petri 
dish and placed 3 mm apart on the opposite sides of an insulating PDMS mold (Figure 9e). 
GelMA/Bio-IL hydrogels at 50/50 and 20/80 ratios, as well as pure GelMA controls were 
photocrosslinked in situ to connect the two pieces of tissue. 50 ms square pulses of direct current 
were applied to the tissue using an Agilent wave generator (Agilent 33220A). The electrical 
 49 
stimulation was applied to the samples using short platinum wires with 0.25 mm diameter and 
99.9% trace metal basis, bought from Sigma-Aldrich (MO, USA). The threshold at which 
contraction was achieved was determined by applying increasing voltages (1 – 10 V) at a constant 
frequency of 1 hertz. Muscle contraction was visually inspected at each voltage, after applying 
electrical stimulation to the sample on the opposite side of the mold. 
2.2.5. In vitro degradation: ECHs were fabricated as previously explained for 
compression test. ECHs were then freeze-dried, weighed and were placed in 24-well plate with 1 
ml of DPBS or DPBS supplemented with 10% FBS solutions at 37 ºC in an oven continuously for 
2 weeks. The DPBS/FBS solutions were refreshed every 3 days to maintain constant enzyme 
activity. At prearranged time points (after 1, 7 and 14 days), the DPBS/FBS solutions were 
removed and the samples were freeze-dried for 24 h and weighed. The percentage degradation 
(D%) of the hydrogels was calculated using the below equation: 𝑫% = 𝑾𝒊,𝑾𝒕𝑾𝒊 × 𝟏𝟎𝟎% , (2) 
where Wi is the initial dry weight of the sample and Wt is the dry weight after time t. 
2.2.6. Swelling ratio measurements: The equilibrium swelling ratio of 
GelMA/Bio-IL and PEGDA/Bio-IL composite hydrogels were evaluated. For this purpose, 
cylinder-shaped hydrogels were prepared (7 mm in diameter, 2 mm in depth) as described 
previously. Prepared hydrogels were washed three times with DPBS. Then, they were lyophilized 
and weighed in dried condition. Thereafter, the samples were immersed in DPBS at 37 °C for 4, 8 
and 24 h and weighed again after immersion. The swelling ratio and water uptake capacity of the 
samples were calculated as the ratio of the swelled sample mass to the mass of lyophilized sample. 
2.2.7. SEM analysis: SEM analysis was performed to evaluate the porosity of the 
engineered GelMA/Bio-IL and PEGDA/Bio-IL hydrogels. The samples were prepared in a similar 
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procedure as described for swelling ratio test. The freeze-dried samples were then coated by 
gold/palladium (Au/Pd) before SEM analysis. The SEM images were acquired by using a 
FEI/Phillips XL30 FEG SEM (10 kV). Pore size analysis of the GelMA/Bio-IL hydrogels was 
performed by measuring the pore sizes of at least three images of four samples (n=50) using ImageJ 
software. 
2.2.8. Wound closure adhesion test: Wound closure adhesion test was performed 
using cardiopatches on porcine skin and rat myocardium. For wound closure on porcine skin, 
samples of tissue were cut into 40 ´ 20 mm pieces with a thickness of about 5 mm. The skin was 
glued with a cyanoacrylate adhesive onto glass slides. Two sections of porcine skin were then 
butted up against each other and a section of cardiopatch was placed to the top overlapping each 
section of skin tissue equally. The cardiopatch was then photocrosslinked for a period of 300 s. 
The glass slides were then connected to an Instron 5944 mechanical tester and analyzed to 
determine the adhesive strength of patches on porcine skin. The same test was performed using 
the same protocol but using rat myocardium. 
2.2.9. Burst pressure adhesion test: Burst pressure adhesion test was performed 
using cardiopatches on porcine intestinal tissue and cardiac tissue of female rats. Burst pressure 
using porcine intestinal tissue was performed by locking the tissue in a chamber connected to an 
air pump. A small defect in the intestinal tissue was created and covered by a cardiopatch. The 
cardiopatch was photocrosslinked for 300 s before the syringe pump was enabled with an infusion 
rate of 5 mL/min. Ex vivo burst pressure analysis was performed by placing a cardiopatch on the 
defect area of rat myocardium. Similarly, the syringe pump was set to 5 mL/min until failure of 
the patch. 
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2.2.10. Lap shear adhesion test: The shear strength of the engineered hydrogels 
with and without LA was evaluated using a modified ASTMF 2255-05. Two glass slides (1 cm ´ 
3 cm) were cut and placed end to end. Each glass slide had one end coated with 20% (w/v) porcine 
gelatin, which was allowed to dry at room temperature. Afterwards, 20 µL of the adhesive hydrogel 
propolymer solution was applied on a 1 cm ´ 1 cm area on the gelatin of one glass slide. The 
second gelatin-coated glass slide was then placed over the adhesive, followed by 180 s of 
irradiation with UV light. The two glass slides were then placed into an Instron mechanical tester 
for shear testing by tensile loading with a strain rate of 1 mm/min. The shear strength of the sealant 
sample was determined at the point of detaching. Each tested adhesive group contained three 
samples. 
2.2.11. In vitro hemostatic evaluation: Whole blood was added to a solution of 
3.6% (w/v) sodium citrate in a ratio of 1:9 (citrate solution : whole blood) to prevent clotting. A 
volume of 630 µL of the citrated blood was then pipetted into a 1 mL Eppendorf tube. A total of 
70 µL of 0.3 M calcium chloride (CaCl2) was added, followed by vortexing for 10 s. Engineered 
hydrogels were synthesized and 100 µL of prepolymer solution was pipetted onto the bottom of 
the wells of a 48 well plate ensuring complete coating of the bottom surface. Then 200 µL of blood 
was pipetted into the sequential wells containing hydrogels with varying concentrations of LA. At 
selected time points, each well was washed with 0.9% (9 g/L) saline solution to halt the clotting 
process. The liquid was aspirated and washed repeatedly until the solution was clear to ensure the 
removal of soluble blood components. After a trial was complete, the clotting time was determined 
based on the observation of a visible clot. In addition, clots were dried and weighed to determine 
the clot mass clot over time. 
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2.2.12. Primary CM isolation: Primary rat CMs were isolated from 2-day-old 
neonatal Sprague Dawley pups according to the protocol approved by the ICAUC at Northeastern 
University. All experiments were performed in accordance with relevant guidelines and 
regulations. Briefly, pups were quickly decapitated with scissors after disinfecting the neck and 
sternum with 70% ethanol. A vertical incision was made across the sternum to excise the heart, 
which was placed in cold Hank’s Balanced Salt Solution (HBSS) buffer. The atria and blood 
vessels were carefully removed and each heart was quartered and incubated overnight in a solution 
of 0.05% (w/v) trypsin in HBSS at 4 °C. Trypsin digestion was stopped by adding culture media, 
followed by shaking for 5 min at 37 °C in a water bath. The tissues were then serially digested in 
0.1% collagenase type II solution in HBSS (10 min shaking incubation at 37 °C). The collagenase 
solution with the CMs were centrifuged at 500 xg for 5 min. Primary cells were resuspended in 
DMEM supplemented with 10% FBS and pre-plated for 1 h to enrich for cardiomyocytes. 
2.2.13. Surface seeding (2D culture): Hydrogels were formed by placing a 7-μl 
drop of hydrogel precursor in a spacer with 150-μm height and covered by a glass slide coated 
with 3-(trimethoxysilyl) propyl methacrylate (TMSPMA, Sigma-Aldrich). Hydrogel precursor 
was then photocrosslinked for 20 s using a Genzyme FocalSeal LS100 xenon light source. Primary 
rat CMs (2.5 × 105 cells/scaffold) were seeded on the surface of the hydrogels and placed in 24-
well plates with 400 μL of growth medium (DMEM supplemented with 10% fetal bovine serum 
(FBS, Invitrogen) and 1% penicillin/streptomycin (Invitrogen)). 2D cultures were maintained at 
37 ºC in a 5% CO2 humidified atmosphere, for 10 days and culture medium was replaced every 48 
h. 
2.2.14. 3D cell encapsulation: Hydrogel precursors were prepared in cell culture 
medium containing 1.5% TEOA, 1% VC, and 0.1 mM Eosin Y. A cell suspension containing 
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freshly isolated CMs and CFs in culture medium (2:1 ratio of CMs:CFs and 1.8x107 cells/ml total 
cell density) was gently mixed with an equal volume of the precursor solution. 7-µl drops were 
then pipetted on 150-µm thick spacers and covered by TMSPA-coated glass slides. Hydrogels 
were then photocrosslinked for 120 s using a Genzyme FocalSeal LS100 xenon light source, as 
described before for 2D cultures. Cell-laden hydrogels were placed in 24-well plates with 400 μl 
of growth medium and maintained at 37 ºC in a 5% CO2 humidified atmosphere for 10 days. 
2.2.15. Cell viability: The viability of primary CMs grown on the surface of 
GelMA and GelMA/Bio-IL hydrogels was evaluated using a commercial live/dead viability kit 
(Invitrogen), according to instructions from the manufacturer. Briefly, cells were stained with 0.5 
μl/ml of calcein AM and 2 μl/ml of ethidium homodimer-1 (EthD-1) in DPBS for 15 min at 37 °C. 
Fluorescent image acquisition was carried out at days 1, 4, and 7 post-seeding using an 
AxioObserver Z1 inverted microscope (Zeiss). Viable cells appeared as green and apoptotic/dead 
cells appeared as red. The number of live and dead cells was quantified using the ImageJ software. 
Cell viability was determined as the number of live cells divided by the total number of live and 
dead cells. 
2.2.16. Metabolic activity: The metabolic activity of the cells was evaluated at 
days 1, 3, and 5 post-seeding, using a PrestoBlue assay (Life Technologies) according to 
instructions from the manufacturer. Briefly, 2D cultures of primary CMs were incubated in 400 
μL of growth medium with 10% PrestoBlue reagent for 2 h at 37 °C. The resulting fluorescence 
was measured (excitation 530 nm; emission 590 nm) using a Synergy HT fluorescence plate reader 
(BioTek). Control wells without cells were used to determine the background for all experiments. 
2.2.17. Cell adhesion, proliferation and spreading: CM spreading on the surface 
of the engineered composite hydrogels was visualized through fluorescent staining of F-actin 
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filaments and cell nuclei. Briefly, 2D cultures at days 1, 4, and 7 post-seeding were fixed in 4% 
(v/v) paraformaldehyde (Sigma) for 15 min., permeabilized in 0.1% (w/v) Triton X-100 (Sigma) 
for 5 min, and then blocked in 1% (w/v) bovine serum albumin (BSA, Sigma) for 30 min. Samples 
were then incubated with Alexa-fluor 488-labeled rhodamine-phalloidin (20/800 dilution in 0.1% 
BSA, Invitrogen) for 45 min. After three consecutive washes with DPBS, samples were 
counterstained with 1 μL/mL DAPI (4’,6-diamidino-2-phenylindole, Sigma) in DPBS for 5 min. 
Fluorescent image acquisition was carried out using an AxioObserver Z1 inverted microscope. 
2.2.18. Immunostaining of cardiac markers: Immunocytofluorescent staining 
was performed on 2D cultures of primary CMs in order to evaluate the expression of the cardiac 
differentiation marker sarcomeric α-actinin. Briefly, CMs growing on the surface of GelMA and 
GelMA/Bio-IL hydrogels gel were fixed in 4% paraformaldehyde for 1 h at room temperature at 
day 7 post-seeding. Samples were washed three times with DPBS, permeabilized in 0.1% (w/v) 
Triton X-100 for 30 min, and blocked in 10% (v/v) goat serum in DPBS containing 0.1% Triton 
x-100 for 1 h. Samples were incubated overnight with anti-sarcomeric α-actinin primary antibody 
(1:200 dilution) in 10% (v/v) goat serum at 4 °C. After incubation, samples were washed three 
times with DPBS and incubated for 2 h at room temperature with an Alexa Fluor 488-conjugated 
secondary antibody diluted in 10% (v/v) goat serum (1:200 dilution). Lastly, the samples were 
washed three times with DPBS and counterstained with DAPI (1/1000 dilution in DPBS) for 5 
min at room temperature. Image acquisition was performed using an AxioObserver Z1 inverted 
microscope. 
2.3. In vivo evaluation of biomaterial properties 
2.3.1. In vivo biodegradation and biocompatibility: All animal experiments 
were reviewed and approved by the ICAUC (protocols 15-0521R and 15-1248R) at Northeastern 
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University, and all experiments were performed in accordance with relevant guidelines and 
regulations. Male Wistar rats (200-250 grams) were obtained from Charles River (Boston, MA, 
USA) and housed in the local animal care facility under conditions of circadian day–night rhythm 
and feeding ad libitum. Anesthesia was achieved by 2.0 to 2.5% isoflurane inhalation, followed by 
0.02 to 0.05 mg/kg SC buprenorphine administration. After inducing anesthesia, eight 1-cm 
incisions were made on the posterior medio-dorsal skin, and small lateral subcutaneous pockets 
were by prepared blunt dissection around the incisions. GelMA/Bio-IL hydrogels (1 × 5 mm disks) 
were implanted into the pockets, followed by anatomical wound closure and recovery from 
anesthesia. Animals were euthanized by anesthesia/exsanguination at days 4, 14 and 28 post-
implantation, after which the samples were retrieved with the associated tissue and placed in 
DPBS. 
2.3.2. Histological analysis and immunofluorescent staining: Histological 
analyses were performed on cryosections of the explanted hydrogel samples in order to 
characterize the inflammatory response elicited by the implanted material. After explantation, 
samples were fixed in 4% paraformaldehyde for 4 hours, followed by overnight incubation in 30% 
sucrose at 4 ºC. Samples were then embedded in Optimal Cutting Temperature compound (OCT) 
and flash frozen in liquid nitrogen. Frozen samples were then sectioned using a Leica Biosystems 
CM3050 S Research Cryostat. 15-µm cryosections were obtained and mounted in positively 
charged slides using DPX mountant medium (Sigma). The slides were then processed for 
hematoxylin and eosin staining (Sigma) according to instructions from the manufacturer. 
Immunohistofluorescent staining was performed on mounted cryosections as previously 
reported[2]. Anti-CD3 [SP7] (ab16669) and anti-CD68 (ab125212) (Abcam) were used as primary 
antibodies, and an Alexa Fluor 488-conjugated secondary antibody (Invitrogen) was used for 
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detection. All sections were counterstained with DAPI (Invitrogen), and visualized on an 
AxioObserver Z1 inverted microscope (Zeiss). 
2.3.3. In vivo liver bleeding model: A median laparotomy was performed, and 
the central liver lobe was exposed by retraction of skin. A standard liver laceration was created by 
taping a #11 scalpel 5 mm from the tip. The tip of the scalpel was used to lacerate the liver tissue 
up to the tape. Immediately after the injury, nanocomposite hydrogels (n = 4; 150 µL) or Surgicel 
was (n = 4) applied on the site of lesion. Hemostatic properties were quantified by measuring the 
mass of blood absorbed on filter paper after 1 minute and 10 minutes post laceration for each 
sample. Rats were then sacrificed by severing the aorta.  
 
 
 
 
3. RESULTS AND DISCUSSION 
3.1.Engineering biodegradable and biocompatible bio-ionic liquid conjugated hydrogels 
with tunable conductivity and mechanical properties 
3.1.1. Synthesis of Bio-IL conjugated ECHs 
Herein, we describe a versatile method to conjugate choline-based Bio-ILs to both natural 
and synthetic polymers, to yield biodegradable and biocompatible ECHs (Figures 8). GelMA 
biopolymer was synthesized according to a methodology reported previously[233]. The Bio-IL 
was synthesized based on the reaction between choline bicarbonate and acrylic acid (Figure 8a). 
Different ratios of GelMA and Bio-IL were then mixed at room temperature. The resulting 
GelMA/Bio-IL prepolymer was then crosslinked into a hydrogel via visible-light initiated 
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photopolymerization, using Eosin Y, vinyl caprolactone (VC), and triethanolamine (TEOA) 
(Figure 8b). Composite hydrogels were synthesized using 100/0 (control), 80/20, 50/50, and 20/80 
polymer/Bio-IL ratios at 10%, 15% and 20% (w/v) final polymer concentrations. 
The acrylation of choline bicarbonate was confirmed by comparing the 1H NMR spectra 
of choline bicarbonate with that of the choline acrylate (Bio-IL). The appearance of a peak related 
to the hydrogen atoms in the acrylate groups at d=5.8-6.1 ppm was indicative of the acrylation of 
choline bicarbonate (Figures 8c). In addition, the 1H NMR spectra were collected for GelMA 
prepolymer (Figure 8d), and GelMA/Bio-IL composite hydrogel (Figure 8e) to confirm the 
conjugation of Bio-IL to GelMA. We used Equation 1 to calculate the continuous decrease of the 
C=C double bond signal in the GelMA methacrylate groups after exposure to visible light. By 
comparison between 1H NMR spectra of GelMA prepolymer (Figure 8d) and GelMA/Bio-IL 
composite hydrogel (Figure 8e), it was found that 94.1 ± 4.6 % of the methacrylate groups in 
GelMA/Bio-IL composites disappeared after photocrosslinking. In addition, 57.4 ± 4.3 % of the 
peak area related to C=C double bonds of the acrylate groups in Bio-IL (Figure 8c) also 
disappeared in composite GelMA/Bio-IL hydrogels following crosslinking (Figure 8e). This can 
confirm the incorporation of both Bio-IL and GelMA in the resulting composite hydrogel. The 
appearance of a sharp peak at d=3.1-3.2 ppm in composite hydrogel (Figure 8e), corresponded to 
the three hydrogen atoms of choline (ammonium ion), can also confirm the conjugation of Bio-IL 
to the hydrogel network. This peak was absent in the GelMA prepolymer spectrum (Figure 8d), 
but it was observed in both the Bio-IL (Figure 8c) and the composite GelMA/Bio-IL hydrogel 
(Figure 8e). 
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Figure 8. Synthesis and characterization of Bio-IL functionalized GelMA hydrogels. The 
panels show schematics of the proposed reactions for (a) the acrylation of choline bicarbonate to 
form Bio-IL, and (b) the reaction between GelMA and Bio-IL in the presence of Eosin Y and 
visible light to form GelMA/Bio-IL hydrogel. 1H-NMR analysis of (c) Bio-IL prepolymer, (d) 
GelMA prepolymer, and (e) GelMA/Bio-IL composite hydrogel. GelMA/Bio-IL hydrogels were 
formed by using 1% VC, 1.5% TEOA, and 0.1 mM Eosin Y at 120 s light exposure. 
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3.1.2. Characterization of the electroconductive properties of Bio-IL conjugated 
ECHs  
Conventional polymer-based hydrogels, including those based on GelMA and PEGDA, are 
intrinsically non-conductive. This characteristic limits their application for the modulation of 
excitable cell types, such as neurons and CMs. Therefore, we aimed to determine if the conjugation 
of a choline-based Bio-IL could provide electroconductive properties to polymer-based hydrogels. 
Briefly, Bio-IL functionalized GelMA and PEGDA hydrogels were synthesized as described 
before and allowed to dry for 24 h. In particular, we could not form stable hydrogels with 20/80 
polymer/Bio-IL ratios at 10% final polymer concentration. This was likely due to the low 
concentration of polymer within the network. The partially dried hydrogels were placed in a two-
probe electrical station connected to a Hewlett Packard 4155A Semiconductor Parameter analyzer 
to measure their conductivity (Figure 9a). A probe was placed at each end of the hydrogels and 
voltage was applied in increments of 0.05 V, from -1 to 1 V. The variations in the current were 
recorded, and the conductivity was calculated using Ohm’s Law[141]. These results demonstrated 
that the use of different final polymer concentrations, as well as different polymer/Bio-IL ratios 
enabled the modulation of the electrical properties of the composite ECHs. For instance, the 
conductivity of 50/50 GelMA/Bio-IL hydrogels increased from 3.03 × 10-05 ± 0.72 × 10-05 S/m 
to 4.27 × 10-05 ± 0.21 × 10-05 S/m, and 5.03 × 10-05 ± 0.80 × 10-05 S/m, when the final polymer 
concentration was increased from 10% to 15% and 20%, respectively (Figure 9b). Furthermore, 
the conductivity of 15% GelMA/Bio-IL hydrogels increased more than 63-fold, from 4.27 × 10-05 ± 0.21 × 10-05 S/m to 272 × 10-05 ± 27.05 × 10-05 S/m, when the GelMA/Bio-IL ratio was changed 
from 50/50 to 20/80 (Figure 9b).  
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Figure 9. Electrical conductivity of the engineered polymer/Bio-IL hydrogels crosslinked by 
visible light. (a) Experimental set-up of the two-probe electrical station used to measure the 
electrical conductivity of the engineered hydrogels. Conductivity measurements of Bio-IL 
conjugated (b) GelMA and (c) PEGDA hydrogels at different polymer concentrations and 
polymer/Bio-IL ratios (1% VC, 1.5% TEOA, 0.1 mM Eosin Y, and 120 s exposure to visible light 
were used to form GelMA and PEGDA hydrogels). (d) Electrical conductivity of 15% 
GelMA/Bio-IL composite hydrogels at 50/50 ratio, which was stretched up to 0%, 20%, 30%, and 
40% strain level demonstrating no significant changes in conductivity after stretching. (e) 
Schematic of ex vivo experiments performed using rat abdominal muscle tissues, connected using 
15% final polymer concentration and 50/50 GelMA/Bio-IL ratio, and pure GelMA hydrogels (f) 
Threshold voltages at which contraction was achieved using 15% final polymer concentration 
GelMA/Bio-IL at 50/50 and 20/80 ratios, as well as pure 15% GelMA hydrogels. Error bars 
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indicate standard error of the means, asterisks mark significance levels of p < 0.05 (*), p < 0.01 
(**), and p < 0.001 (***). 
 
Similar to what we observed for GelMA-based hydrogels, the conductivity of 50/50 
PEGDA/Bio-IL hydrogels also increased from 485 × 10-05 ± 54.93 × 10-05 S/m to 608 × 10-05 ± 
44.85 × 10-05 S/m and 1262 × 10-05 ± 421 × 10-05 S/m, when the final polymer concentration was 
increased from 10% to 15% and 20%, respectively (Figure 9c). In addition, the conductivity of 
15% PEGDA/Bio-IL hydrogels were also increased from 121 × 10-05 ± 1.01 × 10-05 S/m to 608 × 10-05 ± 44.85 × 10-05 and 711 × 10-05 ± 320 × 10-05 S/m, when the PEGDA/Bio-IL ratio was 
changed from 80/20 to 50/50 and 20/80, respectively (Figure 9c). Interestingly, hydrogels with 
80/20 GelMA/Bio-IL ratios did not exhibit any apparent conductivity in our experiments (Figure 
9b). However, PEGDA-based hydrogels with the same polymer/Bio-IL ratio did show measurable 
levels of conductivity, at all final polymer concentrations tested (Figure 9c). These observations 
suggest that the use of different polymer base systems could also influence the degree of 
conductivity of Bio-IL conjugated hydrogels. Taken together, these results demonstrated that the 
conductivity of the engineered ECHs increased consistently by increasing the concentrations of 
Bio-IL (Figures 9b and 9c). In particular, the maximum conductivity observed in our tests 
corresponded to 516 × 10-05 ± 50 × 10-05 S/m and 1,262 × 10-05 ± 420 × 10-05 S/m, for GelMA- 
and PEGDA-based hydrogels, respectively (Figures 9b and 9c). These results suggest that the 
20/80 GelMA/Bio-IL formulation, which exhibited a conductivity of 516 × 10-05 S/m, could 
potentially be implemented in cardiac tissue engineering applications, since the conductivity of the 
native myocardium has been shown to be approximately 500 × 10-05 S/m[39, 235]. 
The engineering of elastic and conductive materials that retain their electrical properties 
under substantial stretch and bending, still constitutes a major technical challenge[236, 237]. 
Therefore, we aimed to investigate the conductivity of the Bio-IL conjugated hydrogels at different 
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levels of stretching. However, no conductivity measurements at different strain levels could be 
obtained from PEGDA/Bio-IL hydrogels, since the samples broke after applying stretch at all 
polymer and Bio-IL concentrations tested. Hence, we focused our analysis solely on GelMA-based 
hydrogels. Briefly, GelMA/Bio-IL hydrogels were dried for 2 h to retain trace amounts of moisture 
and maintain their flexibility. The samples were then stretched, and the conductivity was measured 
at different strain levels, using a two-probe electrical station. These results showed that there were 
no statistically significant differences between the conductivity of hydrogels at different levels of 
stretching (Figure 9d). In contrast, alternative methods to engineer ECHs, such as the 
incorporation of dispersed metallic nanoparticles, often suffer from a rapid and nonlinear decrease 
in conductivity during stretching[236, 238, 239]. 
One of the most widely explored applications of ECHs is their use as conductive scaffolds 
for engineering excitable tissue constructs. Thus, we evaluated the potential of Bio-IL conjugated 
polymers to restore the propagation of electrical stimuli across severed skeletal muscle tissues ex 
vivo. Briefly, the rectus abdominis muscles of female Wistar rats were explanted after euthanasia 
and cut into square pieces. The tissues were placed 3 mm apart, in an electrically insulated PDMS 
mold. GelMA/Bio-IL hydrogels, as well as pure GelMA controls were photocrosslinked in situ, 
between the two pieces of tissue (Figure 9e). Pulsed direct current test runs were conducted by 
applying 50 ms square pulses at increasing frequencies, using short platinum wires that were 
positioned on one of the two pieces of muscle tissue. The induction of contraction was visually 
inspected in the sample on the opposite end of the hydrogel, after applying electrical pulses at 
increasing voltages. These results demonstrated that muscle tissue samples joined together using 
GelMA/Bio-IL hydrogels exhibited a significantly lower excitation threshold, when compared to 
pure GelMA controls (Figure 9f). These observations suggest that Bio-IL functionalized polymers 
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could be used to restore functional integrity, in tissues in which electrophysiological 
communication has been interrupted. Previous works have demonstrated the ability of ECHs to 
restore electrophysiological coupling of severed skeletal muscle tissue ex vivo, using PPy-
chitosan[240] and GO/MeTro hydrogels[2]. However, the incorporation of the PPy polymer, as 
well as GO nanoparticles into the hydrogel networks was associated with poorly tunable 
conductive properties. In contrast, Bio-IL functionalized hydrogels exhibited a wide range of 
electroconductive properties (Figures 9b and 9c). 
3.1.3. Characterization of the mechanical properties of engineered ECHs  
Hydrogels used in biomedical applications must provide adequate mechanical support to 
cells and tissues, as well as the effective transduction of physicochemical stimuli. In particular, 
mechanical cues are known to modulate key cellular functions such as cell proliferation, 
differentiation, migration, and apoptosis[241]. Here, we characterized the mechanical properties 
of the engineered composite hydrogels. Tensile and compression tests were performed on Bio-IL 
conjugated hydrogels at different polymer/Bio-IL ratios, as well as different final polymer 
concentrations (Figures 10). Bio-IL conjugated hydrogels exhibited highly tunable compressive 
moduli in the range of 0.60 ± 0.20 kPa to 32.07 ± 8.61 kPa (Figure 10a) and 1.27 ± 0.05 kPa to 
178.13 ± 20.59 kPa (Figure 10b) for GelMA- and PEGDA-based hydrogels, respectively. In 
addition, results revealed that the compressive moduli for both GelMA- and PEGDA-based 
hydrogels increased concomitantly, by increasing the final polymer concentration as well as the 
ratio of polymer to Bio-IL. For instance, the compressive moduli of 15% GelMA/Bio-IL hydrogels 
were shown to increase from 0.60 ± 0.20 kPa to 22.10 ± 1.56 kPa, when the ratio of GelMA to 
Bio-IL was increased from 20/80 to 100/0, respectively (Figure 10a). In addition, the compressive 
moduli of 50/50 GelMA/Bio-IL hydrogels were also increased from 2.65 ± 1.06 kPa to 5.53 ± 
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0.76 kPa and 8.87 ± 1.83 kPa, when the final polymer concentration was increased from 10% to 
15% and 20%, respectively (Figure 10a). This trend was also observed for PEGDA/Bio-IL 
hydrogels. However, the use of PEGDA-based hydrogels yielded significantly higher compressive 
moduli, as compared to GelMA-based hydrogels (Figure 10b). For instance, the compressive 
moduli of 15% PEGDA/Bio-IL hydrogels were increased from 1.27 ± 0.06 kPa to 78.17 ± 12.80 
kPa, when the ratio of PEGDA to Bio-IL was increased from 20/80 to 100/0, respectively (Figure 
10b). In addition, the compressive moduli of 50/50 PEGDA/Bio-IL hydrogels were also increased 
from 2.17 ± 0.23 kPa to 28.73 ± 6.31 kPa and 89.83 ± 13.59 kPa, when the final polymer 
concentration was raised from 10% to 15% and 20%, respectively (Figure 10b). 
 
 
Figure 10. Mechanical properties of Bio-IL conjugated GelMA and PEGDA hydrogels 
crosslinked with visible light. Compressive moduli for (a) GelMA/Bio-IL and (b) PEGDA/Bio-
IL hydrogels engineered by varying polymer concentration and polymer/Bio-IL ratios. Elastic 
moduli for (c) GelMA/Bio-IL and (d) PEGDA/Bio-IL hydrogels with varying polymer 
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concentration and polymer/Bio-IL ratios (1% VC, 1.5% TEOA, 0.1 mM Eosin Y, and 120 s light 
exposure were used to form GelMA and PEGDA hydrogels). Error bars indicate standard error of 
the means, asterisks mark significance levels of p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***). 
 
We also performed tensile tests to measure the elastic modulus of the composite hydrogels. 
These exhibited a wide range of elastic moduli, in the range of 5.20 ± 1.15 kPa to 100.77 ± 23.95 
kPa (Figure 10c) and 2.60 ± 0.46 kPa to 172.70 ± 2.86 kPa (Figure 10d) for GelMA- and 
PEGDA-based hydrogels, respectively. Similar to what we observed for the compressive moduli, 
the elastic moduli of Bio-IL conjugated hydrogels were also dependent on the final polymer 
concentration, as well as the ratio of polymer to Bio-IL. For instance, the elastic moduli of 15% 
GelMA/Bio-IL hydrogels were shown to increase consistently from 5.40 ± 0.87 kPa to 89.30 ± 
15.65 kPa, when the ratio of polymer to Bio-IL was increased from 20/80 to 100/0, respectively 
(Figure 10c). Further, the ultimate strain of GelMA/Bio-IL hydrogels were shown to increase by 
increasing the concentration of Bio-IL. For example, for 15% GelMA/Bio-IL hydrogels the 
ultimate strain increased from 13.93 ± 4.50% to 31.25 ± 5.10% when the ratio of GelMA to Bio/IL 
was changed from 100/0 to 20/80, respectively (Figure 11a). However, the ultimate stress 
decreased by increasing the concentration of Bio-IL. As shown in Figure 11c the ultimate stress 
decreased from 9.97 ± 1.42 kPa to 0.97 ± 0.25 kPa when the GelMA to Bio-IL ratio was changed 
from 100/0 to 20/80 at 15% final polymer concentration. In addition, the elastic moduli of 50/50 
GelMA/Bio-IL hydrogels were also increased from 5.20 ± 1.15 kPa to 21.30 ± 5.75 kPa and 33.13 ±	4.78 kPa, when the final polymer concentration was increased from 10% to 15% and 20%, 
respectively (Figure 10c). Once again, the use of PEGDA-based hydrogels yielded significantly 
higher elastic moduli, as compared to GelMA-based hydrogels (Figure 10d). The elastic moduli 
of 15% PEGDA/Bio-IL hydrogels increased from 2.73 ± 0.43 kPa to 60.00 ± 15.85 kPa, when 
the ratio of PEGDA to Bio-IL was increased from 20/80 to 100/0, respectively (Figure 10d). 
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Similar to GelMA/Bio-IL hydrogels, the ultimate strain of 15% PEGDA/Bio-IL hydrogels were 
shown to increase from 9.28 ± 2.26% to 59.65 ± 11.59% when the ratio of PEGDA to Bio/IL was 
changed from 100/0 to 20/80, respectively (Figure 11b). The ultimate stress also increased from 
1.53 ± 0.40 kPa for the 20/80 ratio, to 6.10 ± 3.22 kPa for the 100/0 for 15% PEGDA/Bio-IL 
hydrogels (Figure 11d). Lastly, the elastic moduli of 50/50 PEGDA/Bio-IL hydrogels were also 
increased from 2.60 ± 0.46 kPa to 13.43 ± 3.20 kPa and 54.37 ± 6.34 kPa, when the final polymer 
concentration was increased from 10% to 15% and 20%, respectively.  
 
Figure 11. Ultimate stress and ultimate strain of Bio-IL functionalized GelMA and PEGDA 
hydrogel crosslinked with visible light. Ultimate strain values for (a) GelMA/Bio-IL and (b) 
PEGDA/Bio-IL hydrogels engineered by varying polymer concentration and polymer/Bio-IL 
ratios. Ultimate stress for (c) GelMA/Bio-IL and (d) PEGDA/Bio-IL hydrogels with varying 
polymer concentration and polymer/Bio-IL ratios (1% VC, 1.5% TEOA, 0.1 mM Eosin Y, and 
120 s light exposure were used to form GelMA and PEGDA hydrogels). Error bars indicate 
standard error of the means, asterisks mark significance levels of p < 0.05 (*), p < 0.01 (**), and 
p < 0.001 (***). 
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Taken together, our results revealed that the mechanical properties of the composite 
scaffolds could be efficiently modulated by varying both the final polymer concentration, as well 
as the polymer/Bio-IL ratio. The enhanced mechanical properties at higher polymer concentrations 
could be explained in part due to the presence of a greater number of available crosslinking 
sites[242]. Moreover, the engineered scaffolds present several technical advantages in the context 
of biomedical applications. For example, previous studies have demonstrated that the stiffness of 
the native human myocardium ranges from 20 kPa to 100 kPa[243, 244]. Therefore, the highly 
versatile and tunable mechanical properties of these biomaterials could be used to generate ECHs 
with varying degrees of stiffness, which will mimic the mechanical properties of the native cardiac 
tissues. 
3.1.4. Characterization of pore size, swelling ratios and in vitro degradation of 
engineered ECHs 
The porosity of the hydrogels is an important factor in the modulation of cell and tissue 
interactions, as well as in the penetration of cells into the scaffold, in both 2D culture and 3D cell 
encapsulation[245]. Therefore, we aimed to characterize the porosity of GelMA/Bio-IL (Figure 
12a) and PEGDA/Bio-IL (Figure 12b) hydrogels, using scanning electron microscopy (SEM). 
SEM image analysis determined that the average size of the pores in the GelMA/Bio-IL (Figure 
12c) and PEGDA/Bio-IL (Figure 12d) hydrogels is also dependent on the final polymer 
concentration, as well as the polymer/Bio-IL ratio. For instance, the overall pore sizes of 50/50 
GelMA/Bio-IL hydrogels decreased from 85.1 ± 18.4 μm to 61.5 ± 13.1 μm, by increasing the 
final polymer concentration from 10% to 20%. Similarly, the dimensions of the pores decreased 
from 86.4 ± 20.3 μm to 39.0 ± 7.9 μm, by increasing the ratio of GelMA to Bio-IL from 100/0 to 
20/80 at 15% final polymer concentration. Although, a similar trend could be observed for 
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PEGDA/Bio-IL hydrogels, we were not able to observe any apparent pores in all 20/80 hydrogels, 
as well as 50/50 hydrogels formed at 15% and 20% final polymer concentrations (Figure 12d). 
Previous studies have shown that hydrogels with large pores allow better cell penetration, as well 
as new tissue formation within the microstructure of the scaffold, when compared to hydrogels 
with lower porosity[245, 246]. Therefore, the tunable porosity of Bio-IL conjugated hydrogels 
could be used to modulate the spatial distribution of cells within the scaffolds. 
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Figure 12. Pore characteristics, in vitro swelling, and degradation of polymer/Bio-IL 
hydrogels Representative SEM images of (a) GelMA/Bio-IL and (b) PEGDA/Bio-IL hydrogels 
formed by using 100/0 and 50/50 polymer/Bio-IL ratio at 15% (w/v) polymer concentration (1% 
VC, 1.5% TEOA, and 0.1 mM Eosin Y at 120 s light exposure were used to form the hydrogels).  
Average pore sizes of (c) GelMA/Bio-IL and (d) PEGDA/Bio-IL hydrogels at varying polymer 
concentrations and polymer/Bio-IL ratios. Swelling ratios of (e) GelMA/Bio-IL and (f) 
PEGDA/Bio-IL hydrogels at 15% final polymer concentration and 50/50 polymer/Bio-IL ratio in 
DPBS after 4, 8 and 24 h. Degradation of (g) GelMA/Bio-IL and (h) PEGDA/Bio-IL hydrogels at 
15% final polymer concentration and 50/50 polymer/Bio-IL ratio in DPBS supplemented with 
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10% FBS over a two-week period. Error bars indicate standard error of the means, asterisks mark 
significance levels of p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***). 
 
In the context of tissue engineering, excessive water uptake and degradation could 
potentially lead to impaired mechanical and electroconductive properties. Therefore, we evaluated 
the water uptake ability and the in vitro degradation rate of the composite hydrogels. These results 
demonstrated that the maximum swellability was achieved after 4 h of incubation, with no further 
increases observed after 8 and 24 h. In addition, the swelling ratio after 4 h of incubation for 15% 
GelMA/Bio-IL (Figure 12e) and PEGDA/Bio-IL (Figure 12f) hydrogels, increased from 38.1% 
± 5.0% to 83.3% ± 8.6%, and from 11.6% ± 3.6% to 185.7% ± 17.1%, respectively, by changing 
the polymer/Bio-IL ratio from 100/0 to 20/80. In general, the highest swelling ratios for 
GelMA/Bio-IL (Figure 12e) and PEGDA/Bio-IL (Figure 12f) hydrogels were observed in 
hydrogels synthesized using a polymer/Bio-IL ratio of 20/80. These observations can be explained 
in part due to the presence of hydroxyl (-OH) and amine (-NH2) hydrophilic residues in the choline 
acrylate structure, which would lead to increased water uptake into the scaffold[247]. Previous 
studies have reported that the swellability of IL-based hydrogels is highly dependent on the 
concentration of IL in the system[154, 248]. In our experiments, the highest swelling ratio 
observed (223.7 ± 28.5) was lower than that reported for other IL conjugated polymers, such as 
chitosan (>400%)[249]. This characteristic is remarkably advantageous for the implementation of 
Bio-IL functionalized hydrogels in the context of physiological wet tissues.  
Lastly, we aimed to evaluate the in vitro degradation of the engineered composite 
hydrogels. For this, we incubated Bio-IL conjugated hydrogels in Dulbecco's phosphate-buffered 
saline (DPBS) and DPBS with 10% fetal bovine serum (FBS), at 37 °C for 14 days. These results 
showed that in vitro degradation of 15% GelMA/Bio-IL (Figure 12g) and PEGDA/Bio-IL (Figure 
12h) hydrogels occurred mainly after 24 h of incubation, for all polymer/Bio-IL ratios tested. 
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Furthermore, the results also showed that the rate of degradation decreased consistently, by 
increasing the ratio of polymer to Bio-IL. After 14 days of incubation in DPBS supplemented with 
10% FBS 52.70 ± 4.24 % of 20/80 PEGDA/Bio-IL hydrogel degraded, which was considerably 
higher than 36.59 ± 3.95 % of 20/80 GelMA/Bio-IL hydrogel. This general trend was also 
observed for 10%, and 20% GelMA/Bio-IL and PEGDA/Bio-IL hydrogels at varying 
polymer/Bio-IL ratios, both in DPBS and DPBS supplemented with 10% FBS. In general, 
composite hydrogels containing lower concentrations of Bio-IL exhibited slower degradation rate 
after 1, 7 and 14 days of incubation. It is important to note that the due to the organic nature of this 
compound, the degradation of the Bio-IL functionalized hydrogels will not result in the generation 
of any cytotoxic byproducts[250]. 
Taken together, the physical characterization of Bio-IL conjugated hydrogels demonstrated 
that the microarchitecture, electrical conductivity, porosity, and in vitro degradation can be 
modulated by varying the final polymer concentration, as well as the polymer/Bio-IL ratio. This 
remarkable degree of tunability suggests that Bio-IL conjugated hydrogels could be readily 
tailored to different biomedical and tissue engineering applications. 
3.1.5. In vitro 2D cell seeding on the engineered GelMA/Bio-IL hydrogels 
Hydrogels with electroconductive properties possess a remarkable potential for tissue 
engineering since they can serve as bioactive scaffolds to modulate excitable cell types. In 
particular, the use of various synthetic and natural biomaterials has been investigated for the 
engineering of functional tissue constructs for different cardiac tissue engineering 
applications[251, 252]. Naturally derived polymers, such as collagen and its denatured form 
gelatin, have been shown to efficiently promote the attachment, proliferation, and migration of 
various cell types in vitro[253, 254].  This is mainly due to the presence of cell-binding motifs and 
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protease-sensitive degradation sites that modulate the attachment of cells to the ECM in vivo. In 
contrast, synthetic materials such as PEG and its acrylated form, PEGDA, exhibit no intrinsic cell-
binding activity due to inert nature of PEG-based polymers[255]. Therefore, we aimed to 
investigate the potential of GelMA/Bio-IL conjugated hydrogels to support the growth, spreading 
and function of primary rat CMs in 2D cultures in vitro. A commercial live/dead assay was used 
to determine the viability of CMs growing on the surface of GelMA (Figure 13a) and GelMA/Bio-
IL (Figure 13b) hydrogels, over a period of 5 days. Similarly, cell attachment and spreading on 
GelMA (Figure 13c) and GelMA/Bio-IL (Figure 13d) hydrogels were evaluated through F-
actin/DAPI immunofluorescent staining. We also investigated the ability of GelMA/Bio-IL 
scaffolds to maintain the native phenotype and function of primary CMs in 2D cultures in vitro. 
For this, we evaluated the expression of the cardiac differentiation marker sarcomeric α-actinin 
(Figures 13g, and 13h), as well as the contractile behavior (Figure 13i) of primary CMs seeded 
on the surface of 15% (w/v) GelMA and 50/50 GelMA/Bio-IL hydrogels. Our results demonstrated 
that the viability of CMs seeded on engineered hydrogels was not affected due to the presence of 
the Bio-IL (Figure 13e). Cells seeded on the surface of GelMA/Bio-IL hydrogels appeared to 
exhibit slightly lower viabilities at day one post-seeding, when compared to GelMA controls. 
However, there were no statistically significant differences between the composite scaffolds and 
the controls, at days 3 and 5 post-seeding. Furthermore, the metabolic activity of the primary 
cultures was shown to increase consistently throughout the duration of the culture, as shown by 
the commercial PrestoBlue assay (Figure 13f). This behavior could be explained in part due to the 
adaptation of the CMs to the conditions in vitro, as well as the proliferation of CFs that could not 
be removed during CM isolation. Immunofluorescent staining revealed that primary CMs on the 
surface of GelMA/Bio-IL hydrogels exhibited homogeneous distribution of sarcomeric α-actinin 
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(Figure 13h), compared to the intermittent pattern observed in GelMA controls (Figure 13g). In 
addition, GelMA/Bio-IL hydrogels exhibited significantly higher cell numbers than pure GelMA 
controls at day 5 post-seeding, as shown by quantification of DAPI-stained cell nuclei (Figure 
13j). Taken together, these results demonstrated that the biocompatibility of GelMA/Bio-IL 
hydrogels was similar to that of GelMA controls, and that they could promote the growth and 
spreading of primary CMs in vitro. 
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Figure 13. 2D in vitro studies using GelMA/Bio-IL hydrogels seeded with CMs. Representative 
live/dead images from CMs cultured on (a) GelMA (control) and (b) GelMA/Bio-IL hydrogels on 
days 1 and 5 (scale bar = 200 μm). Representative F-Actin/DAPI stained images from CMs seeded 
on (c) GelMA and (d) GelMA/Bio-IL on days 1 and 5. (e) Cell viability quantification of CMs 
cultured on the hydrogels after 1, 3, and 5 days of culture. (f) Quantification of metabolic activity, 
RFU (relative fluorescence intensity) using PrestoBlue assay, 1, 3, and 5 days after seeding with 
CMs. Immunofluorescent staining of sarcomeric α-actinin in CMs seeded on GelMA (g) and 
GelMA/Bio-IL (h) hydrogels on day 7 (scale bar = 25 μm). (i) Characterization of synchronous 
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contraction in CMs seeded on GelMA and GelMA/Bio-IL hydrogels over 7 days of culture. (*p < 
0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001). 
 
CMs maintained in 2D environments tend to revert to a less mature phenotype and lose the 
ability to respond to physiological stimuli[256]. Thus, apart from the maintenance of metabolically 
active cells, the preservation of the native phenotype is critical to promote the spatial and functional 
organization of CMs[257]. Immunofluorescent staining of the cardiac differentiation marker 
sarcomeric α-actinin revealed that CMs in GelMA/Bio-IL hydrogels were distributed in spatially-
relevant multi-cellular organizations (Figure 13g). Moreover, these images also showed that CMs 
still exhibited characteristic cross-striations after 7 days of culture, which are indicative of the 
sarcomeric structures present in the native ventricular myocardium. In addition, CMs growing in 
GelMA/Bio-IL hydrogels exhibited a more robust and stable spontaneous contraction profile, 
when compared to CMs growing on GelMA controls (Figure 13i). For example, on day 7, the 
beating frequency of CMs seeded on GelMA/Bio-IL was 83.05 ± 9.54 beats/min, which was 
considerably higher than the beating frequency of cells seeded on pure GelMA hydrogel (52.61 ± 
5.43 beats/min). These observations suggest that GelMA/Bio-IL hydrogels promoted the 
formation of interconnected cellular networks on the surface of the scaffolds, which in turn aided 
to maintain tissue-level function of primary CMs in vitro. 
Although PEGDA/Bio-IL hydrogels could not be used for cell culture due to the intrinsic 
inert nature of PEGDA, previous groups have reported the modification of PEG-based hydrogels 
via tethering of bioactive motifs, such as the incorporation of Arg-Gly-Asp (RGD) and matrix 
metalloproteinase-sensitive degradation domains[258-260]. These modifications have been shown 
to enhance the cell-binding ability and the biodegradability of PEG-based hydrogels for tissue 
engineering applications. Furthermore, due to their intrinsic resistance to cell adhesion and protein 
adsorption, PEG-based hydrogels exhibit minimal adverse host responses and highly specific 
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bioactivity via the conjugation of specific bioactive agents[261]. The intrinsic differences between 
PEGDA and GelMA polymers clearly demonstrate the remarkable potential of Bio-IL 
functionalization to engineer new conductive biomaterials with a wide range of biological and 
physicochemical properties, which can be tailored for different biomedical applications. 
3.1.6. 3D encapsulation of primary CMs/CFs inside the engineered GelMA/Bio-IL 
hydrogels 
Biomaterials-based cardiac tissue models that rely on 2D cultures of primary CMs have 
been extensively reported in the literature to investigate many cellular and biochemical 
mechanisms relevant for cardiac physiology[251]. More recently, in vitro models with increased 
physiological relevance have been engineered to recapitulate the interactions between different 
cell types and the 3D architecture of native tissues[262]. However, the use of ECHs for 3D 
encapsulation of primary cardiac cells in highly biocompatible ECHs with tunable 
electroconductive and mechanical properties has not been fully explored. Here, we investigated 
the ability of GelMA/Bio-IL hydrogels to support the growth and function of 3D encapsulated 
CMs and CFs in vitro. Similar to 2D cultures, we used a live/dead assay, F-actin/DAPI staining, 
and a PrestoBlue assay to determine the viability (Figures 14a-14d), spreading (Figures 14e-14h), 
and metabolic activity (Figure 14j) of 3D encapsulated cells in 15% (w/v) 50/50 GelMA/Bio-IL 
hydrogels. Although the overall viability of 3D encapsulated cells was comparatively lower than 
that observed for 2D cultures (Figure 14e), cells in GelMA/Bio-IL hydrogels exhibited 
significantly higher viabilities compared to pure GelMA hydrogels (Figure 14i). In addition, these 
results also showed that the metabolic activity of cells encapsulated in GelMA/Bio-IL hydrogels 
increased consistently during the 5 days of culture (Figure 14j). However, no significant 
differences between GelMA/Bio-IL and GelMA controls were observed regarding the 
proliferation (cells/mm2) of 3D encapsulated cells (Figure 14k). Lastly, similar to what we observe 
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for 2D cultures, our results demonstrated that CMs encapsulated in GelMA/Bio-IL hydrogels 
exhibited comparatively better contractile profiles, compared to pure GelMA controls (Figure 
14l). Overall, in vitro assessment of GelMA/Bio-IL hydrogels demonstrated that the engineered 
ECHs are cytocompatible and promote cell growth and spreading in 3D cultures in vitro. Although 
no statistically significant differences in cell number could be observed in cell number (Figure 
14k), the viability (Figure 14i) and metabolic activity (Figure 14j) of CMs/CFs 3D encapsulated 
in GelMA/Bio-IL hydrogels were higher, when compared to pure GelMA controls. The 
mechanism underlying the improved growth of 3D encapsulated CMs in GelMA/Bio-IL hydrogels 
was not investigated in this study. However, previous studies have described that electrical stimuli 
could influence cell fate, through the modulation of the calcium/calmodulin pathway[263, 264]. 
Briefly, electrical stimuli propagate across the cell membrane, raising the intracellular calcium 
concentration by activating voltage-gated calcium channels. Elevated intracellular calcium levels 
activate the cytoskeletal form of calmodulin, which results in enhanced proliferation and increased 
expression of vascular endothelial growth factor (VEGF), and transforming growth factor (TGF)-
ß[265]. This characteristic of GelMA/Bio-IL scaffolds could be critical in the restoration of 
impaired electrical conductivity and tissue function in scarred peri-infarct regions. 
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Figure 14. In vitro 3D cell encapsulation of cardiomyocytes (CMs) and cardiac fibroblasts 
(CFs) in GelMA/Bio-IL hydrogels. CMs and CFs (2:1 ratio) were 3D encapsulated inside visible 
light-crosslinked GelMA (control) and GelMA/Bio-IL hydrogels. Representative live/dead images 
from CMs/CFs encapsulated in GelMA hydrogels (a, b) and GelMA/Bio-IL (c, d) at days 1 and 7 
post-encapsulation. Representative F-Actin/DAPI fluorescent images of CMs/CFs encapsulated in 
GelMA (e, f) and GelMA/Bio-IL (g, h) hydrogels, at days 1 and 7 post-encapsulation (scale bar = 
200 μm). (i) Quantification of cell viability for 3D-encapsulated CMs/CFs at days 1, 4, and 7 post-
encapsulation. (j) Quantification of metabolic activity, RFU (relative fluorescence intensity) using 
PrestoBlue assay, at days 1, 3, and 5 post-encapsulation. (k) Quantification of cell proliferation 
based on DAPI-stained cell nuclei, at days 1, 4, and 7 post-encapsulation. (l) Characterization of 
synchronous contraction in co-cultures of CMs/CFs 3D-encapsulated in GelMA (control) and 
GelMA/Bio-IL hydrogels over 7 days of culture. (*p < 0.05, **p < 0.01, ***p < 0.001 and ****p 
< 0.0001). All hydrogels were synthesized using 15% (w/v) final polymer concentration and 50/50 
polymer/Bio-IL ratio. Error bars indicate standard error of the means, asterisks mark significance 
levels of p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***). 
 
In vitro 3D co-cultures of CMs and CFs are being explored to engineer myocardial tissue 
constructs for drug screening and tissue engineering applications[266-268]. However, the 
successful 3D encapsulation of CMs/CFs in highly biocompatible hydrogels with tunable 
mechanical and electroconductive properties has not been fully explored. Apart from material 
biocompatibility, the integration of physiological stimuli is critical to promote growth, survival, 
and the functional organization of excitable cell types, such as nerve and muscle[25, 257].  After 
myocardial infarction, the nonconductive nature of the resulting scar tissue leads to ventricular 
dysfunction, as well as the electrical uncoupling of viable CMs in the infarcted region[269]. Due 
to the limited regenerative potential of adult CMs, several regenerative cardiac tissue engineering 
approaches have been developed using two main strategies: cell-based and/or material-based 
scaffolds[270]. However, one of the major limitations of conventional biomaterial-based 
approaches is that the insulating polymeric scaffolds diminish the transfer of electrical signals 
between CMs, which could lead to arrhythmias after implantation[271]. Thus, ECHs could be used 
to engineer scaffolds that promote impulse propagation and synchronize contraction, which in turn 
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could help restore ventricular function by electrically coupling isolated CMs to the native 
tissue[240].  
3.1.7. In vivo biodegradation and biocompatibility of GelMA/Bio-IL hydrogels 
One of the limitations of conventional conductive polymers is that they are often not 
biodegradable in vivo, which could trigger a persistent inflammatory response due to their 
prolonged half-lives in the organism[35]. We investigated the in vivo degradation and interactions 
of GelMA-Bio-IL hydrogels with the local tissues, as well as their immunogenicity profile when 
implanted subcutaneously in vivo in an animal host. Explanted samples recovered at days 4, 14, 
and 28 post-implantation revealed that GelMA/Bio-IL hydrogels exhibited sustained 
biodegradation throughout the duration of the 28-day experiment (Figure 15a). This observation 
suggests that the engineered hydrogels were efficiently degraded in vivo, through enzymatic 
hydrolysis of the hydrogel matrix. Visual inspection of the explanted samples also revealed 
significant infiltration of host tissues within the hydrogels (Figure 15b). Although complete 
biodegradation of the scaffold was not observed due to the length of the study, previous works 
have demonstrated that GelMA-based hydrogels contain peptide sequences that facilitate cell-
mediated degradation in vivo[230, 272, 273]. Furthermore, the conjugation of the Bio-IL to 
different polymers could be used to engineer ECHs with varying degrees of biodegradability. For 
example, biomaterials with more hydrolytically-stable backbones such as PEGDA would result 
ideal for long-term applications, where a more biostable implantable scaffold is needed[274].  
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Figure 15. In vivo biodegradation and biocompatibility of GelMA/Bio-IL composite hydrogel 
using a rat subcutaneous model. (a, b) Evaluation of the in vivo degradation of GelMA/Bio-IL 
on days 0, 4, 14 and 28 post implantation (n = 4). (a) In vivo degradation of GelMA/Bio-IL 
hydrogels based on weight loss of the implants. The in vivo degradation profile of GelMA/Bio-IL 
hydrogels exhibits an approximately linear behavior during 28 days after implantation. (b) Images 
of the GelMA/Bio-IL composite hydrogels at 0, 4, 14, and 28 days after implantation. (c-e) 
Hematoxylin and eosin (H&E) staining of GelMA/Bio-IL sections after (c) 4 days, (d) 14 days, 
and (e) 28 days of implantation (scale bars = 500 µm). The H&E shows a negligible amount of 
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inflammatory cells. (f-h) Fluorescent immunohistochemical analysis of subcutaneously implanted 
GelMA/Bio-IL hydrogels showing no significant local lymphocyte infiltration (CD3) at days (f) 
4, (g) 14 and (h) 28 (scale bars = 200 µm), are exhibiting remarkable macrophages (CD68) only 
at day (i) 4 but significantly disappeared at days (j) 14 and (k) 28 (scale bars = 200 µm). Green, 
red and blue colors in (f-k) represent the GelMA/Bio-IL hydrogels, the immune cells, and the cell 
nuclei (DAPI). 1% VC, 1.5% TEOA, and 0.1 mM Eosin Y at 120 s light exposure were used to 
form the hydrogels. All hydrogels were synthesized using 15% final polymer concentration and 
50/50 polymer/Bio-IL ratio. 
 
One crucial characteristic of implantable hydrogel-based scaffolds for tissue engineering 
is their ability to be efficiently biodegraded, in a period of time that allows the growth of new 
autologous tissue. Since both the mechanical and electroconductive properties of Bio-IL 
functionalized hydrogels rely on their physical integrity, sustained biodegradation will certainly 
influence the performance of the scaffolds in vivo. However, our results demonstrate that the 
degradation rate of Bio-IL hydrogels can be readily tuned by varying the final polymer 
concentration and the polymer/Bio-IL ratio (Figures 12g and 12h). As opposed to conventional 
methods to engineer electroconductive hydrogels, Bio-IL functionalization provides homogeneous 
and intrinsic electroconductive properties to the entire polymer network. This in turn suggests that 
the decay in the mechanical and electroconductive performance of the engineered hydrogels is 
directly proportional to the degradation rate. Therefore, the biodegradability of Bio-IL 
functionalized hydrogels could be further optimized depending on the specific application, to 
ensure adequate mechanical and electroconductive performance during the desired period of time. 
The biodegradability profile of GelMA/Bio-IL hydrogels allows for sustained cellular ingrowth, 
as well as the eventual replacement of the implanted sample with new autologous tissue. 
Accordingly, histological assessment of the explanted hydrogels revealed ingrowth of 
predominantly non-inflammatory tissue, as well as low deposition of a fibrous collagenous capsule 
(Figures 15c-15e). This observation was further confirmed by immunohistofluorescent analysis 
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of the explanted samples. Fluorescent immunostaining of the CD3 antigen revealed no sustained 
infiltration of pro-inflammatory leukocytes (Figures 15f-15h). In addition, implantation of 
GelMA/Bio-IL hydrogels elicited a macrophage response by expression of CD63 antigen, initially 
at day 4; however, they were significantly reduced by day 28 (Figures 15i-15k). These results 
demonstrated that GelMA/Bio-IL hydrogels elicit minimal inflammatory responses in vivo. In 
addition, specific physiological responses could be triggered through the use of different 
biopolymers. For example, previous studies have demonstrated the remarkable suitability of 
GelMA-based hydrogels for the induction of angiogenesis[275]. In contrast, the conjugation of 
Bio-IL to the bioactive polymer alginate could be used for studies involving osteogenesis, as well 
as other bone tissue engineering applications[276]. 
The physicochemical cues from the extracellular microenvironment play a key role in various 
physiological and pathological processes that modulate tissue function[277]. For example, after 
myocardial infarction, the nonconductive nature of the resulting scar tissue leads to the electrical 
uncoupling of the infarcted area, and eventually to ventricular dysfunction[269]. Due to the limited 
regenerative potential of adult CMs, several biomaterials-based tissue engineering approaches for 
myocardium regeneration have been developed[278]. However, the non-conductive nature of most 
biopolymers greatly diminishes the propagation of electrical stimuli across the scaffold[271]. 
Thus, biomaterials-based approaches, like the one presented in this work, could help restore 
ventricular function by mechanically and electrically coupling the area around the infarcted 
myocardium[240]. Future work will investigate mechanical and electrical recoupling of impaired 
myocardium using GelMA/Bio-IL composite hydrogels. Furthermore, in addition to its role in the 
excitation-contraction coupling, electrical stimulation of CMs is also known to modulate cell 
proliferation and function[279, 280]. Therefore, the ability of the GelMA/Bio-IL composite 
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hydrogels to efficiently transduce multiple physiological stimuli to modulate tissue function, holds 
a remarkable potential for cardiac tissue engineering applications. 
3.2. Highly adhesive and electroconductive cardiopatches to improve cardiac function 
following myocardial infarction 
In the next project, our group recently introduced a new method to generate electroconductive 
biomaterials based on the conjugation of a choline-based Bio-IL to different polymer-based 
systems[234]. Here, we aimed to develop electroconductive fibrous scaffolds that could adhere 
strongly to the native myocardium to provide mechanical support and minimize cardiac 
remodeling following MI. For this, we electrospun the highly biocompatible GelMA into fibrous 
patches that were chemically conjugated with Bio-IL. We then characterized the physical, 
mechanical, electroconductive, and tissue-adhesive properties of GelMA/Bio-IL cardiopatches, as 
well as their ability to support the growth and function of co-cultures of CMs and CFs in vitro. 
Lastly, we evaluated the feasibility of in vivo suture-free delivery and the cardioprotective effect 
of GelMA/Bio-IL cardiopatches using a murine model of MI. These intrinsically adhesive and 
electroconductive fibrous patches could be used to provide support to the infarcted myocardium, 
while also establishing a cell-supportive microenvironment that restores electromechanical 
coupling and minimizes cardiac remodeling following MI. 
3.2.1. Physicochemical characterization of GelMA/Bio-IL cardiopatches 
We first confirmed the successful conjugation of Bio-IL to the GelMA network and 
characterized the fiber diameter of the scaffolds. For this, fibrous patches were prepared by 
electrospinning different concentrations of the GelMA precursor mixed with 1,1,1,3,3,3-
hexafluoro-2-propanol (HFIP), onto a static metal collector. Electrospun patches were then 
incubated in 1.25% (w/v) Irgacure 2959 in ethanol, followed by direct addition of Bio-IL and 
crosslinking via exposure to UV light (Figure 16a). Chemical conjugation of Bio-IL to GelMA 
 85 
was first confirmed via proton nuclear magnetic resonance (1H NMR) as described 
previously[234]. Briefly, 1H NMR spectra were obtained for Bio-IL, electrospun GelMA prior to 
crosslinking, and GelMA/Bio-IL patches after UV exposure. We then determined the degree of 
consumption of C=C double bonds in methacryloyl groups during free radical polymerization, 
which occurs due to the crosslinking of GelMA and the conjugation of Bio-IL to GelMA. These 
results showed that 70.2 ± 7.8% of methacryloyl groups were consumed after photocrosslinking 
of GelMA/Bio-IL, which was significantly higher than that calculated for pure GelMA patches 
(56.7 ± 9.1%). The larger rate of decay of the C=C double bonds in GelMA/Bio-IL cardiac patch 
represents the chemical conjugation of acrylate groups in Bio-IL to methacryloyl groups in 
GelMA.  
The native cardiac ECM is comprised of several structural fibrillar proteins such as 
collagen and elastin, which range from 10 to several hundred nanometers in diameter[281]. Fiber 
size also plays an important role in the physical characteristics of TE scaffolds, such as their 
mechanical strength, porosity, and surface area/volume ratio[282]. Hence, we aimed to 
characterize the fiber topology of GelMA/Bio-IL cardiopatches synthesized using different 
concentrations of Bio-IL via scanning electron microscopy (SEM). SEM images showed that 
control patches synthesized from 10% (w/v) GelMA and 0% (v/v) Bio-IL yielded scaffolds with 
fiber diameter of 579 ± 170 nm (Figure 16b). Scaffolds fabricated with 33% (v/v) Bio-IL exhibited 
slightly larger fiber sizes (i.e., 638 ± 160 nm) when compared to pristine GelMA controls (Figure 
16c). However, there were no statistically significant differences in fiber diameter between all Bio-
IL concentrations tested at 10% (w/v) GelMA. These results demonstrated that Bio-IL conjugation 
does not influence fiber diameter, which is highly advantageous to produce scaffolds with tunable 
conductivity without varying the microstructure of the patches. 
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Figure 16. Synthesis and physical properties of engineered cardiopatches. a) Schematic of the 
fabrication of GelMA/Bio-IL cardiopatches using HFIP to prepare a prepolymer solution with 
GelMA. Representative SEM images of GelMA/Bio-IL cardiopatches fabricated with a b) 0, and 
c) 33 %(v/v) concentration of Bio-IL. d) The electrical conductivity of cardiac patches fabricated 
with varying concentrations Bio-IL. e) The electroconductive properties of cardiopatches after 
incubation in DPBS at 37 °C for 2 and 4 d show no significant change in conductivity during 
biodegradation. The f) swelling ratio and g) degradation rate of cardiopatches following incubation 
in DPBS at 37 °C. h) The elastic modulus of cardiopatches increased when fabricated with higher 
concentrations of GelMA, and with higher concentrations of Bio-IL. Error bars indicate standard 
error of the means, asterisks mark significance levels of p < 0.05 (*), p < 0.01 (**), and p < 0.001 
(***). 
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3.2.2. Electroconductive properties of GelMA/Bio-IL cardiopatches 
The conductive properties of the scaffolds were analyzed using a two-probe electrical 
station connected to a Hewlett Packard 4155A Semiconductor Parameter analyzer[234]. Briefly, a 
probe was placed at each end of the scaffolds and voltage was applied in increments of 0.05V, 
from -2 to 2 V. The resulting data was analyzed to determine the electrical conductivity of each 
sample using Ohm’s Law. Our results showed that the conductivity of the scaffolds could be tuned 
by varying the concentrations of both GelMA and Bio-IL from 2.27  10-2 ± 1.85  10-3 S × m-1 
(10% (/v) GelMA and 33% (v/v) Bio-IL) to 3.81  10-1 ± 1.13  10-2 S × m-1 (15% (w/v) GelMA 
and 100% (v/v) Bio-IL) (Figure 16d). For instance, the electrical conductivity of scaffolds 
fabricated with 10% (w/v) GelMA increased from 2.27  10-2 ± 1.85  10-3 S × m-1 to 1.38  10-
1 ± 1.27  10-2 S × m-1, and 1.90  10-1 ± 1.83  10-2 S × m-1, when the Bio-IL concentration was 
increased from 33% to 66%, and 100% (v/v), respectively. As expected, GelMA patches fabricated 
with 0% (v/v) Bio-IL did not demonstrate any conductivity, as GelMA itself is not inherently 
conductive. On the other hand, patches fabricated with 66% (v/v) Bio-IL exhibited an increase in 
electrical conductivity from 1.38 ´ 10-1 ± 0.13 ´ 10-1 S/m to 1.77 ´ 10-1 ± 0.15 ´ 10-1 S/m, and 
3.18 ´ 10-1 ± 0.01 ´ 10-1 S/m when the GelMA concentration increased from 10% to 12.5%, and 
15% (w/v), respectively. Though GelMA itself is not inherently conductive, this increase in 
conductivity may be attributed to more functional groups available in the GelMA prepolymer at 
higher concentration that can react with Bio-IL. Furthermore, these values are within the range of 
the electrical conductivity of the native myocardium, which has been shown to be between 1.6  
10-1 S × m-1 (longitudinally) and 5  10-3 S × m-1 (transversally)[38].  
The conductivity of the scaffolds was also characterized after 0, 2, and 4 days of incubation 
in Dulbecco’s phosphate buffered saline (DPBS) at 37 °C to determine the effect of scaffold 
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degradation on electrical conductivity. These results showed that the conductivity of GelMA/Bio-
IL cardiopatches exhibited no statistically significant differences after 4 days of incubation for all 
conditions tested (Figure 16e). Furthermore, we also evaluated the conductivity of GelMA/Bio-
IL cardiopatches under mechanically strained conditions to determine the effect of scaffold 
deformation on electrical conductivity. For this, the scaffolds were first dried for 2 h to retain trace 
amounts of moisture and prevent stiffening. The presence of moisture led to increased conductivity 
readings as compared to dried samples, however, allowed samples to be mechanically stretched 
without breaking. The samples were then stretched at a strain rate of 20% and 40%, and electrical 
conductivity was measured in the stretched state as described before. Our results showed that there 
were no statistically significant differences in conductivity of the GelMA/Bio-IL cardiopatches up 
to 40% strain, compared to static conditions. These results demonstrated that the conductivity of 
the scaffolds remained unaffected following degradation or stretching, which is critical to maintain 
a consistent supportive microenvironment for the excitable phenotypes that comprise the 
contractile myocardium. 
3.2.3. In vitro swellability and degradation rates of GelMA/Bio-IL cardiopatches 
Excess water intake could potentially compromise the mechanical and conductive 
properties of TE scaffolds. Hence, we aimed to evaluate the water uptake capacity of GelMA/Bio-
IL cardiopatches. Our results showed that scaffolds fabricated with 10% (w/v) GelMA swelled 
rapidly after 4 hours of incubation, with no significant increases in water uptake after 8 and 24 
hours for all Bio-IL concentrations (Figure 16f). These results also showed that scaffolds 
fabricated with 66% and 100% (v/v) Bio-IL underwent significantly higher swelling when 
compared to scaffolds with a lower Bio-IL concentration. This behavior could be explained in part 
due to the presence of hydroxyl (-OH) and amine (-NH2) hydrophilic groups in the Bio-IL 
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structure, which enhances the swelling ratio. There was no statistically significant difference in the 
swelling ratio of cardiopatches fabricated with 66% and 100% Bio-IL after 8 h. However, we 
observed a decrease in swelling ratio from 66% to 100% (v/v) Bio-IL concentration after 4 h. This 
can be explained, in part, due to a higher percentage of Bio-IL that is not conjugated to the GelMA 
polymer network and is washed out in the first 4 h while submerged in DPBS. Furthermore, 
scaffolds fabricated with 15% (w/v) GelMA showed a similar trend, with higher swelling ratios 
obtained at higher concentrations of Bio-IL. 
Following implantation, TE scaffolds must be able to be biodegraded enzymatically or 
hydrolytically into nontoxic byproducts to allow the growth of new autologous tissue[283]. Thus, 
we aimed to characterize the in vitro enzymatic degradation profile of GelMA/Bio-IL 
cardiopatches. Briefly, scaffolds were lyophilized and weighed, followed by incubation in DPBS 
and 5.0 U/mL of collagenase type II solution at 37 °C for up to 72 h. At the end of this period, the 
samples were lyophilized and re-weighed to determine the changes in dry mass after degradation. 
The collagenase solution was replaced daily. Our results showed that the degradation rate 
increased concomitantly when the Bio-IL concentration was increased for cardiopatches 
containing 10% (w/v) GelMA (Figure 16g). For example, our results show that following 24 h of 
incubation in collagenase type II solution, cardiopatches demonstrated a degradation rate of 49.65 
± 11.60% and 71.90 ± 4.55% for scaffolds fabricated with 33% (v/v) and 100% (v/v) Bio-IL, 
respectively. In addition, we evaluated the in vitro degradation profile of our cardiopatches 
incubated in DPBS solution. Our results showed that after 1 day of incubation, scaffolds fabricated 
using 10% GelMA and 33% (v/v) Bio-IL exhibited degradation rates corresponding to 25.75% ± 
3.57%. At 14 days following incubation, cardiopatches containing 10% (w/v) GelMA and 33% 
(v/v) Bio-IL exhibited 45.32 ± 4.27% degradation. Moreover, the degradation rate increased 
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concomitantly when the Bio-IL concentration was increased for cardiopatches containing both 
10% and 15% (w/v) GelMA. In addition, we did not observe any statistical differences between 
the degradation rate of the patches fabricated with 10% and 15% (w/v) GelMA after 1 and 14 days. 
Both degradation studies performed in DPBS as well as in a collagenase solution demonstrated 
that more rapid degradation occurred in cardiopatches fabricated with a higher concentration of 
Bio-IL. This trend could be attributed in part to higher amounts of unconjugated Bio-IL that were 
washed out of the hydrogel network. 
3.2.4. Mechanical characterization of GelMA/Bio-IL cardiopatches 
Scaffolds used for cardiac TE should possess similar mechanical properties to the native 
myocardium to prevent mechanical mismatches that could impair its contractile function[284, 
285]. Thus, we evaluated the mechanical properties of scaffolds fabricated using varying 
concentrations of GelMA and Bio-IL (Figures 16h and 17). Our results show that the scaffolds 
exhibited highly tunable elastic moduli (i.e., 8.76 ± 0.42 kPa to 145.50 ± 4.10 kPa), which were in 
the range of the stiffness reported for the native myocardium (20 kPa to 100 kPa)[243, 244]. Our 
results showed that the elastic moduli increased concomitantly with higher GelMA concentrations 
(Figure 16h). For instance, the elastic moduli of scaffolds fabricated with 33% (v/v) Bio-IL 
increased from 19.67 ± 1.70 kPa to 86.23 ± 5.61 kPa, and 110.00 ± 5.56 kPa when the 
concentration of GelMA increased from 10% to 12.5%, and 15% (w/v), respectively (Figure 16h). 
These results also showed that the elastic moduli of the scaffolds could also be increased by 
increasing the concentration of Bio-IL. For instance, the elastic moduli of scaffolds fabricated with 
12.5% (w/v) GelMA increased from 86.23 ± 5.61 kPa to 110.45 ± 9.97 kPa, and 134.06 ± 5.06 
kPa when the concentration of Bio-IL was increased from 33% to 66%, and 100% (v/v), 
respectively (Figure 16h). This increase in mechanical properties of the patches may be due to the 
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electrostatic interactions between the positively charged groups in Bio-IL and the negatively 
charged functional groups present in the GelMA polymer. Ionic interactions, such as these, have 
previously been shown to increase mechanical strength in hydrogels [286]. In addition, there might 
be chemical bonding between the Bio-IL and GelMA prepolymer through photopolymerization, 
which can also increase the mechanical properties of the patches. Furthermore, the ultimate strain 
and ultimate stress of the scaffolds was also shown to vary by changing the concentrations of both 
Bio-IL and GelMA (Figure 17a). For instance, the ultimate strain of scaffolds with 10% (w/v) 
GelMA decreased from 84.2 ± 11.46 kPa to 54.65 ± 11.10 kPa, and 47.9 ± 8.91 kPa when the 
concentration of Bio-IL was increased to 33%, 66%, and 100% (v/v), respectively (Figure 17a). 
Moreover, the ultimate stress of scaffolds fabricated with 33% (v/v) Bio-IL increased to 31.31 ± 
5.18 kPa, 64.59 ± 11.19 kPa, and 89.03 ± 10.41 kPa when the concentration of GelMA was 
increased from 10% to 12.5%, and 15% (w/v), respectively (Figure 17b). Taken together, these 
results demonstrated the remarkable mechanical tunability of GelMA/Bio-IL cardiopatches, which 
is highly advantageous for the engineering of electroconductive scaffolds for a variety of TE and 
biomedical applications. 
 
Figure 17. Mechanical properties of cardiopatches. a) The ultimate strain and b) ultimate stress 
exhibited by GelMA/Bio-IL cardiopatches. Error bars indicate standard error of the means, 
asterisks mark significance levels of p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***). 
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3.2.5. GelMA/Bio-IL patches as biomimetic adhesives to cardiac tissue 
Biomaterials with strong adhesive properties to wet tissues have emerged as promising 
strategies for sutureless wound closure following surgical procedures[287]. In this regard, in our 
previous studies, we demonstrated that GelMA-based hydrogels possess high adhesive strength to 
various physiological tissues, while also exhibiting superior mechanical performance when 
compared with commercially available tissue adhesives[288, 289]. Here, we aimed to evaluate the 
adhesive strength of GelMA/Bio-IL cardiopatches to the native myocardium to determine their 
potential for sutureless application following MI. We used standard wound closure and burst 
pressure tests from the American Society for Testing and Materials (ASTM) as well as ex vivo 
experiments using murine cardiac tissue to evaluate the adhesive properties of our engineered 
cardiopatches. First, wound closure experiments were carried out to evaluate the adhesive strength 
of the scaffolds to porcine skin (Figure 19a-b), and murine left ventricular myocardium (Figures 
18a-c). Wound closure tests showed that the adhesiveness of GelMA/Bio-IL cardiopatches to 
porcine skin increased up to 61.97 ± 2.50 kPa by increasing the concentration of Bio-IL (Figure 
19b). Furthermore, the adhesive strength of scaffolds synthesized using 66% and 100% (v/v) Bio-
IL was shown to be significantly higher than the commercial surgical sealants such Coseal™ (19.4 
± 17.3 kPa) and Evicel® (26.3 ± 4.7 kPa) (Figure 19b). In addition, visual inspection revealed that 
scaffolds photocrosslinked on the surface of the tissue also adhered strongly to the native murine 
myocardium (Figure 18a). Similarly, wound closure tests on murine myocardium (Figure 18b) 
revealed that the adhesiveness of GelMA/Bio-IL cardiopatches increased from 5.1 ± 0.4 to 24.89 
± 2.34 kPa as the Bio-IL concentration enhanced from 0% to 100% (v/v) (Figure 18c). Moreover, 
the adhesive strength of the engineered GelMA/Bio-IL cardiopatches was significantly higher than 
other synthesized cardiac sealants such as poloxamine-based hydrogels (~17 kPa)[290], and 
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poly(glycerol sebacate)-co-lactic acid (24 kPa)[291], as well as commercial sealants such as 
Coseal™ and Evicel®. These results demonstrated that GelMA/Bio-IL cardiopatches can be 
readily applied to the surface of the myocardium and adhere strongly without the need for sutures 
or additional tissue adhesives. 
 
Figure 18. Ex vivo adhesive properties and electrical conductivity of GelMA/Bio-IL 
cardiopatches. a) Representative image of a GelMA/Bio-IL cardiopatch photocrosslinked on 
explanted rat heart demonstrating the high adhesion of the cardiopatch (red arrows) to cardiac 
tissues. b) Standard wound closure test using explanted rat heart as the biological substrate to test 
the adhesion strength of GelMA/Bio-IL cardiopatches. c) Quantification of the adhesion strength 
exhibited by cardiopatches fabricated with 10% (w/v) GelMA and varying concentrations of Bio-
IL on explanted rat heart. Cardiopatches fabricated with higher concentrations of Bio-IL 
demonstrated higher adhesion strength to cardiac tissue. d) Representative images of GelMA/Bio-
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IL cardiopatch fabricated with 10% (w/v) GelMA and 66% (v/v) Bio-IL photocrosslinked on the 
defect site of an explanted rat heart to measure the burst pressure. e) Quantification of the burst 
pressure of GelMA/Bio-IL cardiopatches formed with varying concentrations of Bio-IL and 
photocrosslinked on the defect site of rat heart showed no significant difference when compared 
to the burst pressure of a healthy rat heart. f) H&E staining of cardiopatch-tissue interfaces. The 
tight interface indicates a strong bonding of the GelMA/Bio-IL cardiopatch to the murine 
myocardium. The schematic in panel f showing the electrostatic forces between positively charged 
Bio-IL and negatively charged surface of cardiac muscle tissue and cells, as well as covalent bonds 
between methacrylate groups of GelMA and NH2 functional groups in cardiac tissue. These two 
types of bonding led to strong adhesion. g) Schematic of ex vivo abdominal tissue placed adjacently 
on GelMA/Bio-IL cardiopatches fabricated with 10% (w/v) and varying concentrations of Bio-IL 
to determine the threshold voltage needed to stimulate both sections of abdominal tissue. h) 
Quantification of the threshold voltage of GelMA/Bio-IL cardiopatches significantly decreased for 
patches fabricated with 100% (v/v) Bio-IL compared to those fabricated with 33% (v/v) Bio-IL 
suggesting enhanced electrical properties with higher concentrations of Bio-IL. Error bars indicate 
standard error of the means, asterisks mark significance levels of p < 0.05 (*). 
 
We also evaluated the ability of GelMA/Bio-IL cardiopatches to seal tissue defects under 
applied pressure using collagen sheets based on a standard burst pressure test[289, 292] (Figure 
19c-d), as well as ex vivo explanted rat hearts (Figures 18d-e). For burst pressure test using 
collagen sheets, we first created small defects on sections of the tissue, which were then sealed by 
photocrosslinking the cardiopatch on top of them. We then applied increasing air pressure using a 
syringe pump connected to a pressure sensor until failure occurred (Figure 19c). Our results 
showed that the burst pressure of GelMA/Bio-IL cardiopatches adhered onto collagen sheets 
increased up to 5.36 ± 1.01 kPa by increasing the concentration of Bio-IL (Figure 19d). Moreover, 
the burst pressure of patches fabricated with 100% (v/v) Bio-IL was significantly higher than the 
burst pressure of both Coseal™ (1.7 ± 0.1 kPa) and Evicel® (1.5 ± 1.0 kPa) (Figure 19d). We also 
measured the ex vivo burst pressure of explanted rat heart sealed with our adhesive patches 
fabricated with 10% (w/v) GelMA and varying concentrations of Bio-IL (Figure 18d,e). For the 
ex vivo experiments, after sacrificing the animals, the blood vessels at the base of the heart were 
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sealed with clamps, and a defect was created near the apex, which was then sealed with the patch 
by applying the GelMA/Bio-IL scaffold and photocrosslinking for 5 min. Our results showed that 
failure occurred at a pressure of 29.97 ± 5.56 kPa, 32.22 ± 4.38 kPa, and 30.56 ± 4.82 kPa for the 
heart sealed by the engineered cardiopatch containing 33%, 66%, and 100% (v/v) Bio-IL, 
respectively. The burst pressure of these cardiopatch formulations were similar to the pressure at 
failure for the intact heart (i.e., 31.05 ± 0.67 kPa) (Figure 18e). Furthermore, visual inspection 
revealed that failure did not occur due to detachment or rupture of the adhesive patches for all 
formulations, but due to bursting of the myocardium distal to the defect. The strong bonding of 
GelMA/Bio-IL cardiopatches to the myocardium was further confirmed via histological evaluation 
of the interface between the patch and the tissue (Figure 18f). H&E stained micrographs revealed 
a tight interlocking between the scaffold and the myocardium, which further demonstrated the 
intrinsic ability of the scaffolds to adhere strongly to the native tissue.  
Standard wound closure (Figure 18c) and burst pressure (Figure 18e) tests demonstrated 
the high adhesive strength of the scaffolds, which was superior to commercial tissue adhesives, as 
well as other proposed bioadhesives, such as a hydrophobic light activated heart glue[293]. These 
observations were further confirmed via histological evaluation, which revealed the tight 
interlocking at the interface between the patches and the myocardium (Figure 18f).  GelMA has 
been previously reported as a suitable material to obtain strong adhesion to wet tissues[289]. This 
is due to the covalent bonds formed between methacrylate groups of GelMA and amine groups of 
tissue during photocrosslinking[294]. Thus, once photocrosslinking has been completed, the 
anterior side of our cardiopatches will not adhere to the pericardial sac. In addition, GelMA/Bio-
IL cardiopatches demonstrated significantly stronger adhesion to cardiac tissue when fabricated 
with higher concentrations of Bio-IL. This can be attributed to electrostatic interactions between 
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the negatively charged surface of cardiac tissue (carboxyl group) and our positively charged 
choline-based Bio-IL[295-298]. In fact, the strong adhesion between GelMA/Bio-IL patches and 
tissues can be attributed to the formation of two different types of chemical bonds: covalent bonds 
between GelMA and tissue, and ionic bonds between Bio-IL and tissue (schematic shown in 
Figure 18f). 
 
Figure 19. In vitro adhesion strength of GelMA/Bio-IL cardiopatches. a) Schematic of wound 
closure test on cardiac patches using porcine skin. b) Patches fabricated with 10% (w/v) GelMA 
and varying concentrations of Bio-IL displayed an increasing adhesion strength to porcine skin 
when fabricated with increasing concentration of Bio-IL. Additionally, these GelMA/Bio-IL 
cardiac patches showed a significantly higher adhesion strength when compared with 
commercially available tissue sealants, such as Coseal™, and Evicel®. c) Schematic of the 
measurement of the burst pressure of cardiac patches. d) Cardiopatches fabricated with 10% (w/v) 
GelMA and varying concentrations of Bio-IL exhibited an increasing burst pressure strength when 
fabricated with an increasing concentration of Bio-IL. The burst pressure strength of GelMA/Bio-
IL cardiac patches was also greater than Coseal™, and Evicel®. Error bars indicate standard error 
of the means, asterisks mark significance levels of p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***). 
 
Recent studies have also reported the development of adhesive and conductive cardiac 
patches based on the incorporation of gold-nanorods[171] and dopamine[299] in synthetic polymer 
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networks. While these suture-free strategies greatly enhance the clinical translation of 
bioengineered cardiopatches by minimizing the risk of additional tissue damage, they may not lead 
to tissue repair and regeneration due to the absence of cell binding sites in the polymer network. 
In addition, previous groups have demonstrated the intrinsic potential of GelMA-based scaffolds 
to act as potent angiogenic niches[300]. Therefore, in contrast to alternative strategies, 
GelMA/Bio-IL cardiopatches could also act as proangiogenic patches that could help salvage the 
ischemic myocardium during the early stages following MI[301]. These scaffolds could also be 
used as a supportive layer that can minimize the risk of free wall rupture during the later stages of 
cardiac remodeling[302], owing to their strong tissue-adhesiveness biomimetic mechanical 
properties. 
3.2.6. Evaluation of GelMA/Bio-IL cardiopatches capability to restore impulse 
propagation across severed striated muscle ex vivo 
Electroconductive scaffolds could be used to restore electrical communication between 
excitable cell types to preserve the functionality of the tissue. Thus, we evaluated the ability of 
GelMA/Bio-IL cardiopatches to restore impulse propagation between two pieces of skeletal 
muscle ex vivo. For this, the rectus abdominis muscles of Wistar rats were explanted post-mortem, 
cut into square pieces, and placed 3 mm apart from each other on top of the scaffolds (Figure 18g). 
Pulsed direct current test runs were conducted by applying 50 ms square pulses at increasing 
frequencies, using short platinum wires that were placed on one of the two samples. Muscle 
contraction was visually assessed on the opposite sample and the threshold voltage was recorded. 
As expected, our results showed that scaffolds containing higher concentrations of Bio-IL 
exhibited comparatively lower threshold voltages as compared to GelMA patches without Bio-IL 
(Figure 18h). Therefore, the engineered GelMA/Bio-IL cardiopatches could be used to restore the 
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propagation of electrical impulses and preserve the functionality of excitable tissues damaged by 
trauma or disease. 
3.2.7. Cell viability, proliferation, and phenotypic characterization of 
cardiomyocytes and cardiac fibroblasts seeded on electrospun GelMA/Bio-IL 
scaffolds 
One of the most important aspects in the design of TE scaffolds is the accurate 
recapitulation of the different stimuli that modulate cell fate. CMs are electroactive cells that rely 
on electrical stimuli for maintaining tissue homeostasis and function[7]. Therefore, 
electroconductive scaffolds hold great potential for cardiac TE since they can promote the 
propagation of electrical impulses and enhance electromechanical coupling of CMs in vitro[251]. 
Here, we aimed to evaluate the ability of GelMA/Bio-IL cardiopatches to support the growth and 
the contractile function of co-cultures of freshly-isolated CMs and CFs. For this, primary CMs and 
CFs (2:1 ratio) were drop seeded on top of GelMA/Bio-IL scaffolds fabricated using different 
concentrations of Bio-IL. Cell viability and proliferation were evaluated using a commercial 
Live/Dead assay (Figure 20a) and fluorescent F-actin/cell nuclei staining (Figure 20b), 
respectively. The results demonstrated that the viability of CMs/CFs remained >90% up to day 7 
post-seeding for all conditions tested (Figure 20c). In addition, quantitative analysis of fluorescent 
images revealed that GelMA/Bio-IL scaffolds support the proliferation of CFs, which led to 
increasingly higher number of cells throughout the duration of the experiment. The metabolic 
activity of cells growing on GelMA/Bio-IL cardiopatches was significantly higher than those 
growing on GelMA controls (Figure 20d). We also evaluated the contractile activity of CMs 
seeded on GelMA/Bio-IL scaffolds. For this, cell-seeded scaffolds were imaged daily using an 
inverted microscope equipped with a CCD camera and a temperature-controlled chamber at 37 ºC. 
The beating frequency (beats/min, BPM) of the CMs was calculated from digitized video-recorded 
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sequences using a custom MATLAB program. Our results showed that cells grown on 
cardiopatches containing 33% and 66% (v/v) Bio-IL exhibited a comparatively more robust 
contractile behavior, when compared to pristine GelMA and GelMA with 100% (v/v) Bio-IL 
scaffolds (Figure 20e). Moreover, cells grown on GelMA cardiopatches fabricated with 33% and 
66% (v/v) Bio-IL exhibited observable contractility at day 7 post-seeding, and significantly higher 
beating frequencies (157.143 ± 1.742 BPM and 196.524 ± 1.018 BPM, respectively) than those 
growing on pristine GelMA patch and GelMA with 100% (v/v) Bio-IL cardiopatches (104.643± 
5.845 BPM and 110.210 ± 7.360 BPM, respectively) (Figure 20e). The lower contractile activity 
of the cells grown on GelMA patches can be due to the non-conductivity of the scaffold with no 
Bio-IL. On the other hand, when 100% (v/v) Bio-IL was used, the excess amount of Bio-IL might 
cover cell binding sites available on GelMA prepolymer, leading to lower cell attachment and 
contractile activity. Highest beating frequency was observed for the cells cultured on cardiopatches 
with 66% (v/v) Bio-IL. 
The contractile function of the myocardium is established by a complex network of 
interconnected cells that communicate via gap junction proteins termed connexin, which mediate 
the propagation of electrical impulses[303]. Here, we evaluated the expression of phenotypic 
cardiac markers in cells grown on pristine GelMA scaffolds and GelMA cardiopatches containing 
66% (v/v) Bio-IL, via immunofluorescent staining (IFS) against sarcomeric α-actinin (SAA) and 
connexin 43 (Cxs43). Representative fluorescent images revealed that cells seeded on the scaffolds 
self-organized in clusters of contracting CMs, which were attached to a layer of CFs proliferating 
on the surface of the scaffolds (Figure 20f and 20g). Our results also showed that cells grown on 
GelMA cardiopatches with 66% (v/v) Bio-IL exhibited significantly higher levels of Cxs43 
expression, located mainly between the borders of the CFs, as compared to pristine GelMA patches 
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(Figure 20h). These observations suggest that GelMA/Bio-IL cardiopatches could aid in the 
propagation of electrical impulses between isolated cells to enhance the tissue-level functionality 
and beating of cardiac constructs.  
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Figure 20. 2D co-cultures of CMs and CFs on GelMA/Bio-IL cardiopatches. The in vitro 
cytocompatibility of the engineered cardiopatches was evaluated using 2D co-cultures of freshly 
isolated CMs and CFs (ratio 2:1) growing on cardiopatches fabricated with different 
concentrations of Bio-IL. a) Representative Live/Dead images of CMs/CFs growing on patches 
containing 0% and 66% (v/v) Bio-IL at day 7 post-seeding. b) Representative actin/DAPI images 
of CMs/CFs growing on patches fabricated with 0% and 66% (v/v) Bio-IL at day 7 post-seeding 
(Scale bar = 200 µm). Bar graphs showing the quantification of c) cell viability, and d) metabolic 
activity of 2D co-cultures of CMs/CFs at days 1, 4, and 7 post-seeding, growing on cardiopatches 
engineered with different concentrations of Bio-IL. e) Characterization of the beating frequency 
(beats/min) of CMs/CFs throughout 7 days of culture growing on cardiopatches fabricated with 
varying concentrations of Bio-IL. Representative immunofluorescent images of CMs/CFs at day 
7 post-seeding growing on the surface of patches containing f) 0%, and g) 66% (v/v) Bio-IL (green: 
sarcomeric α-actinin, red: connexin 43, blue: DAPI) (Scale bar = 50 µm). Quantification of the 
relative levels of expression (i.e., intensity of fluorescence) of h) connexin 43, and i) sarcomeric 
α-actinin in co-cultures of CMs/CFs on engineered patches at day 7 post-seeding. 
 
The native myocardium is an electroactive tissue that can transfer electrical impulses that 
enable the synchronous contraction of the CMs, which in turn carry out the pump function of the 
heart. Our results demonstrated that GelMA/Bio-IL cardiopatches could effectively promote the 
growth and function (Figure 20) of co-cultures of CMs and CFs in vitro. Bio-IL conjugation led 
to a comparatively better contractile profile than pristine GelMA scaffolds, as demonstrated by the 
increased metabolic activity (Figure 20d) and enhanced beating frequency (Figure 20e) observed 
for conductive cardiopatches. In the context of cardiac electrophysiology, the propagation of 
electrical impulses is mediated via connexin proteins such as Cxs43, which enable heterocellular 
electrical coupling between CMs and CFs[304, 305]. Moreover, previous studies have showed that 
Cxs43-mediated CF coupling in vitro could enable synchronous spontaneous contraction in 
isolated CMs located up to 300 µm apart[306]. In this regard, IFS (Figure 20f and 20g) showed 
that CFs growing on conductive scaffolds exhibited significantly higher levels of expression of 
Cxs43 when compared to GelMA-controls (Figure 20h). Moreover, positive fluorescence against 
this gap junction protein was mainly located to the borders between the proliferating layer of CFs 
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(Figure 20g). These observations suggested that the conductive properties of GelMA/Bio-IL 
scaffolds promoted the electromechanical coupling of isolated CMs through the upregulation of 
Cxs43 in CFs. Furthermore, the disruption of electrical communication between cardiac cells has 
been shown to contribute to the generation of arrhythmias in fibrotic hearts in vivo and hinder the 
contractile function of TE cardiac constructs[306]. Therefore, Bio-IL conjugation could be used 
to aid in the rapid propagation of electrical impulses across heterocellular TE scaffolds, and lead 
to enhanced tissue-level functionality both in vitro and in vivo. 
3.2.8. In vivo evaluation of electrospun GelMA/Bio-IL cardiopatches using a murine 
model of MI via permanent LAD-ligation 
A series of structural and functional abnormalities occur after the onset of MI, which 
compromise the contractile function of the heart and could potentially lead to free wall rupture and 
death[307]. Electrospun fibrous patches have shown great potential to be used as cardio-supportive 
devices to help minimize the formation of non-contractile scar tissue and thinning of the infarcted 
myocardium[308, 309]. However, the delivery of conductive scaffolds to the myocardium presents 
several risks that could potentially lead to impaired cardiac function or fatal arrhythmias[310]. 
Thus, in this study, we evaluated the feasibility, safety and in vivo functionality of GelMA/Bio-IL 
cardiopatches using a murine model of MI via permanent ligation of the left anterior descending 
(LAD) coronary artery (Figure 21ai-iv). All infarcts were confirmed via blanching of the 
myocardium distal to the site of ligation. Following the induction of MI, animals were divided into 
three treatment groups: sham, GelMA control, and GelMA/Bio-IL; and followed for a period of 3 
weeks to allow for cardiac remodeling. We used scaffolds fabricated with 10% (w/v) GelMA and 
33% (v/v) Bio-IL for the treatment group that received conductive cardiopatches. At the end of 
this period, the animals were sacrificed, and the hearts were excised and processed for histological 
evaluation using Masson’s trichrome and IFS against the cardiac markers SAA and Cxs43. Our 
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results showed strong adhesion of both GelMA (Figure 21b) and GelMA/Bio-IL (Figure 21c) 
patches to the myocardial tissue after 3 weeks. In addition, tissue ingrowth inside the scaffolds was 
observed for both GelMA and GelMA/Bio-IL samples. In addition, the cardiopatches were intact 
on the surface of the myocardium 21 days post implantation. Further, it was found that the sham 
controls exhibited significant thinning of the myocardium with a large aneurysmal section on the 
LV (Figure 21di). The infarcted area exhibited a marked reduction in the expression of both SAA 
and Cxs43, which was indicative of extensive CM death and the appearance of non-contractile 
scar tissue (Figure 21dii-iii). In contrast, the animals receiving both the GelMA (Figure 21ei) and 
GelMA/Bio-IL (Figure 19fi) cardiopatches showed comparatively less ventricular wall thinning 
and no apparent aneurysm at the site of MI after 3 weeks. Furthermore, the expression of 
phenotypic cardiac markers was maintained throughout the site of MI, which was indicative of the 
preservation of a fully functional myocardium for both hearts treated with GelMA scaffolds 
(Figure 21eii-iii) and GelMA/Bio-IL cardiopatches (Figure 21fii-iii). These results suggested that 
both GelMA-based patches could establish a cell-supportive microenvironment that prevented the 
remodeling of the myocardium at the site of MI and preserve normal tissue architecture. 
Furthermore, the expression of characteristic phenotypic markers SAA and Cxs43 was indicative 
of the preservation of viable myocardium and the maintenance of normal cardiac function. 
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Figure 21. In vivo evaluation of GelMA/Bio-IL cardiopatches using a murine model of MI. 
Experimental MIs were induced via permanent ligation of the LAD coronary artery. a) 
Representative images showing: a-i) LAD ligation (white circle), a-ii) photocrosslinking of 
cardiopatches (white arrows) using UV light, a-iii) photocrosslinked cardiopatch on the heart, and 
a-iv) excised whole heart with cardiopatch distal to the site of LAD ligation after 21 days. 
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Representative Masson’s trichrome stained images from the interface between b) GelMA and c) 
GelMA/Bio-IL cardiopatches after 21 days (Scale bar = 400 µm). Representative Masson’s 
trichrome and fluorescent stained images of excised hearts showing the location of the MIs in di-
iii) untreated animal (sham), and animals treated with ei-iii) pristine GelMA patches, and fi-iii) 
GelMA/Bio-IL cardiopatches.  
 
Following MI, cardiac remodeling triggers a series of molecular and cellular changes that 
manifest clinically as changes in ventricular wall thickness and the appearance of fibrotic scar 
tissue[302]. In recent years, electrospun scaffolds have shown great potential to be used as cardio-
supportive devices, which can help minimize the formation of non-contractile scar tissue and 
thinning of the ventricular wall following MI[309]. Here, we evaluated the feasibility and safety 
of in vivo delivery as well as the cardioprotective potential of GelMA/Bio-IL cardiopatches using 
a murine model of MI via permanent LAD ligation (Figure 21ai-iv). Histological evaluation 
revealed that the hearts treated with both GelMA and GelMA/Bio-IL patches exhibited minimal 
tissue remodeling and LV wall thinning, when compared to untreated animals (Figure 21d-f). 
These observations suggested that the supportive function of both GelMA and GelMA/Bio-IL 
scaffolds could potentially ameliorate LV wall stress and preserve normal tissue architecture. 
These results were in accordance to previous studies showing that cardio-supportive devices with 
ECM-like properties can mediate endogenous repair mechanisms to improve heart function[311]. 
Moreover, these studies also showed that the attenuation of pathological cardiac remodeling 
occurred mainly due to architectural and compositional cues that potentiated tissue regeneration, 
independent of scaffold electroconductivity.  
Our results suggested that GelMA/Bio-IL scaffolds yielded tissue constructs with 
comparatively better in vitro functionality, which could be due in part to enhanced 
electromechanical coupling via upregulation of the gap junction protein Cxs43. Moreover, in vivo 
evaluation showed that both conductive and non-conductive GelMA-based scaffolds led to the 
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preservation of normal tissue architecture by minimizing cardiac remodeling after MI. These 
observations could be explained in part due to the complex interplay of different bioactive cues 
that are normally present in vivo[312-315], which were not replicated in our experiments in vitro. 
Furthermore, these results demonstrated that cardiac remodeling could be effectively prevented 
using acellular scaffolds without the need for exogenous cytokines or growth factors, which is 
highly advantageous for the clinical translation of these scaffolds. For instance, Montgomery et al. 
recently reported a microfabricated injectable scaffold that could be used to deliver viable and 
functional CMs to the site of MI[316]. Although the scaffolds could be delivered through a 
minimally invasive procedure and significantly improved cardiac function following MI, both 
adult and stem cell-based strategies for the treatment of MI often shown highly heterogenous 
outcomes and poor clinical translation[317, 318]. Moreover, one of the most relevant 
characteristics of GelMA/Bio-IL cardiopatches was their high adhesive strength to the beating 
myocardium after photocrosslinking, even in the presence of blood (Figure 21aiii-iv). Recently, 
Lang et al. reported the development of blood-resistant and light-activated surgical glue that could 
be used to seal cardiac wall defects in large animal models[319]. Although this bioadhesive could 
be used by itself to form an on-demand hemostatic seal or in combination with a patch, 
GelMA/Bio-IL cardiopatches attached strongly to the native tissue without the need for additional 
adhesives or sutures. This also allowed the establishment of a tight interface and enhance the 
interlocking between GelMA and collagen fibers from the ECM-like fibrous patch and the 
myocardium, respectively, which is characteristic of strong tissue adhesives[320, 321]. In addition, 
cardiopatches photocrosslinked on the surface of rat hearts did not exhibit significant changes in 
size due to water uptake of the scaffolds (Figure 21aiii-iv). This demonstrates that swelling of our 
engineered cardiopatches would not significantly compress cardiac tissues in vivo. 
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In situ photocrosslinking of cardiopatches on the beating heart could possibly lead to systemic 
dissemination of unreacted components and thus, trigger toxic or inflammatory responses that 
could not be evaluated in vitro. Our preliminary in vivo experiments confirmed that our 
electroconductive patches could be safely administered on the myocardium via in situ 
photopolymerization and did not induce any cytotoxicity. In addition, the heart is a highly dynamic 
organ and the presence of blood and other fluids, as well as cardiac beating could greatly impair 
the adherence of the patches to the myocardium in vivo. Our in vivo results here demonstrated that 
the engineered patches exhibited high adhesion to the native murine myocardium without the need 
for suturing. Lastly, although the electroconductive and mechanical properties of the patches were 
tuned to mimic the native tissue, the delivery of a scaffold with these features to the myocardium 
could potentially impair cardiac function or even lead to fatal arrhythmias. Therefore, our current 
study aimed on evaluating the safety of in vivo delivery of Bio-IL functionalized patches before 
assessing the therapeutic effects of this strategy. Our future study will focus on evaluating heart 
function after applying the electroconductive patches using echocardiography, as well as studying 
the molecular and cellular mechanisms that could be selectively triggered by the delivery of an 
electroconductive scaffold to the site of MI. 
 
3.3. Development of a highly elastic and hemostatic surgical sealant composed of GelMA, 
elastin-like polypeptide, and Laponite 
 
Operations involving surgical repair, wound closure, and reconstruction of traumatized or 
degenerated soft tissues are common in the clinical setting. During these procedures, surgeons 
often rely on conventional suturing and stapling techniques to reconnect tissues that will result in 
low dehiscence[322, 323]. However, suturing is a very time-consuming process and may only be 
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used on easily accessible regions of the body[292]. Further, the repetition and quickly varying 
stress exerted on soft tissues during these procedures presents several drawbacks, which include 
high infection rate, extensive handling, risk of blood-borne disease transmission, damage to 
secondary tissues, and the possibility for air/fluid leakage[289, 324]. This preventable trauma can 
result in multiple hospital visits, high cost to the patient, slow wound recovery, and a wide range 
of medical complications. Therefore, researchers have investigated alternative approaches to 
reconnect soft tissue that may overcome the limitations associated with sutures and staples.  
Currently, there are a number of commercially available sealants on the market, however, these 
products lack the complete efficacy desired for an implantable adhesive. For example, one of the 
most commonly investigated materials to develop surgical sealants have been using the naturally 
derived biomaterial fibrin. Fibrin glue is a material that mimics that last stage of the physiological 
coagulation cascade, and thus plays an active role in blood clot formation[325]. However, fibrin 
has also been shown to exhibit low mechanical strength and adhesion to wet tissues and, therefore, 
demonstrates poor performance as an adhesive material. Synthetic adhesives have also been 
investigated, such as cyanoacrylate. While cyanoacrylate adhesives have been shown to exhibit 
strong adhesion to tissue, there have been concerns regarding the biocompatibility and 
biodegradation of this material[325]. Recently, significant attention has been given to engineer 
highly elastic hydrogel-based adhesives that demonstrate ideal properties for use as a surgical 
sealant, such as, rapid photopolymerization in situ, a strong bond to wet tissue, appropriate 
swelling and mechanical strength, active role in blood clot formation, and biodegradation at an 
appropriate rate[326].  
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Hydrogels are a particularly attractive material class for the development of tissue adhesives 
owing to their high swellability and robust mechanical properties, which are similar to native soft 
tissue[327]. When attached to the surface of soft tissues, the elasticity of bioadhesives is an 
important factor, especially when used on tissues such as the lungs and blood vessels, where there 
is frequent expansion and contraction. Therefore, many strategies to improve the elastic properties 
of hydrogels have incorporated elastin-based proteins into the polymer matrices. Some of these 
elastin-based proteins include methacrylated tropoelastin, and elastin-like polypeptides, which are 
engineered with the repeating elastin pentapeptide motifs Val-Pro-Gly-Xaa-Gly, where the guest 
residue (Xaa) represents any amino acid except proline. In addition, hemostatic properties of 
surgical sealants are optimized using different strategies. One notable nanoparticle that has 
demonstrated excellent hemostatic performance is Laponite (LA). This highly charged nano clay 
promotes blood clot formation by dehydrating whole blood resulting in a higher concentration of 
clotting factors. Thus, in the final project of this thesis, we have engineered a nanocomposite 
hydrogel fabricated using GelMA to promote adhesiveness to wet tissue, and biocompatibility, 
ELP to improve mechanical properties and elasticity, and LA to impart hemostatic properties. 
These finely tuned properties resulted in a bioadhesive that is proposed to be used as a surgical 
sealant for soft tissue repair.  
3.3.1. Synthesis of nanocomposite GelMA/ELP/LA hydrogels 
Over the last decade, nanocomposite hydrogels have emerged as a new generation of 
biomaterials. These new materials combine biocompatible polymers with any of the various types 
of nanofillers, such as carbon-based nanoparticles (carbon nanotubes, graphene)[328], 
metal/metal-oxide nanoparticles (gold, silver, iron oxide)[329], and inorganic/ceramic 
nanoparticles (hydroxyapatite, silca, silicates, calcium phosphate)[330], to impart novel properties 
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onto the nanocomposite network. By combining nanofillers into polymeric networks, it is possible 
to engineer 3D scaffolds which exhibit unique properties. These nanocomposite hydrogels may be 
tailored to meet the needs required for various biomedical applications, such as tissue engineering, 
drug delivery, and biosensors.  
 
One such nanofiller, Laponite (LA), is a synthetic nanoclay smectite with highly positively 
charged surfaces, and negatively charged ends (Figure 22c). LA is capable to form many different 
interactions with organic molecules and biopolymers, such as hydrogen bonding, cation linking, 
hydrophobic interactions, and anion interchange[331]. This unique characteristic, along with its 
demonstrated high biocompatibility, anisotropic and plate-like morphology, and great surface area 
make it a suitable material to improve hemostatic and physical properties to nanocomposite 
hydrogels[332]. Of particular interest is the ability for LA to significantly improve clotting time in 
vivo. These hemostatic properties are primarily due to the thin plate-like structure and anisotropic 
distribution of surface charge. As a result of their small size and high charge, LA rapidly absorbs 
water when exposed to whole blood, which leads to an increase in the concentration of cells and 
clotting factors that promote blood coagulation[333]. For these attributes, nanocomposite 
hydrogels containing LA shows excellent potential to be developed as a surgical sealant for soft 
tissues. 
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Figure 22. Synthesis and characterization of nanocomposite hydrogels. Gelatin methacryloyl 
(GelMA) (a), elastin-like polypeptide (ELP) (b), and Laponite (LA) (c) were utilized to engineer 
hemostatic hydrogels with high elasticity for application as a surgical sealant for lung tissue. (d) 
Schematic for the fabrication of these nanocomposite hydrogels by photocrosslinking prepolymer 
solutions in the presence of Irgacure 2959 and UV irradiation for 180 s. (e) The engineered 
hemostatic surgical sealants may be used to properly seal lung tissue following the removal of a 
section of tissue. 
 
In contrast to hydrogels engineered with a single polymer network, composite hydrogels 
are a simple and efficient approach that may include multiple functionalities[74]. Thus, the 
blending of biopolymers to form composite hydrogels has been shown to more closely mimic the 
nature of the native physiological environment[334]. Various hydrogel-based biomaterials have 
been widely investigated for application as a surgical sealant, due to their ability to be used for 3D 
cell encapsulation, as well as their ease of modification, swellability, biodegradability, and 
biocompatibility[335]. Gelatin methacryloyl (GelMA) is a widely characterized biopolymer that 
has previously demonstrated appropriate cytocompatibility both in vitro and in vivo, and exhibits 
robust mechanical properties, and high cell adhesion due to the RGD motif (Figure 22a)[289]. In 
addition, elastin-like polypeptides (ELPs) consist of another family of widely characterized 
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biopolymers that are based on the recurrent hydrophobic domains observed in human tropoelastin, 
the soluble precursor to the ECM protein elastin (Figure 22b). Elastin is known for providing 
elasticity in tissues/organs where stretchability is of the main importance, such as lungs, blood 
vessels, ligaments, and skin[336]. Thus, ELPs have gained significant attention for applications in 
tissue engineering, such as soft-tissue repair, vascular grafts, cartilage regeneration, nerve 
guidance conduits, and more[231, 334, 337, 338]. This elastic motif of ELP consists of the 
repeating pentapeptide Val-Pro-Gly-Xaa-Gly, where the guest residue (Xaa) represents any amino 
acid except Pro[339]. Different types of ELPs have been investigated for applications as a surgical 
sealant for soft tissues owing to their tunable mechanical properties, high extensibility, and 
cytocompatibility.  
Our ELPs possess a sequence that has been shown to contain robust mechanical properties 
with high stretchability and has demonstrated high biocompatibility. In addition, this protein 
sequence was designed with a cysteine residue at each end to allow for rapid photocrosslinking by 
incorporating the photoinitiator Irgacure 2959 and exposure to UV radiation. GelMA/ELP 
hydrogels were synthesized by combining different concentrations of GelMA (5-25% (w/v)), and 
ELP (0-20% (w/v)) with a 0.5% (w/v) solution of Irgacure 2959 (Figure 22d). Exposure to 180 s 
of UV radiation immediately led to rapid photocrosslinking and the formation of a 3D hydrogel 
network. GelMA/ELP/LA nanocomposite hydrogels were subsequently formed using 10% 
GelMA and 10% ELP (w/v) and varying concentrations of LA. These nanocomposite hydrogels 
were synthesized by combining 20% GelMA and 20% ELP in a solution containing 1% Irgacure 
2959. A separate solution was prepared by mixing varying concentrations of LA (0, 1, 2, 4% (w/v)) 
in a 4 °C solution of deionized water. The solution was vortexed for 20 m to ensure homogeneous 
dispersion (Figure 22d). The GelMA/ELP and LA solutions were thoroughly mixed at 4 °C at a 
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1:1 ratio. Nanocomposite hydrogels were then formed upon exposure to 180 s UV radiation 
resulting in 3D hydrogel networks. These highly hemostatic and mechanically robust 
nanocomposite hydrogels were designed to be used as a surgical sealant. These hemostatic 
biomaterials show potential to be readily photocrosslinked in situ following the removal of a 
section of tissue to promote hemostasis and aid in the repair and regrowth of new tissues (Figure 
22e). 
3.3.2. Mechanical properties of nanocomposite GelMA/ELP/LA hydrogels 
Cells perceive their microenvironment through physical, chemical, and mechanical cues of 
the ECM matrix and respond appropriately through mechanotransduction pathways that mediate 
tissue homeostasis, morphogenesis, cell growth, contractility, and differentiation[340, 341]. With 
new insights into the influence of mechanical properties on cell behavior, we aimed to characterize 
the mechanical properties of the engineered hydrogels synthesized with varying concentrations of 
GelMA, ELP, and LA. Therefore, the mechanical properties of GelMA/ELP hydrogels and 
GelMA/ELP/LA nanocomposite hydrogels were evaluated by performing tensile and compression 
tests. Tensile tests on GelMA/ELP hydrogels demonstrated that the elastic modulus and ultimate 
strain of the engineered hydrogels could be tuned by varying the concentrations of GelMA and 
ELP (Figure 23a). GelMA/ELP hydrogels were fabricated with between 0-25% (w/v) GelMA and 
5-20% (w/v) ELP. Our results showed that the elastic modulus of the GelMA/ELP hydrogels 
increased with an increasing concentration of GelMA and/or ELP. For example, hydrogels 
containing a fixed concentration of 10% (w/v) ELP exhibited an elastic modulus of 7.3 ± 0.08 kPa, 
33.9 ± 2.14 kPa, 80.6 ± 13.80 kPa, 270.2 ± 5.57 kPa, and 503.7 ± 20.36 kPa when fabricated with 
a GelMA concentration of 5, 7.5, 10, 20, and 25% (w/v), respectively (Figure 23a). Further, when 
hydrogels were fabricated containing a fixed concentration of 10% (w/v) GelMA, they exhibited 
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an elastic modulus of 25.9 ± 4.00 kPa, 27.1 ± 4.55 kPa, 80.6 ± 13.80 kPa, and 112.5 ± 3.43 kPa 
when fabricated with an ELP concentration of 0, 5, 10, and 20% (w/v), respectively (Figure 23a). 
The mechanical properties of hydrogels fabricated for tissue engineering applications may be 
manipulated by controlling the type of crosslinking used, the crosslinking density, or polymer 
concentration. Increasing polymer molecular weight has also shown to increase mechanical 
strength[342]. In addition, crosslinking density can be achieved via crosslinking molecule 
concentration and reaction time. Here, we are able to tune the mechanical properties of 
GelMA/ELP hydrogels by varying the concentration of GelMA and ELP used during synthesis. 
Through varying the polymer concentration of GelMA and ELP, we are able to control polymer 
density and crosslinking density within the polymer matrix. The increase in elastic modulus of 
GelMA/ELP hydrogels is expected to result due to an increase in the number of crosslinking sites 
in the 3D polymetric network. Our results showed that the tunability of our hydrogels was 
primarily achieved through adjusting the concentration of GelMA polymer in the hydrogel matrix. 
This is in contrast to varying the concentration of ELP, which our results showed has a less 
significant impact on tuning the stiffness of the resulting gels. This may be due in part to the many 
crosslinking sites present in the molecular structure of GelMA. By increasing the concentration of 
GelMA, we increase the number of functional groups responsible for rapid photocrosslinking in 
the presence of UV radiation necessary to hold the polymer matrix together. ELP, however, was 
engineered to possess only two crosslinking sites, which limits its impact on the elastic modulus. 
This is consistent with previous studies using the same genetically engineered form of ELP, which 
showed that hydrogels fabricated only with ELP demonstrated significantly lower elastic moduli 
than compared with our GelMA/ELP hydrogels[231]. The relationship between crosslinking 
density and mechanical properties for hydrogels fabricated for tissue engineering applications has 
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also been reported. These studies show that an increase in polymer crosslinking tends to result in 
improved mechanical strength[343, 344]. This is important because the crosslinking density of 
hydrogels plays a critical role in the physical properties of the scaffold, such as mechanical 
stiffness and pore size[345]. These physical properties, in turn, greatly impact cell adhesion, 
metabolism, migration, and proliferation[346, 347].  
The mechanical properties of nanocomposite GelMA/ELP/LA hydrogels were also 
examined for mechanical stiffness. Nanocomposite hydrogels were fabricated with 10% GelMA 
and 10% ELP with varying concentrations of LA up to 2% (w/v). Our results showed that the 
incorporation of LA into the nanocomposite hydrogels did not significantly change the mechanical 
stiffness when added up to 2% (w/v). The engineered hydrogels exhibited an elastic modulus of 
79.3 ± 11.41 kPa, 91.1 ± 11.61 kPa, 116.2 ± 15.15 kPa, and 119.27 ± 26.24 kPa when fabricated 
with a LA concentration of 0, 0.5, 1, and 2% (w/v), respectively (Figure 23b). This is consistent 
with other investigations which showed that hydrogels fabricated with high concentrations (>5% 
(w/v)) of LA exhibited markedly higher mechanical stiffness due to electrostatic interaction, 
however, no significant changes in mechanical properties was observed for hydrogels fabricated 
with lower concentrations (<2.5% (w/v) of LA[332, 348, 349]. The elastic modulus exhibited by 
our hydrogels fabricated with 10% (w/v) GelMA, 10% (w/v) ELP, and 2% (w/v) LA was similar 
to that of recently reported hydrogel scaffolds for surgical sealing of soft tissue applications[350-
352].  
Mechanical characterization of GelMA/ELP hydrogels demonstrated significantly higher 
extensibility when fabricated with higher concentrations of ELP with a maximum strain reaching 
150%. For example, hydrogels containing a fixed 10% (w/v) GelMA concentration exhibited 
ultimate strain values of 31.5 ± 0.95, 44.0 ± 2.50, 59.9 ± 8.11, and 72.6 ± 5.85%, when fabricated 
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with 0, 5, 10, and 20% (w/v) ELP, respectively (Figure 23c). By incorporating higher 
concentrations of ELP in the polymer matrix, the resulting hydrogels were concomitantly imparted 
with elasticity. There have been a number of theories to explain the mechanism behind the 
elasticity of the elastin protein. One theory states that as the polymer is extended, the hydrophobic 
groups in the chain are exposed on the outside. This extension of the protein increases the overall 
energy of the system and enthalpic forces serve as the driving force to recoil elastin. Other theories 
which attempt to explain the mechanism of elasticity in elastin focus on the relationship between 
the hydrophobic and hydrophilic groups[353]. In contrast, GelMA/ELP hydrogels fabricated with 
higher GelMA concentrations resulted lower extensibility up to the failure point of hydrogels, as 
expected due to the increase in crosslinking sites. Our results showed that hydrogels containing a 
fixed 10% (w/v) ELP concentration exhibited ultimate strain values of 105.2 ± 11.27, 75.2 ± 8.16, 
59.9 ± 8.11, 24.9 ± 2.30, and 23.5 ± 0.74% when fabricated with 5, 7.5, 10, 20, and 25% (w/v) 
GelMA, respectively (Figure 23c). We then evaluated the maximum mechanical strain observed 
for nanocomposite hydrogels containing 10% GelMA and 10% ELP and varying concentrations 
of LA. The extensibility of these GelMA/ELP hydrogels was found to be 59.9 ± 8.1, 57.3 ± 11.3, 
56.1 ± 9.4, and 53.8 ± 9.6 kPa when fabricated with a LA concentration of 0, 0.5, 1, and 2% (w/v), 
respectively. Our results showed that the addition of LA did not exhibit significantly different 
extensibility when fabricated with varying concentrations of LA, up to 2% (w/v) (Figure 23d). In 
addition, the ultimate strain of these GelMA/ELP/LA nanocomposite hydrogels was found to be 
similar to recently reported hydrogel sealants for reconnection of soft tissue[290, 354].  
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Figure 23. Mechanical characterization of hemostatic and highly elastic hydrogels for 
applications as surgical sealants for soft tissues. Elastic moduli for hydrogels containing (a) 
varying concentrations of GelMA and ELP, as well as for (b) hemostatic hydrogels containing 
10% GelMA, 10% ELP, and varying concentrations of LA. Ultimate strain for hydrogels 
containing (c) varying concentrations of GelMA and ELP, as well as for (d) hemostatic hydrogels 
containing 10% GelMA, 10% ELP, and varying concentrations of LA. Compressive moduli for 
hydrogels containing (e) varying concentrations of GelMA and ELP, as well as for (f) hemostatic 
hydrogels containing varying concentrations of LA. Error bars indicate standard error of the 
means, asterisks mark significance levels of p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), and p < 
0.0001 (****). 
 
We also evaluated the compressive modulus of GelMA/ELP hydrogels, which was shown 
to be tunable based on the concentration of the biopolymers. Our results show that the compressive 
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moduli of the engineered hydrogels increased concomitantly by increasing either GelMA or ELP. 
For example, hydrogels synthesized with a fixed 10% (w/v) ELP concentration exhibited 
compressive moduli of 7.6 ± 1.11, 38.4 ± 1.27, 89.3 ± 8.48, 161.5 ± 8.27, and 308.2 ± 11.91 kPa 
when fabricated with 5, 7.5, 10, 20, 25% (w/v) GelMA, respectively (Figure 23e). Further, 
hydrogels synthesized with a fixed 10% (w/v) GelMA concentration exhibited compressive moduli 
of 26.7 ± 3.95, 59.2 ± 9.48, 89.3 ± 8.48, and 126.5 ± 17.67 kPa when fabricated with 0, 5, 10, and 
20% (w/v) ELP, respectively (Figure 23e). These results demonstrate that the addition of either 
polymer into the gel matrix resulted in higher stiffness when compressed.  
In addition, GelMA/ELP hydrogels fabricated with 2% (w/v) LA demonstrated 
significantly higher compressive moduli compared to hydrogels containing the same concentration 
of biopolymers, but without LA. Our results show that nanocomposite GelMA/ELP/LA hydrogels 
exhibited compressive moduli of 89.3 ± 8.48, 118.4 ± 9.38, 125.3 ± 17.01, and 143.7 ± 10.32 kPa 
when fabricated with 0, 0.5, 1, and 2% (w/v) LA, respectively (Figure 23f). This increase in 
mechanical strength may be a direct result of the additional biopolymer-nanoparticle interactions 
that exist within the polymer matrix. Silicate nanoparticles have been shown to strengthen 
nanocomposite hydrogel suggesting that these nanoparticles can act as a pseudo crosslinker to 
mechanically reinforce the polymer network[355]. This strengthening of hydrogels due to the 
addition of silicate nanoparticles may be explained by an increase in hydrogen bonding, Van der 
Waals interactions, and ionic coupling[356, 357]. However, it has also been reported that silicate 
nanoparticles at high concentrations (~5%) can have adverse effects on the mechanical toughness 
of hydrogels. Recent studies have shown that the addition of 5% (w/v) silicate nanoparticles into 
nanocomposite hydrogels led to a decrease in elastic and compressive modulus. This may be due 
to large aggregates of nanoparticles interfering with photocrosslinking and thus leading to less 
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covalent crosslinks in the polymer network[358-360]. Taken together, these results show that our 
GelMA/ELP/LA nanocomposite hydrogels demonstrate robust mechanical properties ideal for 
tissue engineering applications involving reconnecting soft tissue. 
3.3.3. In vitro swelling behavior and degradation rates of nanocomposite 
GelMA/ELP/LA hydrogels 
Hydrogels are composed mainly of water due to their high hydrophilic properties, however, 
excessive water uptake could potentially compromise the mechanical properties of the engineered 
scaffolds. Furthermore, unusually high swelling rates of implanted scaffolds could cause 
significant morphological changes and risks compression of nerves and other tissues. Hence, we 
aimed to evaluate the water uptake capacity of GelMA/ELP hydrogels and GelMA/ELP/LA 
nanocomposite hydrogels. Previously, the swelling behavior for hydrophilic GelMA hydrogels has 
been widely characterized to show high water uptake capacity. Generally, higher concentrations 
of GelMA results in a lower swelling ratio and smaller pore size[361]. Here, we evaluated the 
swelling of GelMA/ELP hydrogels with a fixed GelMA concentration of 10% (w/v) and varying 
ELP concentrations to determine the effect ELP on swelling properties.  Our results showed that 
all groups swelled rapidly after 8 h of incubation, with no significant increases in water uptake 
after 8 h up to 24 h for all samples tested (Figure 24a). Further, hydrogels with a higher ELP 
concentration underwent significantly lower swelling when compared to scaffolds fabricated with 
lower ELP concentrations. This is likely due to the highly hydrophobic repeating motifs 
([[VPGVG]4IPGVG]14) present in the chemical structure of ELP[362]. In addition to the 
hydrophobic interactions, the increase in ELP may lead to an increase in crosslinking density, 
which would also contribute to decreased swelling ratios[231]. In addition, we also characterized 
the swelling behavior of nanocomposite hydrogels fabricated with 10% GelMA, 10% ELP, and 
varying concentrations of LA. Our results showed that nanocomposites fabricated with a higher 
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concentration of LA exhibited significantly lower water uptake compared to hydrogels synthesized 
with only GelMA and ELP (Figure 24b). This decrease in water uptake due to the incorporation 
of LA may be explained by interactions such as hydrogen bonding, and electrostatic interactions 
that served to reinforce the polymeric network[363]. Thus, the polymer network is held together 
tighter preventing fluid from entering the matrix. Taken together, these hydrophilic 
GelMA/ELP/LA nanocomposite hydrogels demonstrate ideal swelling behavior for use as a 
surgical adhesive. 
  
Figure 24. In vitro swelling behavior and degradation rates of hemostatic and highly elastic 
hydrogels for applications as lung tissue sealants. Swelling ratios of highly elastic hydrogels 
containing (a) 10% GelMA and varying concentrations of ELP, as well as (b) 10% GelMA/10% 
ELP and varying concentrations of LA. Results showed that the addition of ELP into the hydrogels 
led to less water uptake due to the presence of hydrophobic elastin motifs. Degradation rates of 
elastic hydrogels containing (c) 10% GelMA and varying concentrations of ELP, as well as (d) 
nanocomposite hydrogels containing 10% GelMA/10% ELP and varying concentrations of LA. 
Our results show that the addition of ELP significantly slowed down the degradation of the 
engineered hydrogels after 28 d. 
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Following the reconnecting or sealing of tissues using nanocomposite hydrogel in the 
clinical setting, the polymeric network should biodegrade into non-toxic byproducts, as it is no 
longer needed, to allow for the regrowth of new autologous tissue[364]. Thus, we aimed to 
characterize the in vitro degradation profile of these nanocomposite GelMA/ELP/LA hydrogels. 
Briefly, hydrogels were lyophilized, weighed, and incubated in DPBS at 37 °C for up to 28 d. At 
the end of given timepoints, the samples were rinsed, lyophilized, and re-weighed to determine the 
changes in dry mass after degradation. GelMA/ELP hydrogels were fabricated with a 10% (w/v) 
GelMA concentration and varying concentration of ELP. Our results demonstrated that in vitro 
degradation rates of the engineered hydrogels were significantly slower when fabricated with 
higher concentrations of ELP. For example, at day 28, scaffolds were 85.6 ± 7.75, 65.7 ± 5.48, 
51.8 ± 3.50, and 39.3 ± 3.30% degraded when hydrogels were fabricated with an ELP 
concentration of 0, 5, 10, and 20% (w/v) respectively (Figure 24c). These biopolymer-based 
hydrogels are expected to degrade hydrolytically - a process where water cleaves the bonds of 
functional groups[365]. Degradation via hydrolysis occurs relatively faster in highly hydrophilic 
proteins. By increasing the concentration of ELP, we postulate that the combination of 
hydrophobic groups along with higher concentrations of polymer in the hydrogel matrix resulted 
in the hinderance of enzymatic solution into the scaffold. This would explain the slower 
degradation rates of GelMA/ELP hydrogels compared to pure GelMA hydrogels. 
The enzymatic degradation profile of nanocomposite GelMA/ELP/LA hydrogels was then 
investigated by incubating samples in a 5.0 U/mL collagenase in DPBS at 37 °C. For in vitro 
enzymatic degradation, we chose to use collagenase for its known ability to degrade biopolymers 
in vivo[366]. Our results showed that in vitro hydrolytic degradation rates further decreased with 
an increasing LA concentration (Figure 24d). This decrease in degradation rates could be 
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attributed to stronger cohesion forces in the polymeric network as LA acts as an additional 
crosslinker forming hydrogen bonding and ionic interactions between biopolymers[367]. This 
increase in crosslinking sites may further prevent hydrolyzing medium from being absorbed by 
the scaffold. In addition, previous studies investigating nanocomposite hydrogels using silicate 
nanoparticles have reported similar degradation profiles for hydrogels with an increasing clay 
concentration[363, 368]. The decreased in degradation rate may further ensure that there is 
adequate time for tissue regeneration to occur as scaffold byproducts are removed. Taken together, 
these results suggest that GelMA/ELP/LA nanocomposite hydrogels are capable of controlled 
degradation and removal from the physiological environment following implantation. 
3.3.4. In vitro adhesive properties of nanocomposite GelMA/ELP/LA hydrogels 
There is a growing need for new concepts in surgical closure and treatment of tissue 
defects. Currently, wound closure is primarily achieved using sutures and staples, however, several 
drawbacks of these techniques, such as high infection rate, risk of blood-borne disease 
transmission, leakage of bodily fluid or air, and secondary tissue damage remains a challenge in 
the clinical setting[369, 370]. For these reasons, significant attention has been given toward the 
development of injectable protein-based adhesives and sealants that may replace the need for 
classical suturing techniques. Therefore, we used ASTM standard in vitro tests, including adhesion 
strength, shear strength, and wound closure to evaluate the adhesive properties of the 
nanocomposite GelMA/ELP/LA hydrogels.  
The adhesive strength of GelMA/ELP hydrogels was also evaluated using a standard 
ASTM F2458-05 wound closure test. Briefly, a small section of porcine skin was glued to two 
glass slides at each end. The porcine skin was then severed in the center and glued together using 
adhesive GelMA/ELP hydrogels (Figure 25a). The adhesive strength of the engineered hydrogels 
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was then determined by carefully placing the glass slides into an Instron mechanical tester used 
for tensile loading. Our results demonstrated tunable and robust adhesive properties to wet tissue. 
Further, it was demonstrated that the adhesive strength increased concomitantly with an increasing 
concentration of GelMA. For example, when the engineered hydrogels were fabricated with a fixed 
10% (w/v) ELP concentration, the adhesion strength of the engineered hydrogels exhibited 
adhesive strength of 9.1  ± 1.23, 12.3 ± 4.32, 27.2 ± 5.18, 42.8 ± 3.98, and 46.9 ± 3.29 kPa with a 
GelMA concentration of 5, 7.5, 10, 20, and 25% (w/v), respectively (Figure 25b). This is likely 
due to the many crosslinking sites present in the biopolymer which was able to form covalent 
bonds to the functional groups of soft tissue. In contrast, the addition of ELP did not elicit a 
significant change of the adhesive properties of the engineered hydrogels. Further, the adhesive 
strength of nanocomposite hydrogels fabricated with 10% GelMA, 10% ELP, and varying 
concentrations of LA was evaluated. Our results showed that there was no significant change in 
adhesive strength with the addition of LA up to 2% (w/v) (Figure 25c).  
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Figure 25. In vitro sealing properties of hemostatic hydrogel for application as a lung tissue 
sealant. (a) Schematic for the modified standard test method to determine adhesion strength 
(ASTM F2458-05) of GelMA/ELP/LA nanocomposite hydrogels. Adhesion strength for (b) 
elastic hydrogels containing varying concentrations of both GelMA and ELP, as well as for (c) 
nanocomposite hydrogels containing 10% GelMA/10% ELP and varying concentrations of LA. 
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(d) Schematic of a standard lap shear test (ASTM F2255-05) to determine the shear strength of 
GelMA/ELP/LA nanocomposite hydrogels. Shear stress of (e) elastic hydrogels containing 
varying concentrations of GelMA and ELP, as well as (f) nanocomposite hydrogels containing 
10% GelMA/10% ELP and varying concentrations of LA. (g) Schematic for the standard burst 
pressure test (ASTM F2392-04) to determine the burst pressure for GelMA/ELP/LA hydrogels. 
(h) Burst pressure for elastic hydrogels containing varying concentrations of both GelMA and ELP 
using collagen sheets as a substrate. (i) Burst pressure for nanocomposite hydrogels fabricated with 
10% GelMA/10% ELP and varying concentrations of LA. Error bars indicate standard error of the 
means, asterisks mark significance levels of p < 0.05 (*), and p < 0.01 (**). 
 
The shear strength of the GelMA/ELP hydrogels was also measured using the ASTM 
F2255-05 method where two gelatin-coated glass slides are attached together using the engineered 
hydrogels as an adhesive. The two glass slides are placed into an Instron and evaluated under 
tensile loading (Figure 25d). Our results showed that shear strength increased concomitantly with 
an increase in both GelMA and ELP concentrations. When the GelMA concentration was fixed at 
10% (w/v) the lap shear strength of the GelMA/ELP hydrogels increased from 106.0 ± 7.94, to 
178.4 ± 21.73 and 214.4 ± 27.27 kPa with increasing ELP concentrations of 0, 10, and 20% (w/v), 
respectively (Figure 25e). Further, when the ELP concentration was fixed at 10% (w/v), shear 
strength increased concomitantly with an increasing concentration of GelMA up to 20% (w/v). 
Additionally, the shear strength of nanocomposite GelMA/ELP/LA hydrogels was measured using 
10% GelMA, 10% ELP and a varying concentration of LA. The incorporation of LA up to 2% 
(w/v) into nanocomposite hydrogels did not result in significantly different shear strength (Figure 
25f). These results are consistent with other groups who have recently investigated the effect of 
silica nanoparticles on the adhesive properties to wet tissues[371, 372]. Further, LA has previously 
demonstrated poor adhesion to wet tissues when incorporated in synthetic polymer-based 
hydrogels[373]. Alternative strategies to develop nanocomposite hydrogels with strong adhesive 
strength to wet tissues include the combination of LA with dopamine, a catecholic moiety that has 
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shown to have strong intermolecular crosslinking ability[374-376]. Further, an understanding at 
the molecular level is required to improve LA-polymer interactions that vary widely depending on 
the polymer structure, molecular weight, temperature, and hydrophilicity, as well as the size and 
dispersion of the silica nanoparticles.  
Lastly, we evaluated in vitro adhesive properties using a standard ASTM F2392-04 burst 
pressure test. Briefly, a small circular defect was created in the center of moist collagen sheets, 
and the defect was covered with adhesive hydrogel prepolymer followed by photocrosslinking via 
exposure to UV radiation. The collagen sheets were then placed in a burst pressure testing chamber 
that slowly increased air pressure until failure of the hydrogel was observed (Figure 25g). Here, 
our results showed that the burst pressure of GelMA/ELP hydrogels increased concomitantly with 
an increasing concentration of GelMA. For example, when ELP concentrations were fixed at 10% 
(w/v), the engineered hydrogels exhibited a burst pressure of 4.3 ± 1.29, 11.0 ± 2.59, 19.0 ± 2.82, 
23.2 ± 3.18, and 28.2 ± 2.57 kPa with a GelMA concentration of 0, 5, 7.5, 10, 20, and 25% (w/v), 
respectively (Figure 25h). This is likely due to the formation of covalent bonds between 
methacrylate groups of GelMA and -NH2 functional groups present in the collagen sheets[294]. 
Further, evaluation of nanocomposite GelMA/ELP/LA hydrogels synthesized with 10% GelMA, 
10% ELP, and a varying concentration of LA showed an increase in burst pressure strength when 
LA was increased up to 2% (w/v) (Figure 25i). The addition of LA into the nanocomposite 
hydrogels demonstrated that there was improved cohesive and adhesive strength, which may be 
attributed to its strong binding affinity to various nucleophiles in the hydrogel network.  
These results together demonstrate the tunable adhesive properties of GelMA/ELP/LA 
nanocomposite hydrogels to various biological substrates. Further, these engineered 
nanocomposite hydrogels exhibited significantly superior adhesive properties than what has 
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recently been reported for several commercially available sealants, including Evicel™, Coseal™, 
and fibrin glue[288, 292, 377]. Our results demonstrated competitive results with biomaterial-
based hydrogel networks, such as those composed of methacrylated tropoelastin and GelMA[288], 
and enhanced with mussel-inspired catechol groups[368, 378, 379]. We propose that the strong 
adhesive properties of the nanocomposite hydrogels to wet tissues can be attributed to the covalent 
bonding of GelMA with the amine functional groups of wet tissue substrates created during 
photocrosslinking[380], hydrogel-tissue interlocking[381], and hydrogen bonding at the GelMA 
and biological interface[382]. These results strongly suggest that nanocomposite GelMA/ELP/LA 
hydrogels may be used as a surgical gel for the reconnection of tissues during surgery without the 
need for additional suturing or stapling. 
3.3.5. In vitro evaluation of LA on the clotting of whole blood 
The formation of blood clots or hemostasis is of critical importance to prevent major blood 
loss in the clinical setting to prevent hemorrhagic shock or death related to excessive blood loss.  
Although there is currently a wide variety of commercially available hemostatic products on the 
market, such as SurgiSeal, TISSEEL, and CoSeal, there have been concerns related to 
biocompatibility, hemostatic efficiency, and high cost[383]. Therefore, several approaches have 
been investigated to develop a biomaterial-based hemostatic surgical sealant that may be easy to 
apply, prevent infection, control bleeding, and is cost effective. Hydrogels composed of 
nanoparticles, including silica, TiO2 nanotubes, and carbon nanotubes, have gained significant 
attention due to their hemostatic properties. Further, silicate nanoparticles in particular have been 
reported to demonstrate excellent biocompatibility and degrade into no toxic byproducts[384, 
385]. Nanocomposite hydrogels fabricated with LA initiate hemostasis when in contact with whole 
blood by absorbing water thus increasing the concentration of clotting factors[333]. This is in 
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contrast to other systems that take advantage of mechanical sealing to promote hemostasis. 
Recently, silicate nanoparticles have demonstrated improvements in hemostatic performance when 
incorporated in nanocomposite hydrogels. Thus, we aimed to evaluate the hemostatic properties 
of our engineered nanocomposite GelMA/ELP/LA hydrogels as a function of time. Briefly, 
hydrogels fabricated with 10% GelMA, 10% ELP, and varying concentration of LA were  
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Figure 26. In vitro evaluation of LA on the clotting of whole blood. (a) Clot formation as a 
function of time and composition of hemostatic lung tissue sealants. (b) Quantitative clot time for 
whole blood added to nanocomposite hydrogels. (c) Quantitative clot mass measured at 14 mins 
following the addition of whole blood to hydrogels fabricated with 10% GelMA/10% ELP and 
varying concentrations of LA. Error bars indicate standard error of the means, asterisks mark 
significance levels of p < 0.01 (**), p < 0.001 (***), and p < 0.0001 (****).  
 
photocrosslinked at the bottom of a 48 well plate. Fresh whole blood from a human source was 
then added to the surface of the hydrogels. At selected time points, saline was added to well to halt 
blood clotting. Resulting blood clots were then dried and weighed to determine the hemostatic 
efficacy of the nanocomposite hydrogels. The representative images of wells at selected time 
points show that hemostasis was achieved at a significantly faster rate when whole blood was 
applied to hydrogels containing higher concentrations of LA (Figure 26a). For example, a visible 
clot was observed at 11.5 ± 1.25, 10.2 ± 1.07, and 6.5 ± 1.50 min when whole blood was added to 
the surface of hydrogels containing a LA concentration of 0, 1, and 2% (w/v), respectively (Figure 
26b). Additionally, it was shown that at a time point of 14 min, blood clots formed on the surface 
of nanocomposite hydrogels containing a higher concentration of LA exhibited a significantly 
higher weight (Figure 26c). These results suggest the addition of negatively charged LA played a 
critical role in denaturing fibrinogen and activating clot formation. The blood thrombogenic 
chemical cascade is a complex process resulting in clot formation[332]. Studies have shown that 
when negatively charged nanoparticles come in contact with whole blood, the intrinsic pathway of 
thrombogenesis is initiated, which triggers the formation of clotting factors, such as FXII, as well 
as thrombin[386]. Thrombin then converts plasma fibrinogen into fibrin monomers, which are able 
to polymerize into a fibrous mesh that results in a clot[387]. Therefore, the addition of LA into 
nanocomposite hydrogels may significantly decrease blood clotting times when exposed to whole 
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blood by initiating the formation of blood clotting factors. In addition, it has been shown that 
hydrophilic polymers coupled with charged nanoparticles show strong fluid uptake and thus may 
rapidly absorb the water when in contact with blood, resulting in the increase of clotting factor 
concentration in whole blood. It is clear that nanocomposite hydrogels formed with 10% 
GelMA/10% ELP demonstrated a significantly improved hemostatic performance when fabricated 
with a LA concentration of 2% (w/v). Therefore, these results suggest that this biocompatible 
nanocomposite hydrogel would be a good candidate to be used as a hemostatic agent to reduce 
bleeding during surgical procedures. 
3.3.6. In vitro evaluation of the cytocompatibility of nanocomposite GelMA/ELP/LA 
hydrogels 
To evaluate cytocompatibility of the nanocomposite GelMA/ELP/LA hydrogels, we 
evaluated the in vitro viability, spreading, and metabolic activity of human-derived lung fibroblast 
cells using surface seeding (2D cultures). Cell viability and spreading were evaluated using a 
commercial live/dead kit and Actin/DAPI staining, respectively. In addition, metabolic activity 
was assessed using PrestoBlue assays. Hydrogels fabricated with pure 20% GelMA, 10% 
GelMA/10% ELP, and 10% GelMA/10% ELP/2% LA (w/v) were evaluated for cytocompatibility. 
2D cell studies revealed that all three hydrogel variations showed excellent cell survival up to 7 
days post-seeding (Figure 27a-f) with >90% cell viability (Figure 27m). Furthermore, 
quantitative analysis of fluorescent images (Figure 27g-l) revealed that nanocomposite 
GelMA/ELP/LA hydrogels support cell proliferation with significantly higher number of cells 
throughout the duration of the experiment (Figure 27n). Lastly, the metabolic activity increased 
rapidly up to 4 days post-seeding as cells reached maturity (Figure 27o). Taken together, these 
results suggest that these nanocomposite GelMA/ELP/LA hydrogels demonstrate excellent 
biocompatibility and would be suitable to support tissue repair in vivo. 
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Figure 27. In vitro cytocompatibility evaluation of GelMA/ELP/LA hydrogels. Representative 
live/dead images of human lung fibroblast cells (hLFCs) seeded on the surface of (a) GelMA, (b) 
GelMA/ELP, and (c) GelMA/ELP/LA hydrogels after 1 day post-seeding. Representative 
live/dead images of hLFCs seeded on the surface of (d) GelMA, (e) GelMA/ELP, and (f) 
GelMA/ELP/LA after 5 days post-seeding. Representative phalloidin (green)/DAPI (blue) stained 
images from hLFCs seeded on (g) GelMA, (h) GelMA/ELP, and (i) GelMA/ELP/LA after 1 day 
post-seeding. Representative phalloidin/DAPI images of hLFCs seeded on (j) GelMA, (k) 
GelMA/ELP, and (l) GelMA/ELP/LA after 5 days post seeding. (m) Quantification of cell viability 
for hLFCs seeded on the surface of engineered hydrogels at days 1, 4, and 7 post-seeding. (n) 
Quantification of cell proliferation based on DAPI-stained cell nuclei at days 1, 4, and 7 post-
seeding. (o) Quantification of metabolic activity, relative fluorescence units (RFU), using a 
PrestoBlue assay at days 1, 4, and 7 post seeding. 
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3.3.7. In vivo biodegradation of nanocomposite GelMA/ELP/LA hydrogels using a 
rat subcutaneous implantation model 
We next aimed to investigate the in vivo biodegradation of our nanocomposite 
GelMA/ELP.LA hydrogels via a rat subcutaneous implantation model. Hydrogels fabricated with 
20% pure GelMA, 10% GelMA/10% ELP, and 10% GelMA/10% ELP/2% LA (w/v) were 
evaluated in this study. The scaffolds were implanted in subcutaneous pockets prepared along the 
dorsomedial skin of male Wistar rats. Harvesting of samples at time points 7, 28, and 56 days 
revealed that the implanted hydrogels maintained their shape over 56 days suggesting excessive 
biodegradation did not occur (Figure 28a). A slight decrease in the size of implanted hydrogels 
was observed, along with change in pigment, which suggests that tissue ingrowth occurred as 
biodegradation took place. The incorporation of LA into nanocomposites did not significantly 
affect biodegradation. Our results showed that while samples fabricated with GelMA/ELP 
degraded by, 60.2 ± 6.28%, nanocomposite GelMA/ELP/LA hydrogels degraded by 55.4 ± 7.81% 
after 56 days post implantation (Figure 28b). Further, hematoxylin and eosin staining of implanted 
hydrogels shows early stage tissue ingrowth into the samples suggesting biocompatibility and 
integration by the host (Figure 28c-g). These results suggest that nanocomposite GelMA/ELP/LA 
hydrogels do not elicit a cytotoxic response when implanted in vivo. Additionally, degraded 
byproducts of the engineered scaffold are slowly cleared and replaced by new tissue further 
suggesting that these biomaterials show promise to be further developed into surgical sealants for 
soft tissue repair. 
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Figure 28. In vivo biodegradation and biocompatibility of nanocomposite GelMA/ELP/LA 
hydrogels using a rat subcutaneous implantation model. (a) Representative images of GelMA, 
GelMA/ELP, and GelMA/ELP/LA hydrogels before implantation (day 0), and on days 7, 28, and 
56 post-implantation. (b) In vivo biodegradation of the engineered hydrogels on days 0, 7, 28, and 
56 post-implantation, based on weight loss of the implant (n=4). Hematoxylin and eosin (H&E) 
staining of 20 %(w/v) GelMA hydrogel sections (hydrogels with the surrounding tissue) after (c) 
7, (d) 28, and (e) 56 days of implantation (scale bar = 200 µm). H&E staining of GelMA/ELP 
10/10 %(w/v) hydrogel sections after (f) 7, (g), 28 and (h) 56 days implantation. H&E staining of 
GelMA/ELP/LA 10/10/2 %(w/v) hydrogel sections after (i) 7, (j), 28, and (k) 56 days post 
implantation. Hydrogels were formed using 0.5% Irgacure 2959 and 180 s UV exposure time. 
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3.3.8. In vivo evaluation of nanocomposite hydrogels as hemostats using a rat liver 
bleeding model 
In vivo hemostatic performance of our nanocomposite GelMA/ELP/LA hydrogels was 
investigated using a rat liver bleeding model via 1 cm incisions. The hemostatic treatment was 
immediately administered directly to the injury site and blood was collected using filter paper 
(Figure 29a). The mass of blood collected was recorded at time points of 1 and 10 minutes after 
creating the defect in liver tissue. Commercially available Surgicel (Figure 29b), nanocomposite 
GelMA/ELP/LA hydrogels (Figure 29c), and pure GelMA hydrogels were evaluated in this 
experiment. Our results showed that there was a significantly higher amount of blood collected at 
10 minutes compared to blood collected at 1 minute for pure GelMA hydrogel and Surgicel 
treatments suggesting that these materials failed to adequately promote blood coagulation (Figure 
29d). In contrast, bleeding discontinued within 1 minute for livers treated with nanocomposite 
GelMA/ELP/LA hydrogels. The incorporation of LA into nanocomposite hydrogels demonstrated 
remarkable hemostatic properties in vivo and show excellent potential to be utilized for vascular 
or soft tissue injuries to promote rapid blood clotting. 
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Figure 29. In vivo evaluation of nanocomposite hydrogels as hemostats using a rat liver 
bleeding model. (a) Schematic of engineered hydrogel placement onto a lethal liver wound. 
Representative images of (b) Surgicel hemostatic patch and (c) GelMA/ELP/LA nanocomposite 
hydrogels being used to accelerate blood clotting in a rat in vivo liver bleeding model. (d) 
Quantification of in vivo blood loss after application of GelMA/ELP/LA nanocomposite hydrogels 
shows significant improvement compared to treatment with GelMA hydrogels or Surgicel 
hemostatic patch. Error bars indicate standard error of the means, asterisks mark significance levels 
of p < 0.0001 (****). 
 
 
4. CONCLUSION 
We introduced a new method to generate electroconductive polymer-based biomaterials 
through the conjugation of a choline-based Bio-IL to different polymers. We demonstrated that 
the mechanical properties, porosity, degradability, and swellability of the engineered hydrogels 
could be finely tuned by varying the final polymer concentration, as well as the ratio of polymer 
to Bio-IL. We also investigated the ability of Bio-IL conjugated hydrogels to transduce 
physicochemical stimuli and modulate the growth of primary CMs in both 2D and 3D cultures in 
vitro. We demonstrated that the engineered hydrogels are highly biodegradable and biocompatible 
in vitro, and that they do not elicit inflammatory responses when implanted in vivo. Taken together, 
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our results suggest that Bio-IL conjugated hydrogels could be implemented and readily tailored to 
different biomedical and tissue engineering applications. Further, we demonstrated the ability to 
engineer cardiopatches with conductivity and mechanical properties that are finely tunable by 
optimizing the concentration of GelMA and Bio-IL. GelMA/Bio-IL cardiopatches demonstrated 
excellent adhesiveness to cardiac tissues, and biocompatibility in vitro. CMs and CFs seeded on 
the surface of cardiac patches demonstrated excellent cell attachment and proliferation, and the 
scaffold supported the expression of gap junction proteins indicating the cells ability to function 
synchronously. Furthermore, histological assessment was indicative of comparatively lower 
thinning of the ventricular wall 3 weeks after induction of experimental MI. However, further 
experiments focusing on the evaluation of cardiac function following MI are needed to elucidate 
the cardioprotective efficacy of this strategy. In addition, the long-term effects of the epicardial 
application of the cardiopatches and the potential development of co-morbidities such as 
constrictive pericarditis, arrhythmias and other systemic syndromes should also be evaluated. 
GelMA/Bio-IL cardiopatches hold great potential to be used as scaffolds to provide mechanical 
stabilization to the injured myocardium and to restore electromechanical coupling at the site of 
MI. In addition, our group developed a rapidly photocrosslinkable hemostatic surgical sealant with 
robust mechanical properties based on the biopolymers GelMA and elastin-like polypeptide (ELP). 
Our nanocomposite hydrogels were made hemostatic by the incorporation of LA. We 
demonstrated the finely tunable mechanical and adhesive properties of these nanocomposite 
hydrogels by varying the concentrations of GelMA and ELP. We also investigated how varying 
the concentrations of GelMA, ELP, and LA affect the swellability and degradation of the 
nanocomposite hydrogels. The excellent hemostatic performance of these scaffolds were displayed 
both in vitro and in vivo by increasing the concentration of LA. Our nanocomposite 
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GelMA/ELP/LA hydrogels also showed remarkable biocompatibility both in vitro and in vivo and 
did not elicit an inflammatory response when implanted subcutaneously. Taken together, these 
nanocomposite GelMA/ELP/LA hydrogels demonstrate remarkable potential to be used as 
surgical sealants for soft tissue. 
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